10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark one)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2012

OR

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from  to

Commission file number 1-434

THE PROCTER & GAMBLE COMPANY

(Exact name of registrant as specified in its charter)

Ohio	31-0411980
(State of Incorporation)	(I.R.S. Employer Identification Number)

One Procter & Gamble Plaza, Cincinnati, Ohio	45202
(Address of principal executive offices)	(Zip Code)

(513) 983-1100

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes þ     No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     Yes þ     No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer (as defined in Rule 12b-2 of the Exchange Act).

Large accelerated filer þ                    Accelerated filer  o                   Non-accelerated filer  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes o     No þ

There were 2,740,105,964 shares of Common Stock outstanding as of March 31, 2012.

PART I. FINANCIAL INFORMATION 

Item I.     Financial Statements.

The Consolidated Statements of Earnings of The Procter & Gamble Company and subsidiaries (the “Company”, "Procter & Gamble", “we” or “our”) for the three months and nine months ended March 31, 2012 and 2011, the Consolidated Balance Sheets as of March 31, 2012 and June 30, 2011, and the Consolidated Statements of Cash Flows for the nine months ended March 31, 2012 and 2011 follow. In the opinion of management, these unaudited Consolidated Financial Statements contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, such financial statements may not necessarily be indicative of annual results.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF EARNINGS

	Three Months Ended March 31				Nine Months Ended March 31
Amounts in millions except per share amounts	2012		2011		2012		2011
Net Sales	$	20,194	$	19,893	$	63,468	$	60,653
Cost of products sold	10,237		9,789		31,894		29,327
Selling, general and administrative expense	6,636		6,399		19,769		19,010
Goodwill and indefinite lived intangibles impairment charges	22		—		1,576		—
Operating Income	3,299		3,705		10,229		12,316
Interest expense	179		202		587		619
Other non-operating income/(expense), net	67		104		238		171
Earnings From Continuing Operations Before Income Taxes	3,187		3,607		9,880		11,868
Income taxes on continuing operations	754		748		2,776		2,638
Net Earnings from Continuing Operations	2,433		2,859		7,104		9,230
Net Earnings from Discontinued Operations	34		47		133		158
Net Earnings	2,467		2,906		7,237		9,388
Less: Net earnings attributable to noncontrolling interests	56		33		112		101
Net Earnings Attributable to Procter & Gamble	$	2,411	$	2,873	$	7,125	$	9,287
Basic Net Earnings per Common Share (1)
Earnings from continuing operations	$	0.84	$	0.99	$	2.47	$	3.18
Earnings from discontinued operations	0.01		0.02		0.05		0.06
Basic Net Earnings per Common Share	0.85		1.01		2.52		3.24
Diluted Net Earnings per Common Share (1)
Earnings from continuing operations	0.81		0.94		2.37		3.04
Earnings from discontinued operations	0.01		0.02		0.05		0.05
Diluted Net Earnings per Common Share	0.82		0.96		2.42		3.09
Dividends	$	0.5250	$	0.4818	$	1.5750	$	1.4454
Diluted Weighted Average Common Shares Outstanding	2,937.8		2,999.3		2,944.9		3,008.6

(1)Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble

See accompanying Notes to Consolidated Financial Statements

2

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

Amounts in millions			March 31, 2012			June 30, 2011
ASSETS
CURRENT ASSETS
Cash and cash equivalents			$	3,991		$	2,768
Accounts receivable			6,200			6,275
Inventories
Materials and supplies			1,866			2,153
Work in process			728			717
Finished goods			4,645			4,509
Total inventories			7,239			7,379
Deferred income taxes			1,219			1,140
Prepaid expenses and other current assets			3,817			4,408
Assets held for sale, net			642			—
TOTAL CURRENT ASSETS			23,108			21,970
PROPERTY, PLANT AND EQUIPMENT
Buildings			7,503			7,753
Machinery and equipment			32,154			32,820
Land			897			934
Total property, plant and equipment			40,554			41,507
Accumulated depreciation			(20,170		)	(20,214		)
NET PROPERTY, PLANT AND EQUIPMENT			20,384			21,293
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill			54,833			57,562
Trademarks and other intangible assets, net			31,429			32,620
NET GOODWILL AND OTHER INTANGIBLE ASSETS			86,262			90,182
OTHER NONCURRENT ASSETS			4,851			4,909
TOTAL ASSETS			$	134,605		$	138,354
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable			$	6,684		$	8,022
Accrued and other liabilities			8,449			9,290
Debt due within one year			11,771			9,981
TOTAL CURRENT LIABILITIES			26,904			27,293
LONG-TERM DEBT			21,341			22,033
DEFERRED INCOME TAXES			11,297			11,070
OTHER NONCURRENT LIABILITIES			9,154			9,957
TOTAL LIABILITIES			68,696			70,353
SHAREHOLDERS’ EQUITY
Preferred stock			1,202			1,234
Common stock – shares issued –	31-Mar	4,008.4	4,008
	30-Jun	4,007.9				4,008
Additional paid-in capital			63,068			62,405
Reserve for ESOP debt retirement			(1,356		)	(1,357		)
Accumulated other comprehensive income (loss)			(5,063		)	(2,054		)
Treasury stock			(69,918		)	(67,278		)
Retained earnings			73,324			70,682
Noncontrolling interest			644			361
TOTAL SHAREHOLDERS’ EQUITY			65,909			68,001
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY			$	134,605		$	138,354

See accompanying Notes to Consolidated Financial Statements

3

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

	Nine Months Ended March 31
Amounts in millions	2012			2011
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	$	2,768		$	2,879
OPERATING ACTIVITIES
Net earnings	7,237			9,388
Depreciation and amortization	2,427			2,103
Share-based compensation expense	277			295
Deferred income taxes	(5		)	186
(Gain)/loss on sale of businesses	(201		)	(70		)
Goodwill and indefinite lived intangibles impairment charges	1,576			—
Changes in:
Accounts receivable	(347		)	(495		)
Inventories	(287		)	(817		)
Accounts payable, accrued and other liabilities	(1,558		)	(223		)
Other operating assets and liabilities	131			(831		)
Other	61			(84		)
TOTAL OPERATING ACTIVITIES	9,311			9,452
INVESTING ACTIVITIES
Capital expenditures	(2,663		)	(2,066		)
Proceeds from asset sales	290			89
Acquisitions, net of cash acquired	(4		)	(489		)
Change in investments	90			97
TOTAL INVESTING ACTIVITIES	(2,287		)	(2,369		)
FINANCING ACTIVITIES
Dividends to shareholders	(4,521		)	(4,237		)
Change in short-term debt	(122		)	(420		)
Additions to long-term debt	3,985			1,536
Reductions of long-term debt	(2,514		)	(188		)
Treasury stock purchases	(4,023		)	(4,536		)
Impact of stock options and other	1,439			691
TOTAL FINANCING ACTIVITIES	(5,756		)	(7,154		)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(45		)	138
CHANGE IN CASH AND CASH EQUIVALENTS	1,223			67
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	3,991		$	2,946

See accompanying Notes to Consolidated Financial Statements

4

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1. These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated by the Company’s Form 8-K filed on February 10, 2012. The results of operations for the three-month and nine-month periods ended March 31, 2012, are not necessarily indicative of annual results.

2. New Accounting Pronouncements and Policies- Beginning with the quarter ended December 31, 2011, we elected to revise our Consolidated Statements of Earnings to present separately the net expense for earnings attributable to noncontrolling interests. This change was applied retrospectively. The amount reclassified to net earnings attributable to noncontrolling interests for the nine months ended March 31, 2011, totaling $101 million, had an offsetting impact on other non-operating income/(expense) within the Consolidated Statement of Earnings and on "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. In connection with this change, we also made a change to prior year Consolidated Statement of Cash Flow amounts to appropriately classify dividends paid to noncontrolling interests. Such dividends had historically been included in "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. These dividend payments ($67 million for the nine months ended March 31, 2011) were reclassified to "impact of stock options and other" within Financing Activities of the Consolidated Statement of Cash Flows.

No new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the Consolidated Financial Statements.

3. Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended March 31, 2012 and 2011 was $3,778 millionand $4,767 million, respectively. For the nine months ended March 31, 2012 and 2011, total comprehensive income was $4,228 millionand $13,715 million, respectively.

4. Segment Information - Effective during the quarter ended December 31, 2011, we implemented a number of changes to the organization structure of the Beauty and Grooming GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Beauty reportable segment and are now included in the Grooming reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Grooming reportable segment to the Beauty reportable segment. These changes have been reflected in our segment reporting for all periods presented.

In February 2012, we announced an agreement to divest the Snacks business to The Kellogg Company subject to necessary regulatory approvals. As a result of this transaction the Snacks business is reported as discontinued operations effective with the quarter ended March 31, 2012. Therefore Snacks sales and earnings are no longer included in the results of the continuing operations of the Company. The transaction is expected to close by the end of the current fiscal year. Additionally, as a result of this change, the Pet Care business is now included in the Fabric Care and Home Care segment. These changes have been reflected in our consolidated and segment reporting for all periods presented.

Following is a summary of segment results.

5

		Three Months Ended March 31									Nine Months Ended March 31
Amounts in millions		Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations			Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations
Beauty	2012	$	4,844		$	710		$	523		$	15,512		$	2,652		$	2,008
	2011	4,814			704			510			14,955			2,836			2,161
Grooming	2012	1,962			530			398			6,332			1,861			1,401
	2011	1,963			580			416			6,103			1,831			1,370
Health Care	2012	3,018			638			411			9,492			2,222			1,490
	2011	2,962			658			427			9,084			2,178			1,453
Fabric Care and Home Care	2012	6,595			1,161			716			20,703			3,643			2,280
	2011	6,548			1,250			789			19,951			3,906			2,533
Baby Care and Family Care	2012	4,153			903			573			12,394			2,511			1,583
	2011	3,968			832			528			11,550			2,383			1,500
Corporate	2012	(378		)	(755		)	(188		)	(965		)	(3,009		)	(1,658		)
	2011	(362		)	(417		)	189			(990		)	(1,266		)	213
Total	2012	20,194			3,187			2,433			63,468			9,880			7,104
	2011	19,893			3,607			2,859			60,653			11,868			9,230

5. Goodwill and Other Intangible Assets - Goodwill as of March 31, 2012, is allocated by reportable segment as follows (amounts in millions):

	Beauty			Grooming			Health Care			Fabric Care and Home Care			Baby Care and Family Care			Corporate			Total Company
GOODWILL at June 30, 2011	$	18,039		$	22,650		$	8,179		$	6,735		$	1,553		$	406		$	57,562
Acquisitions and divestitures	(2		)	(10		)	415			34			—			—			437
Goodwill impairment charges	(431		)	(899		)	—			—			—			—			(1,330		)
Reclassification to held for sale	—			—			—			—			—			(95		)	(95		)
Translation and other	(716		)	(643		)	(194		)	(128		)	(58		)	(2		)	(1,741		)
GOODWILL at March 31, 2012	$	16,890		$	21,098		$	8,400		$	6,641		$	1,495		$	309		$	54,833

On February 15, 2012, the Company announced an agreement for the sale of the global Snacks business, with an expected closing by the end of the current fiscal year subject to necessary regulatory approvals. As a result, the Snacks goodwill was moved to the Corporate Segment and is included in assets held for sale, net, in accordance with the required held for sale treatment. The Pet Care goodwill was moved to the Fabric Care and Home Care segment for all periods presented.

During the second quarter of fiscal 2012, we changed our annual goodwill impairment testing date from July 1 to October 1 of each year. This change was made to better align the timing of our annual impairment testing with the timing of the Company's annual strategic planning process. We believe this change is preferable because it allows us to more efficiently utilize the reporting units' long-term financial projections, which are generated from the annual strategic planning process, as the basis for performing our annual impairment testing. This change did not result in any delay, acceleration or avoidance of impairment, nor did this change result in adjustments to previously issued financial statements. This change was applied prospectively beginning on October 1, 2011; retrospective application to prior periods was impracticable as the Company was unable to objectively determine, without the use of hindsight, the assumptions that would have been used in those earlier periods. We also test our indefinite lived intangibles for impairment during the second fiscal quarter of each year, and accordingly performed this testing during the quarter ended December 31, 2011.

We tested goodwill for impairment as of July 1, 2011 (the testing date under our previous policy) and no impairments were indicated. Our goodwill impairment testing as of October 1, 2011 (the testing date under our new policy) determined that certain goodwill amounts were impaired. Specifically, the results of our impairment testing during the quarter ended December 31, 2011, indicated that the estimated fair values of our Appliances and Salon Professional reporting units were less than their respective carrying amounts. The test to evaluate goodwill for impairment is a two step process. In the first step, we compare the fair value of each reporting unit to its carrying value. If the fair value of any reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the

6

impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment. The second step of the goodwill impairment evaluations were finalized during the quarter ended March 31, 2012 resulting in no material adjustments to the impairments recorded in the prior quarter. As a result of our impairment testing, we recorded an estimated non cash before and after tax impairment charge of $1,330 million to reduce the carrying amount of goodwill for these units to an estimated fair value of $899 million related to Appliances and $431 million related to Salon Professional. Following the impairment charges, the carrying values of the Appliances and Salon Professional goodwill were $614 million and $422 million, respectively.

Our impairment testing for indefinite lived intangible assets during the quarter ended December 31, 2011, also indicated a decline in the fair value of our Koleston Perfect and Wella trade name intangible assets below their respective carrying values. This resulted in a non cash before tax impairment charge of $246 million ($173 million after tax) to reduce the carrying amounts of these assets to their respective fair values. Following the impairment charges, the carrying values of the Koleston Perfect and Wella trade names were $308 million and $605 million, respectively. All of the impairment charges are included in Corporate for segment reporting.

To determine the fair value of our reporting units and indefinite lived intangibles, we use a discounted cash flow (DCF) approach, which we believe is the most reliable indicator of fair value of the business, and is most consistent with the approach a market-place participant would use. Under this approach, we estimate the future cash flows of the respective reporting units and indefinite lived intangible assets and discount those cash flows at a rate of return that reflects the relative risk of each business.

The declines in the fair value of the Appliances and Salon Professional reporting units and the underlying Koleston Perfect and Wella trade name intangibles were driven by a combination of similar competitive and economic factors, which are resulting in a reduction in the forecasted growth rates and cash flows used to estimate fair value. These factors include: (1) a more prolonged and deeper deterioration of the macroeconomic environment than was previously expected which, due to the more discretionary nature of the Appliances and Salon Professional businesses, is leading to a reduction in the overall market size in the short term and a more significant and prolonged reduction in the expected underlying market growth rates and resulting sales levels in the longer term. This is particularly evident in Europe, which is where we have historically generated a majority of the Appliances and Salon Professional sales; (2) increasing competitive levels of innovation in Salon Professional negatively impacting our current and nearer-term projected market share progress; and (3) an increasing level of competitive pricing activities negatively impacting pricing levels and lowering overall category profitability. As a result of these factors, we have recently reduced our current and longer-term sales and earnings forecasts for these businesses.

The goodwill and intangible asset valuations are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion, and Company business plans. We believe these estimates and assumptions are reasonable. However, actual events and results could differ substantially from those used in our valuation. To the extent such factors result in a failure to achieve the level of projected cash flows used in our valuations, we may need to record additional non cash impairment charges in the future.

Goodwill also decreased from June 30, 2011, due to currency translation across reportable segments and the divestiture of PUR, the water filtration brand, in our Health Care reportable segment. These decreases were partially offset by the establishment of goodwill related to the business combinations with Teva Pharmaceuticals Industries in our Health Care reportable segment and Powermat Ltd. in our Fabric Care and Home Care segment.

Identifiable intangible assets as of March 31, 2012, are comprised of (amounts in millions):

	Gross Carrying Amount		Accumulated Amortization
Amortizable intangible assets with determinable lives	$	8,880	$	4,497
Intangible assets with indefinite lives	27,046		—
Total identifiable intangible assets	$	35,926	$	4,497

Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist primarily of brands.

The amortization of intangible assets for the three months ended March 31, 2012 and 2011 was $122 million and $128 million, respectively. For the nine months ended March 31, 2012 and 2011, the amortization of intangible assets was $373 million and $399 million, respectively.

7

6. Share-Based Compensation - Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards.

Total share-based compensation for the three months and nine months ended March 31, 2012 and 2011 are summarized in the following table (amounts in millions):

	Three Months Ended March 31				Nine Months Ended March 31
	2012		2011		2012		2011
Share-Based Compensation
Stock options	$	86	$	101	$	224	$	254
Other share-based awards	23		14		53		41
Total share-based compensation	$	109	$	115	$	277	$	295

Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience.

7. Postretirement Benefits - The Company offers various postretirement benefits to its employees.

The components of net periodic benefit cost for defined benefit plans are as follows:

	Pension Benefits						Other Retiree Benefits
	Three Months Ended March 31						Three Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	62		$	65		$	35		$	40
Interest cost	149			146			69			72
Expected return on plan assets	(140		)	(123		)	(109		)	(108		)
Amortization of deferred amounts	6			4			(5		)	(3		)
Recognized net actuarial loss	25			39			25			25
Gross benefit cost (credit)	102			131			15			26
Dividends on ESOP preferred stock	—			—			(19		)	(20		)
Net periodic benefit cost (credit)	$	102		$	131		$	(4	)	$	6

	Pension Benefits						Other Retiree Benefits
	Nine Months Ended March 31						Nine Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	192		$	191		$	106		$	110
Interest cost	458			430			207			203
Expected return on plan assets	(428		)	(364		)	(325		)	(323		)
Amortization of deferred amounts	17			13			(15		)	(13		)
Recognized net actuarial loss	77			114			74			72
Gross benefit cost (credit)	316			384			47			49
Dividends on ESOP preferred stock	—			—			(56		)	(59		)
Net periodic benefit cost (credit)	$	316		$	384		$	(9	)	$	(10	)

For the year ending June 30, 2012, the expected return on plan assets is 7.4% and 9.2% for defined benefit and other retiree benefit plans, respectively.

8. Risk Management Activities and Fair Value Measurements- As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices.

For details on the Company’s risk management activities and fair value measurement policies under the fair value hierarchy,

8

refer to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated by the Company’s Form 8-K filed on February 10, 2012.

Fair Value Hierarchy

The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period.

The following table sets forth the Company’s financial assets and liabilities as of March 31, 2012 and June 30, 2011 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy:

	Level 1				Level 2				Level 3				Total
Amounts in millions	March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011
Assets recorded at fair value:
Investment securities	$	11	$	16	$	—	$	—	$	22	$	23	$	33	$	39
Derivatives relating to:
Foreign currency hedges	—		—		11		1		—		—		11		1
Other foreign currency instruments (1)	—		—		85		182		—		—		85		182
Interest rates	—		—		286		163		—		—		286		163
Net investment hedges	—		—		68		—		—		—		68		—
Commodities	—		—		10		4		—		—		10		4
Total assets recorded at fair value (2)	11		16		460		350		22		23		493		389
Liabilities recorded at fair value:
Derivatives relating to:
Foreign currency hedges	—		—		116		119		—		—		116		119
Other foreign currency instruments (1)	—		—		38		43		—		—		38		43
Interest rates	—		—		30		—		—		—		30		—
Net investment hedges	—		—		36		138		—		—		36		138
Commodities	—		—		8		1		—		—		8		1
Liabilities recorded at fair value (3)	—		—		228		301		—		—		228		301
Liabilities not recorded at fair value:
Long-term debt instruments (4)	22,658		22,423		1,086		995		—		—		23,744		23,418
Total liabilities recorded and not recorded at fair value	22,658		22,423		1,314		1,296		—		—		23,972		23,719

(1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.

(2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets.

(3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.

(4) Long-term debt instruments are not recorded at fair value on a recurring basis however are measured at fair value for disclosure purposes.

The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. In addition, there was no significant activity within the Level 3 assets and liabilities during the periods presented.

Assets and Liabilities Re-measured at Fair Value on a Non-recurring Basis

The Company re-measured operating real estate assets that qualified as held for sale during the quarter at fair value of $8 million using comparable prices for similar assets, incurring a $220 million loss. There were no additional assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented, except for the goodwill and intangible assets discussed in Note 5.

9

Certain of the Company’s financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Company’s credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of March 31, 2012 was $81 million. The Company has never been required to post any collateral as a result of these contractual features.

Fair Values of Other Financial Instruments

Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value.

Disclosures about Derivative Instruments

The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2012 and June 30, 2011 are as follows:

	Notional Amount				Fair Value Asset (Liability)
Amounts in Millions	March 31, 2012		June 30, 2011		March 31, 2012			June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	—	$	—	$	—		$	—
Foreign currency contracts	831		831		(105		)	(118		)
Commodity contracts	9		16		—			4
Total	840		847		(105		)	(114		)
Derivatives in Fair Value Hedging Relationships
Interest rate contracts	10,971		10,308		256			163
Derivatives in Net Investment Hedging Relationships
Net investment hedges	1,758		1,540		32			(138		)
Derivatives Not Designated as Hedging Instruments
Foreign currency contracts	11,059		14,957		47			139
Commodity contracts	157		39		2			(1		)
Total	11,216		14,996		49			138

The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Company’s derivative activity during the period.

	Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion)
Amounts in Millions	March 31, 2012		June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	12	$	15
Foreign currency contracts	25		32
Commodity contracts	—		3
Total	37		50
Derivatives in Net Investment Hedging Relationships
Net investment hedges	17		(88		)

The effective portion of gains and losses on derivative instruments that was recognized in other comprehensive income (OCI) during the three and nine months ended March 31, 2012 and 2011, was not material. During the next 12 months, the amount of the March 31, 2012 accumulated OCI balance that will be reclassified to earnings is expected to be immaterial.

The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2012 and 2011 are as follows:

10

	Amount of Gain (Loss) Reclassified from Accumulated OCI into  Income (1)
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	2		$	1		$	5		$	5
Foreign currency contracts	60			17			33			(51		)
Commodity contracts	2			1			3			19
Total	64			19			41			(27		)
	Amount of Gain (Loss) Recognized in Income
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Fair Value Hedging Relationships(2)
Interest rate contracts	(19		)	(90		)	93			(115		)
Debt	17			92			(97		)	118
Total	(2		)	2			(4		)	3
Derivatives in Net Investment Hedging Relationships (2)
Net investment hedges	9			2			1			1
Derivatives Not Designated as Hedging Instruments (3)
Foreign currency contracts (4)	168			438			(823		)	1,064
Commodity contracts	2			—			1			4
Total	170			438			(822		)	1,068

(1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.

(2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.

(3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.

(4) The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure.

9. Restructuring Program

In February 2012, the Company announced a productivity and cost savings plan to reduce costs in the areas of supply chain, research & development, marketing and overheads. The program was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes in order to help fund the Company's growth strategy. The Company expects to incur approximately $3.5 billion in before-tax restructuring costs over a four year period as part of this plan. The Company expects to incur more than half of the costs under this plan by the end of fiscal 2013, with the remainder incurred in fiscal years 2014 and 2015.

The restructuring activities will be executed across the Company's centralized organization as well as the MDO and GBU organizations. These restructuring activities include a plan for a net reduction in non-manufacturing overhead personnel of 10%, or 5,700 separations, by the end of fiscal 2013. This will be done via the elimination of duplicate work, simplification through the use of technology, and the optimization of functional organizations, and business units. In addition, the plan includes integration of newly acquired companies, optimization of the supply chain and other manufacturing processes.

The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. These ongoing activities are included in the $3.5 billion total

11

plan cost and in the productivity and cost savings plan information provided below. Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the nine months ended March 31, 2012, the Company incurred charges of $686 million for this plan. Approximately $521 million of these charges were recorded in selling, general and administrative expense with the remainder in cost of products sold.

The following table presents accrued restructuring activity for the nine months ended March 31, 2012:

							For the Nine Months Ended March 31, 2012
Amounts in millions	Accrual Balance June 30, 2011		Charges Previously Reported (Six Months ended December 31, 2011)		Charges for the Three Months ended March 31, 2012		Cash Spent		Charges Against Assets		Reserve Balance March 31, 2012
Separations	$	121	$	57	$	213	$	133	$	—	$	258
Asset-Related Costs	—		48		265		—		313		—
Other Costs	30		63		40		106		—		27
Total	151		168		518		239		313		285

Separation Costs

Employee separation charges for the three months and nine months ended March 31, 2012 relate to severance packages for approximately 1,700 and 2,500 employees, respectively. Separations related to non-manufacturing overhead personnel were approximately 1,200 and 1,600 for the three and nine months ended March 31, 2012, respectively; these separations occurred primarily in North America and Western Europe. The packages are predominantly voluntary and the amounts are calculated based on salary levels and past service. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer.

Asset-Related Costs

Asset-related costs consist of both asset write downs and accelerated depreciation. Asset write downs relate to the establishment of a new fair value basis for assets held for sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These shortened-lived assets consist primarily of manufacturing consolidations and technology standardization. The asset-related charges will not have a significant impact on future depreciation charges. The majority of asset-related costs for the nine months ended March 31, 2012, are related to the decision to relocate operations from the Company's offices in Kobe, Japan.

Other Costs

Other restructuring-type charges are incurred as a direct result of the productivity and cost savings plan. Such charges primarily include employee relocation related to separations and office consolidations, termination of contracts related to supply chain redesign, and the cost to change internal systems and processes to support the underlying organizational changes.

Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for segment reporting. Accordingly, 100% of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments.

Amounts in millions	Three Months Ended March 31, 2012		Nine Months Ended March 31, 2012
Beauty	$	36	$	56
Grooming	9		11
Health Care	11		13
Fabric & Home Care	79		98
Baby Care and Family Care	22		38
Corporate (1)	361		470
Total Company	518		686

(1) Corporate includes costs related to allocated overheads, including charges related to our MDO, GBS and Corporate

12

Functions activities.

10.Commitments and Contingencies

Litigation

The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark matters, advertising, contracts, environmental issues, labor and employment matters and income taxes.

As previously disclosed, the Company has had a number of antitrust matters in Europe. These matters involve a number of other consumer products companies and/or retail customers. The Company’s policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines.

In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken.

Several regulatory authorities in Europe have issued separate decisions pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The Company has accrued the assessed fines for each of the decisions, of which all but $16 million has been paid as of March 31, 2012. Most of those decisions are on appeal. As a result of our initial and on-going analyses of other formal complaints, the Company has accrued liabilities for competition law violations totaling $19 million as of March 31, 2012. While the ultimate resolution of the matters for which we have accrued liabilities may result in fines or costs in excess of the amounts reserved, we do not expect any such incremental losses to materially impact our financial statements in the period in which they are accrued and paid, respectively. The remaining authorities' investigations are in various stages of the regulatory process. For these other remaining competition law matters, we cannot reasonably estimate any additional fines to which the Company may be subject as a result of the investigations. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate.

With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.

We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows.

Income Tax Uncertainties

The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50 – 60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2002 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions will significantly increase or decrease within the next 12 months related to audits described above. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.

Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as

13

updated by the Company’s Form 8-K filed on February 10, 2012.

11.Discontinued Operations

In February 2012, the Company announced an agreement to sell its global snacks business to The Kellogg Company for $2.7 billion in an all-cash transaction. The Company expects to complete the transaction by the end of the current fiscal year with final timing pending the receipt of necessary regulatory approvals.

The snacks business had historically been part of the Company’s Snacks & Pet Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the snacks business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Additionally, the balance sheet positions as of March 31, 2012, that are anticipated to transition to The Kellogg Company are presented as held for sale in the Consolidated Balance Sheet.

Following is selected financial information included in net earnings from discontinued operations for the snacks business:

	Three months ended September 30				Three months ended December 31				Three months ended March 31				Nine months ended March 31
Amounts in millions	2011		2010		2011		2010		2012		2011		2012		2011
Net sales	$	387	$	338	$	391	$	371	$	350	$	337	$	1,128	$	1,046
Earnings from discontinued operations before income taxes	84		77		59		73		56		67		199		217
Income tax expense	26		22		18		17		22		20		66		59
Net earnings from discontinued operations	58		55		41		56		34		47		133		158

At March 31, 2012, the major components of assets and liabilities of the snacks business held for sale were as follows:

Amounts in millions	March 31, 2012
Accounts receivable	$	119
Inventories	122
Prepaid expenses and other assets	7
Property, plant and equipment, net	354
Goodwill	95
Total assets held for sale	697
Accrued and other liabilities	55
Total liabilities held for sale	55
Assets held for sale, net	642

14

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” and “Risk Factors.” These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements. A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from such forward-looking statements is included in this section titled "Economic Conditions, Challenges and Risks" and the section titled “Risk Factors” (Part II, Item 1A of this Form 10-Q). We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events, or otherwise.

The purpose of this discussion is to provide an understanding of Procter & Gamble’s financial results and condition by focusing on changes in certain key measures from year to year. Management’s Discussion and Analysis (MD&A) is organized in the following sections:

• Overview

• Summary of Results

• Economic Conditions, Challenges and Risks

• Results of Operations – Three Months Ended March 31, 2012

• Results of Operations – Nine Months Ended March 31, 2012

• Business Segment Discussion – Three and Nine Months Ended March 31, 2012

• Financial Condition

• Reconciliation of Non-GAAP Measures

Throughout MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, free cash flow and free cash flow productivity. Organic sales growth is net sales growth excluding the impacts of foreign exchange, acquisitions and divestitures. Free cash flow is operating cash flow less capital spending. Free cash flow productivity is the ratio of free cash flow to net earnings. We believe these measures provide investors with important information that is useful in understanding our business results and trends. The explanation at the end of MD&A provides more details on the use and the derivation of these measures.

Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in MD&A are based on a combination of vendor-reported consumption and market size data, as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category.

OVERVIEW

The purpose of our business is to provide branded consumer packaged goods of superior quality and value to our consumers around the world. This will enable us to execute our Purpose-inspired growth strategy: to touch and improve more consumers' lives, in more parts of the world, more completely. We believe this will result in leadership sales, earnings and value creation, allowing employees, shareholders and the communities in which we operate to prosper.

Our products are sold in more than 180 countries primarily through mass merchandisers, grocery stores, membership club stores, drug stores and high-frequency stores, which are the neighborhood stores which serve many consumers in developing markets. We continue to expand our presence in other channels, including department stores, perfumeries, pharmacies, salons and e-commerce. We have on-the-ground operations in approximately 80 countries.

Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry

15

segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate-often holding a leadership or significant market share position.

Effective during the quarter ended December 31, 2011 and as reflected in the Company's Form 8-K filed on February 10, 2012, we implemented a number of changes to the organization structure of the Beauty GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Beauty reportable segment and are now included in the Grooming reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Grooming reportable segment to the Beauty reportable segment. These changes have been reflected in our segment reporting for all periods presented.

In February 2012 we announced an agreement to divest the Snacks business to The Kellogg Company subject to necessary regulatory approvals. As a result of this transaction the Snacks business is reported as discontinued operations effective with the January - March 2012 quarter. Therefore, Snacks sales and earnings are no longer included in the results of the continuing operations of the Company. The transaction is expected to close by the end of the current fiscal year. Additionally, as a result of this change we consolidated the Pet Care business into the Fabric Care and Home Care segment effective this quarter. These changes have been reflected in our segment reporting for all periods presented.

The table below provides more information about the components of our reportable business segment structure.

Reportable Segment	Categories	Billion Dollar Brands
Beauty	Antiperspirant and Deodorant, Cosmetics, Hair Care, Hair Color, Hair Styling, Personal Cleansing, Prestige Products, Salon Professional, Skin Care	Head & Shoulders, Olay, Pantene, SKII, Wella
Grooming	Blades and Razors, Electronic Hair Removal Devices, Home Small Appliances, Pre and Post Shave products	Braun, Fusion, Gillette, Mach3
Health Care	Feminine Care, Gastrointestinal, Incontinence, Rapid Diagnostics, Respiratory, Toothbrush, Toothpaste, Other Oral Care	Always, Crest, Oral-B, Vicks
Fabric Care and Home Care	Air Care, Batteries, Dish Care, Fabric Enhancers, Laundry Additives, Laundry Detergents, Pet Care, Surface Care	Ace, Ariel, Dawn, Downy, Duracell, Gain, Iams, Tide, Febreze
Baby Care and Family Care	Baby Wipes, Diapers, Paper Towels, Tissues, Toilet Paper	Bounty, Charmin, Pampers

The following table provides the percentage of net sales and net earnings by reportable business segment for the three months ended March 31, 2012 (excludes net sales and net earnings in Corporate):

	Three Months Ended March 31
	Net Sales		Net Earnings
Beauty	24	%	20	%
Grooming	9	%	15	%
Health Care	15	%	16	%
Fabric Care and Home Care	32	%	27	%
Baby Care and Family Care	20	%	22	%
Total	100	%	100	%

The following table provides the percentage of net sales and net earnings by reportable business segment for the nine months ended March 31, 2012 (excludes net sales and net earnings in Corporate):

16

	Nine Months Ended March 31
	Net Sales		Net Earnings
Beauty	24	%	23	%
Grooming	10	%	16	%
Health Care	15	%	17	%
Fabric Care and Home Care	32	%	26	%
Baby Care and Family Care	19	%	18	%
Total	100	%	100	%

SUMMARY OF RESULTS

Following are highlights of results for the nine months ended March 31, 2012 versus the nine months ended March 31, 2011:

• Net sales increased 5% to $63.5 billion. Organic sales, which exclude the impacts of acquisitions, divestitures and foreign exchange, were up 4%.

• Unit volume grew 1%, with low single digit growth for Beauty, Health Care, Grooming, and Baby Care and Family Care, and a low single digit decline in Fabric Care and Home Care.

• Net earnings attributable to Procter & Gamble were $7.1 billion, a decrease of $2.2 billion or 23% versus the prior year period. The decrease in net earnings was due to sales growth being more than offset by impairment charges, incremental restructuring charges and gross margin contraction. The impairment charges included $1.6 billion of before tax non-cash goodwill and intangible assets impairment charges associated with the Appliances and Salon Professional businesses. The incremental restructuring charges totaled $475 million before tax, resulting from the Company's productivity and cost savings plan announced during the quarter ended March 31, 2012. The decline in gross margin was driven primarily by higher commodity costs, partially offset by price increases.

• Diluted net earnings per share decreased 22% to $2.42 and Diluted net earnings per share from continuing operations decreased 22% to $2.37. The earnings per share decline is different from the net earnings decline due to the impact of share repurchase activity.

• Operating cash flow for fiscal year to date decreased 1% to $9.3 billion. Free cash flow, which is operating cash flow less capital expenditures, was $6.6 billion. Free cash flow productivity, which is the ratio of free cash flow to net earnings, was 92%.

ECONOMIC CONDITIONS, CHALLENGES AND RISKS

Ability to Achieve Business Plans. We are a consumer products company and rely on continued demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers and retail trade customers. Our continued success is dependent on leading-edge innovation with respect to both products and operations, on the continued positive reputations of our brands and our ability to successfully maintain trademark protection. This means we must be able to obtain patents and trademarks, and respond to technological advances and patents granted to competition. Our success is also dependent on effective sales, advertising and marketing programs. Our ability to innovate and execute in these areas will determine the extent to which we are able to grow existing sales and volume profitably, especially with respect to the product categories and geographic markets (including developing markets) in which we have chosen to focus. There are high levels of competitive activity in the environments in which we operate. To address these challenges, we must respond to competitive factors, including pricing, promotional incentives, trade terms and product initiatives. We must manage each of these factors, as well as maintain mutually beneficial relationships with our key customers, in order to effectively compete and achieve our business plans. As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of ongoing acquisition, divestiture and joint venture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Daily conduct of our business also depends on our ability to maintain key information technology systems, including systems operated by third-party suppliers, and to maintain security over our data.

Cost Pressures. Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects, sourcing decisions and certain hedging transactions, as well as consistent productivity improvements. We also must manage our debt and currency exposure, especially in certain countries with currency exchange controls, such as Venezuela, China and India. We need to maintain key manufacturing and supply arrangements, including sole supplier and sole manufacturing plant arrangements, and successfully manage any disruptions at Company manufacturing sites. We must implement, achieve and sustain cost improvement plans, including our outsourcing

17

projects and those related to general overhead and workforce optimization. Successfully managing these changes, including identifying, developing and retaining key employees, is critical to our success.

Global Economic Conditions. Demand for our products has a correlation to global macroeconomic factors. The current macroeconomic factors remain dynamic. Economic changes, terrorist activity, political unrest and natural disasters may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographic markets, due to terrorist and other hostile activities or natural disasters. We could also be negatively impacted by a global, regional or national economic crisis, including sovereign risk in the event of a deterioration in the credit worthiness of or a default by local governments, resulting in a disruption of credit markets. Such events could negatively impact our ability to collect receipts due from governments, including refunds of value added taxes, create significant credit risks relative to our local customers and depository institutions, and/or negatively impact our overall liquidity.

Regulatory Environment. Changes in laws, regulations and the related interpretations may alter the environment in which we do business. This includes changes in environmental, competitive and product-related laws, as well as changes in accounting standards and taxation requirements. Our ability to manage regulatory, tax and legal matters (including product liability, patent, intellectual property, competition law matters and tax policy) and to resolve pending legal matters within current estimates may impact our results.

For more information on risks that could impact our results, refer to Part II, Item 1A Risk Factors in this Form 10-Q.

RESULTS OF OPERATIONS – Three Months Ended March 31, 2012

The following discussion provides a review of results for the three months ended March 31, 2012 versus the three months ended March 31, 2011.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

18

	Three Months Ended March 31
	2012			2011			% CHG
NET SALES	$	20,194		$	19,893		2	%
COST OF PRODUCTS SOLD	10,237			9,789			5	%
GROSS PROFIT	9,957			10,104			(1	)%
SELLING GENERAL & ADMINISTRATIVE EXPENSE	6,636			6,399			4	%
GOODWILL & INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES	22			—
OPERATING INCOME	3,299			3,705			(11	)%
TOTAL INTEREST EXPENSE	179			202
OTHER NON-OPERATING INCOME/(EXPENSE), NET	67			104
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	3,187			3,607			(12	)%
INCOME TAXES ON CONTINUING OPERATIONS	754			748
NET EARNINGS FROM CONTINUING OPERATIONS	2,433			2,859			(15	)%
NET EARNINGS FROM DISCONTINUED OPERATIONS	34			47			(28	)%
NET EARNINGS	2,467			2,906			(15	)%
LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS	56			33			70	%
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	2,411			2,873			(16	)%
EFFECTIVE TAX RATE ON CONTINUING OPERATIONS	23.7		%	20.7		%
BASIC NET EARNINGS PER COMMN SHARE (1):
EARNINGS FROM CONTINUING OPERATIONS	$	0.84		$	0.99		(15	)%
EARNINGS FROM DISCONTINUED OPERATIONS	$	0.01		$	0.02		(50	)%
BASIC NET EARNINGS PER COMMON SHARE	$	0.85		$	1.01		(16	)%
DILUTED NET EARNINGS PER COMMON SHARE (1):
EARNINGS FROM CONTINUING OPERATIONS	$	0.81		$	0.94		(14	)%
EARNINGS FROM DISCONTINUED OPERATIONS	$	0.01		$	0.02		(50	)%
DILUTED NET EARNINGS PER COMMON SHARE	$	0.82		$	0.96		(15	)%
DIVIDENDS PER COMMON SHARE	$	0.5250		$	0.4818		9	%
AVERAGE DILUTED SHARES OUTSTANDING	2,937.8			2,999.3
(1)Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble
COMPARISONS AS A % OF NET SALES							Basis Pt Chg
GROSS MARGIN	49.3		%	50.8		%	(150	)
SELLING, GENERAL & ADMINISTRATIVE EXPENSE	32.9		%	32.2		%	70
OPERATING MARGIN	16.3		%	18.6		%	(230	)
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	15.8		%	18.1		%	(230	)
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	11.9		%	14.4		%	(250	)

Net sales increased 2% to $20.2 billion for the January - March quarter on unit volume that was in line with the prior year period. Baby Care and Family Care, Beauty and Grooming grew volume low single digits. Health Care volume was in line with the prior year period. Fabric Care and Home Care volume decreased low single digits. Volume grew mid-single digits in developing regions and was down mid-single digits in developed regions. Price increases added 5% to net sales, driven by price increases across all business segments and regions, primarily to offset commodity cost increases and devaluing developing market currencies. Negative mix reduced net sales by 2% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Unfavorable foreign exchange reduced net sales by 1%. Organic sales growth was 3% driven by unit volume growth and price increases, partially offset by the impact of unfavorable mix.

19

	Net Sales Change Drivers 2012 vs. 2011 (Three Months Ended Mar. 31)
	Volume with Acquisitions & Divestitures		Volume Excluding Acquisitions & Divestitures		Foreign Exchange		Price		Mix/Other		Net Sales Growth
Beauty	1	%	1	%	-1	%	5	%	-4	%	1	%
Grooming	1	%	1	%	-2	%	3	%	-2	%	0	%
Health Care	0	%	-1	%	-1	%	3	%	0	%	2	%
Fabric Care and Home Care	-3	%	-3	%	-1	%	7	%	-2	%	1	%
Baby Care and Family Care	3	%	3	%	-1	%	5	%	-2	%	5	%
TOTAL COMPANY	0	%	0	%	-1	%	5	%	-2	%	2	%

Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

Gross margin contracted 150 basis points to 49.3% of net sales for the quarter. The reduction in gross margin was driven mainly by a 230 basis point impact from higher commodity and energy costs. Gross margin was also negatively impacted by a 210 basis points from negative product mix behind disproportionate growth in developing regions and mid-tier products, and by 50 basis points from incremental restructuring spending in the current period. These impacts were partially offset by a 230 basis point positive impact from increased pricing and from manufacturing cost savings.

Total selling, general and administrative expenses (SG&A) increased 4% to $6.6 billion, primarily driven by an increase in overhead spending partially offset by a decrease in marketing spending. The increase in overhead spending was driven by $350 million in incremental restructuring spending to support the productivity and cost savings plan, partially offset by reductions in going spending levels. Marketing spending decreased primarily due to the impact of foreign exchange. SG&A as a percentage of net sales increased 70 basis points to 32.9%, as approximately 170 basis points of incremental restructuring spending was partially offset by reductions in other overheads and marketing spending.

Interest expense was $179 million for the quarter, down $23 million versus the prior year period due to lower interest rates on floating rate debt, partially offset by an increase in debt outstanding. Other non-operating income/(expense) decreased $37 million mainly behind the Zest business divestiture gain in the base period. The effective tax rate on continuing operations increased 300 basis points to 23.7% primarily driven by geographic mix of earnings to countries with higher effective tax rates.

Net earnings attributable to Procter & Gamble decreased 16% to $2.4 billion for the quarter as the net sales increase was more than offset by operating margin contraction. Operating margin declined 230 basis points primarily due to the gross margin reduction and SG&A increase discussed above. Diluted net earnings per share from continuing operations decreased 14% to $0.81.

Foreign Currency Translation – Venezuela Impacts

Venezuela is a highly inflationary economy under U.S. GAAP. As a result, the U.S. dollar is now the functional currency for our subsidiaries in Venezuela. Any currency remeasurement adjustments for non-dollar denominated monetary assets and liabilities held by these subsidiaries and other transactional foreign exchange gains and losses are reflected in earnings.

The Venezuelan government has a number of currency controls for companies operating in Venezuela. There is one official exchange rate for imported goods, equal to 4.3 bolivars to one U.S. dollar. Our overall results in Venezuela are reflected in our Consolidated Financial Statements at the 4.3 rate, which is also expected to be applicable to dividend repatriations.

There are also exchange controls over securities transactions in what was the parallel market, which has historically been used to pay for imported goods and services that do not qualify for exchange in the official market and is now controlled by authorities. The Central Bank of Venezuela is currently the only legal intermediary to execute foreign exchange transactions outside of CADIVI (4.3 rate) through the SITME rate which was approximately 5.3 as of March 31, 2012. The notional amount of transactions that run through this foreign exchange rate for non-essential goods is restrictive, which for us has essentially eliminated our ability to access any foreign exchange rate other than the CADIVI (4.3) rate to pay for imported goods and/or manage our local monetary asset balances.

As of March 31, 2012, we had net monetary assets denominated in local currency of approximately $984 million. Approximately $302 million of this balance has been remeasured using the SITME rate because we plan to use that amount of

20

the net assets (largely cash) to satisfy U.S. dollar denominated liabilities that do not qualify for official rate dollars. The availability of the parallel market to settle these transactions is uncertain. The remaining net monetary asset balances are currently reflected within our Consolidated Financial Statements at the 4.3 official exchange rate. Depending on the future availability of U.S. dollars at the official rate, our local U.S. dollar needs, our overall repatriation plans and the creditworthiness of the local depository institutions and other creditors, we have exposure for our local monetary assets. We also have devaluation exposure for the differential between the current and potential future official and parallel exchange rates on the portion of our local monetary assets reflected at the 4.3 official exchange rate.

Our ability to effectively manage sales and profit levels in Venezuela will be impacted by several factors, including the Company's ability to mitigate the effect of any potential future devaluation, further actions of the Venezuelan government, economic conditions in Venezuela, such as inflation and consumer spending, the availability of raw materials, utilities and energy and the future state of exchange controls in Venezuela including the availability of U.S. dollars at the official foreign exchange rate. Sales and profit levels in Venezuela could also be impacted by any actions taken by the government under the recently passed law aimed at controlling market prices, which could restrict our ability to take future pricing or force us to freeze or even reduce current pricing levels.

RESULTS OF OPERATIONS – Nine Months Ended March 31, 2012

The following discussion provides a review of results for the nine months ended March 31, 2012 versus the nine months ended March 31, 2011.

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

(Amounts in Millions Except Per Share Amounts)

Consolidated Earnings Information

21

	Nine Months Ended March 31
	2012			2011			% CHG
NET SALES	$	63,468		$	60,653		5	%
COST OF PRODUCTS SOLD	31,894			29,327			9	%
GROSS PROFIT	31,574			31,326			1	%
SELLING GENERAL & ADMINISTRATIVE EXPENSE	19,769			19,010			4	%
GOODWILL & INDEFINITE LIVED INTANGIBLE IMPAIRMENT CHARGES	1,576			—
OPERATING INCOME	10,229			12,316			(17	)%
TOTAL INTEREST EXPENSE	587			619
OTHER NON-OPERATING INCOME/(EXPENSE), NET	238			171
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	9,880			11,868			(17	)%
INCOME TAXES ON CONTINUING OPERATIONS	2,776			2,638
NET EARNINGS FROM CONTINUING OPERATIONS	7,104			9,230			(23	)%
NET EARNINGS FROM DISCONTINUED OPERATIONS	133			158			(16	)%
NET EARNINGS	7,237			9,388			(23	)%
LESS: NET EARNINGS ATTRIBUTABLE TO NONCONTROLLING INTERESTS	112			101			11	%
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	7,125			9,287			(23	)%
EFFECTIVE TAX RATE ON CONTINUING OPERATIONS	28.1		%	22.2		%
BASIC NET EARNINGS PER COMMN SHARE (1):
EARNINGS FROM CONTINUING OPERATIONS	$	2.47		$	3.18		(22	)%
EARNINGS FROM DISCONTINUED OPERATIONS	$	0.05		$	0.06		(17	)%
BASIC NET EARNINGS PER COMMON SHARE	$	2.52		$	3.24		(22	)%
DILUTED NET EARNINGS PER COMMON SHARE (1):
EARNINGS FROM CONTINUING OPERATIONS	$	2.37		$	3.04		(22	)%
EARNINGS FROM DISCONTINUED OPERATIONS	$	0.05		$	0.05		—	%
DILUTED NET EARNINGS PER COMMON SHARE	$	2.42		$	3.09		(22	)%
DIVIDENDS PER COMMON SHARE	$	1.5750		$	1.4454		9	%
AVERAGE DILUTED SHARES OUTSTANDING	2,944.9			3,008.6
(1)Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble
COMPARISONS AS A % OF NET SALES							Basis Pt Chg
GROSS MARGIN	49.7		%	51.6		%	(190	)
SELLING, GENERAL & ADMINISTRATIVE EXPENSE	31.1		%	31.3		%	(20	)
OPERATING MARGIN	16.1		%	20.3		%	(420	)
EARNINGS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	15.6		%	19.6		%	(400	)
NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE	11.2		%	15.3		%	(410	)

Net sales increased 5% to $63.5 billion fiscal year to date on a 1% increase in unit volume. Volume grew low single digits in Beauty, Health Care, Grooming, and Baby Care and Family Care. Fabric Care and Home Care volume decreased low single digits. Volume grew mid-single digits in developing regions and was down low single digits in developed regions. Price increases added 4% to net sales, driven by price increases across all business segments and regions, primarily to help offset commodity costs and devaluing currencies in certain developing markets. Negative mix reduced net sales by 1% due mainly to disproportionate growth in developing regions and mid-tier value products, both of which have lower than Company average selling prices. Favorable foreign exchange increased net sales by 1% as key foreign currencies strengthened versus the U.S. dollar. Organic sales growth was 4% driven by unit volume growth and price increases, partially offset by the impact of unfavorable mix.

22

	Net Sales Change Drivers 2012 vs. 2011 (Nine Months Ended Mar. 31)
	Volume with Acquisitions & Divestitures		Volume Excluding Acquisitions & Divestitures		Foreign Exchange		Price		Mix/Other		Net Sales Growth
Beauty	2	%	3	%	2	%	3	%	-3	%	4	%
Grooming	1	%	1	%	2	%	2	%	-1	%	4	%
Health Care	1	%	1	%	1	%	3	%	-1	%	4	%
Fabric Care and Home Care	-1	%	-1	%	1	%	6	%	-2	%	4	%
Baby Care and Family Care	2	%	2	%	1	%	4	%	0	%	7	%
TOTAL COMPANY	1	%	1	%	1	%	4	%	-1	%	5	%

Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.

Gross margin contracted 190 basis points to 49.7% of net sales. The reduction in gross margin was driven mainly by a 250 basis point impact from higher commodity and energy costs. Gross margin was also negatively impacted by 240 basis points from negative product mix behind disproportionate growth in developing regions and mid-tier products. These impacts were partially offset by a 190 basis point impact from increased pricing, a 100 basis point impact from manufacturing cost savings and to a lesser extent the favorable impact of volume scale leverage.

Total SG&A increased 4% to $19.8 billion, driven by higher marketing and overhead spending to support growth and a $365 million increase in restructuring spending, partially offset by a reduction in competition law fines (which were $303 million in the prior period compared to $75 million in the current period). SG&A as a percentage of net sales decreased 20 basis points to 31.1%, as 60 basis points of incremental restructuring costs were more than offset by reduced competition law fines and the impact of scale leverage on overhead costs from increased sales.

Goodwill & indefinite lived intangible impairment charges of $1,576 million ($1,503 million after tax), were incurred for the fiscal year to date period. The charges related to the carrying values of goodwill in our Appliances and Salon Professional businesses and our Koleston Perfect and Wella indefinite lived intangible assets, which are part of our Salon Professional business. See Note 5 to our Consolidated Financial Statements for more details, including factors leading to the impairment charges. Since goodwill is included in Corporate for internal management and segment reporting, the goodwill impairment charges are included in the Corporate segment. With respect to the indefinite lived intangible assets, for management reporting purposes the underlying impairment charges were excluded from business unit earnings and included in Corporate. Accordingly, these charges were also included in Corporate for segment reporting.

Interest expense was $587 million for the period, down $32 million versus the prior year period due to lower interest rates on floating rate debt partially offset by an increase in debt outstanding. Other non-operating income/(expense) increased $67 million mainly behind the PUR divestiture gain in the current year period, partially offset by the Zest divestiture gain in the prior year period. The effective tax rate on continuing operations increased 590 basis points to 28.1% primarily due to a 320 basis points impact from non-deductibility of impairment charges in the current year period and the net impact of favorable discrete adjustments related to uncertain income tax positions (which netted to 360 basis points in the prior year and 145 basis points in the current year).

Net earnings attributable to Procter & Gamble decreased 23% to $7.1 billion as the net sales increase was more than offset by operating margin contraction. Operating margin declined 420 basis points due to a 250 basis point impact from goodwill and intangible impairment charges and the 190 basis point gross margin contraction, partially offset by a 20 basis point reduction in SG&A as a percentage of net sales. Diluted net earnings per share from continuing operations decreased 22% to $2.37. The earnings per share decline is different from the net earnings decline due to the impact of share repurchase activity.

BUSINESS SEGMENT DISCUSSION – Three and Nine Months Ended March 31, 2012

The following discussion provides a review of results by business segment. Analyses of the results for the three and nine months ended March 31, 2012, are provided based on a comparison to the same three and nine month periods ended March 31, 2011. The primary financial measures used to evaluate segment performance are net sales and net earnings. The table below provides supplemental information on net sales and net earnings by business segment for the three and nine months ended March 31, 2012, versus the comparable prior year period (amounts in millions):

23

	Three Months Ended March 31, 2012
	Net Sales			% Change Versus Year Ago		Earnings from Continuing Operations Before Income Taxes			% Change Versus Year Ago		Net Earnings Attributable to Procter & Gamble			% Change Versus Year Ago
Beauty	$	4,844		1	%	$	710		1	%	$	523		3	%
Grooming	1,962			—	%	530			(9	)%	398			(4	)%
Health Care	3,018			2	%	638			(3	)%	411			(4	)%
Fabric Care and Home Care	6,595			1	%	1,161			(7	)%	716			(9	)%
Baby Care and Family Care	4,153			5	%	903			9	%	573			9	%
Corporate	(378		)	N/A		(755		)	N/A		(210		)	N/A
Total Company	20,194			2	%	3,187			(12	)%	2,411			(16	)%

	Nine Months Ended March 31, 2012
	Net Sales			% Change Versus Year Ago		Earnings from Continuing Operations Before Income Taxes			% Change Versus Year Ago		Net Earnings Attributable to Procter & Gamble			% Change Versus Year Ago
Beauty	$	15,512		4	%	$	2,652		(6	)%	$	2,008		(7	)%
Grooming	6,332			4	%	1,861			2	%	1,401			2	%
Health Care	9,492			4	%	2,222			2	%	1,490			3	%
Fabric Care and Home Care	20,703			4	%	3,643			(7	)%	2,280			(10	)%
Baby Care and Family Care	12,394			7	%	2,511			5	%	1,583			6	%
Corporate	(965		)	N/A		(3,009		)	N/A		(1,637		)	N/A
Total Company	63,468			5	%	9,880			(17	)%	7,125			(23	)%

Beauty

Beauty net sales increased 1% to $4.8 billion during the third fiscal quarter on unit volume growth of 1%. Organic sales grew 2% on 1% organic volume growth. Price increases contributed 5% to net sales growth. Mix negatively impacted net sales by 4% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in the premium-priced Salon Professional category. Unfavorable foreign exchange reduced net sales by 1%. Volume grew mid-single digits in developing markets and decreased low single digits in developed regions. Volume in Hair Care increased low single digits behind high-single-digit growth in developing markets due to market growth, product innovations and distribution expansions in Asia and Latin America, partially offset by a mid-single digit decline in developed regions due in part to price increases. Global market share of the hair care category was down slightly. Volume in Skin Care, Personal Care and Cosmetics decreased low single digits due to the volume impact of price increases, competitive activity and the Infasil divestiture. Volume in Salon Professional declined low single digits due to market contraction in Europe and non-strategic brand discontinuations. Volume in Prestige Products increased mid-single digits driven by initiative activity across fragrances and SKII, partially offset by minor brand divestitures. Net earnings increased 3% to $523 million due to higher net sales and a 20-basis point increase in net earnings margin. Lower SG&A as a percentage of net sales was largely offset by gross margin contraction. Gross margin decreased primarily due to an increase in commodity costs and unfavorable geographic and product mix, partially offset by manufacturing cost savings and higher pricing. SG&A decreased due to a reduction of marketing and overhead spending.

Beauty net sales increased 4% to $15.5 billion fiscal year to date on unit volume growth of 2%. Organic sales grew 3% on 3% organic volume growth. Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 3% behind disproportionate growth in developing regions, which have lower than segment average selling prices, and a decrease in the premium-priced product categories. Favorable foreign exchange added 2% to net sales growth. Volume increased high single digits in developing regions while developed region volume decreased low single digits. Volume in Retail Hair Care grew mid-single digits behind high single digit growth in developing regions led by Pantene initiatives and Head & Shoulders geographic expansion. Volume in developed regions was down low single digits due in part to price increases. Global market share of the hair care category was up slightly fiscal year to date. Volume in Skin Care, Personal Care and Cosmetics decreased low single digits due to the Zest and Infasil divestitures, a decrease in Olay from competitive activity in North America, and a decrease in the CEEMEA region due to a reduction in customer inventories following relatively high shipments in the June quarter and

24

comparing against a high base period. Volume in Salon Professional was down mid-single digits mainly due to market contraction in Europe and competitive activity. Volume in Prestige Products increased mid-single digits driven by initiatives across SKII, Gucci, Hugo, and Lacoste, partially offset by minor brand divestitures. Net earnings decreased 7% to $2.0 billion, as higher net sales were more than offset by a 150-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction partially offset by lower SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs and unfavorable geographic and product mix, partially offset by manufacturing cost savings and higher pricing. Both marketing and overhead as a percentage of net sales decreased due to scale leverage from increased sales.

Grooming

Grooming net sales were in line with the prior year period at $2.0 billion during the third fiscal quarter on a 1% increase in unit volume. Organic sales were up 2%. Price increases contributed 3% to net sales growth. Unfavorable product mix decreased net sales by 2% mainly due to disproportionate growth in developing markets, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales growth by 2%. Volume grew mid-single digits in developing regions and decreased low single digits in developed regions. Shave Care volume grew low single digits due to mid-single-digit growth in developing regions behind market growth and initiative activity, partially offset by a mid-single-digit decrease in developed regions primarily due to competitive activity and customer inventory adjustments. Global market share of the blades and razors category was up slightly. Volume in Appliances increased low single digits due to product innovation and in-store programs. However, global market share of the dry shave category was down over 1 point. Net earnings decreased 4% to $398 million due to a 90-basis point reduction in net earnings margin. Net earnings margin decreased due to gross margin contraction, partially offset by a reduction in SG&A and a lower effective tax rate. Gross margin decreased due to unfavorable geographic and product mix and an increase in commodity costs, partially offset by higher pricing and manufacturing cost savings. SG&A decreased due to lower marketing spending. The tax rate decreased due to a shift in the geographic mix of earnings to countries with lower statutory tax rates.

Grooming net sales increased 4% to $6.3 billion fiscal year to date on a 1% increase in unit volume. Organic sales were up 2%. Price increases contributed 2% to net sales growth. Unfavorable product mix decreased net sales by 1% mainly due to disproportionate growth in developing markets, which have lower than segment average selling prices. Favorable foreign exchange increased net sales growth by 2%. Volume grew mid-single digits in developing regions and decreased mid-single digits in developed regions. Volume in Shave Care was up low single digits due to mid-single-digit growth in developing regions behind initiatives, Fusion ProGlide geographic expansion and market growth, partially offset by a low single-digit decrease in developed regions due to market contraction and competitive activity. Global market share of the blades and razors category was down slightly. Volume in Appliances decreased high single digits due to market contraction in Western Europe and competitive activity. Global market share of the dry shave category was down about 2 points. Net earnings increased 2% to $1.4 billion as higher net sales were partially offset by a 30-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction partially offset by a decrease in SG&A as a percentage of net sales. Gross margin decreased primarily due to an increase in commodity costs and unfavorable geographic and product mix, partially offset by price increases. SG&A as a percentage of net sales decreased due to overhead scale leverage from increased sales and a reduction in marketing spending.

Health Care

Health Care net sales increased 2% to $3.0 billion during the third fiscal quarter on unit volume that was in line with the prior year period. Organic sales were up 2% on a 1% decrease in organic volume. Price increases contributed 3% to net sales growth. Unfavorable foreign exchange reduced net sales growth by 1%. Volume increased low single digits in developing regions, while developed regions decreased low single digits. Oral Care volume decreased low single digits due to competitive activity and price increases in Asia. Global market share of the oral care category was down half a point. Volume in Personal Health Care decreased mid-single digits, with organic volume decreasing high single digits. Competitive activity, a weak cold and cough season and lower shipments of Prilosec OTC in North America were partially offset by the addition of volume from the Teva transaction. All-outlet value share of the U.S. personal health care market was down more than half a point. Volume in Feminine Care grew low single digits driven by low single digit growth in developing markets behind market growth and product innovation, partially offset by a low single digit decrease in developed regions due to competitive activity. Global market share of the feminine care category was down about a half a point. Net earnings decreased 4% to $411 million as higher net sales were more than offset by an 80-basis point decrease in net earnings margin. Net earnings margin declined due to reduced gross margin, partially offset by reduced SG&A as a percentage of net sales. Gross margin declined due to increased commodity costs and negative mix, partially offset by higher pricing. SG&A costs as a percentage of net sales declined due to reduced overhead costs.

25

Health Care net sales increased 4% to $9.5 billion fiscal year to date on 1% growth in unit volume. Organic sales were up 2%. Price increases contributed 3% to net sales growth. Mix negatively impacted net sales by 1% due to disproportionate growth in countries and products with lower than segment average selling prices. Favorable foreign exchange increased net sales growth by 1%. Volume increased low single digits in developing regions and was in line with the prior period in developed regions. Oral Care volume was in line with the prior year period as the expansion of Oral-B toothpaste in Western Europe and Latin America, and toothbrush initiatives in Asia were offset by competitive activity in developed markets and Asia and the impacts from price increases in Asia. Global market share of the oral care category was down slightly. Volume in Personal Health Care was in line with the prior year period driven by market growth and Vicks initiative activity, offset by lower shipments of Prilosec OTC in North America. All-outlet value share of the U.S. personal health care market was down slightly. Volume in Feminine Care was up low single digits driven by mid-single digit growth in developing markets due to distribution expansions in CEEMEA and initiative activity in India. Net earnings increased 3% to $1.5 billion, largely in line with net sales growth. Net earnings margin decreased 30 basis points due to gross margin contraction, partially offset by lower SG&A as a percentage of net sales. Gross margin declined due to higher commodity costs and unfavorable product and geographic mix, partially offset by manufacturing cost savings and price increases. SG&A as a percentage of net sales decreased primarily due to scale leverage from increased sales.

Fabric Care and Home Care

Fabric Care and Home Care net sales increased 1% to $6.6 billion during the third fiscal quarter on a 3% decline in unit volume. Organic sales were up 2%. Price increases contributed 7% to net sales growth. Mix reduced net sales by 2% due primarily to disproportionate growth in developing regions, which have lower than segment average selling prices. Unfavorable foreign exchange reduced net sales growth by 1%. A mid-single digit increase in volume in developing regions was offset by a mid-single digit decrease in developed regions. Fabric Care volume decreased low single digits as a low single digit increase in developing regions driven by initiative activity and market growth was more than offset by a mid-single digit decrease in developed regions due to competitive activity and the impact of price increases. Global market share of the fabric care category decreased half a point. Home Care volume decreased low single digits driven by a mid-single digit decrease in developed markets, due to the impact of price increases, partially offset by double digit growth in developing regions from initiative activity and distribution expansion. Global market share of the home care category was down slightly. Batteries volume was in line with the prior year period, as double-digit growth in developing markets from market growth and distribution expansion was offset by a high-single digit decrease in developed markets due to market contraction and distribution losses. Global market share of the batteries category increased slightly. Pet Care volume decreased double digits due to market contraction and customer inventory reductions. Net earnings decreased 9% to $716 million as net sales growth was more than offset by an 120-basis point decrease in net earnings margin. Net earnings margin decreased mainly due to gross margin contraction, partially offset by reduced SG&A as a percentage of net sales. Gross margin decreased due to higher commodity costs, unfavorable product and geographic mix and negative scale impacts from reduced volumes, partially offset by manufacturing cost savings and higher pricing. SG&A as a percentage of net sales decreased due to a reduction in overhead spending.

Fabric Care and Home Care net sales increased 4% to $20.7 billion fiscal year to date. Unit volume decreased 1%. Organic sales were up 3%. Price increases contributed 6% to net sales growth. Mix negatively impacted net sales growth by 2% due to disproportionate growth of mid-tier product lines and developing regions, which have lower than segment average selling prices. Favorable foreign exchange increased net sales by 1%. Volume in developing regions grew mid-single digits, while volume in developed regions decreased mid-single digits. Fabric Care volume decreased low single digits mainly due to the impact of price increases in North America, partially offset by growth in Asia. Global market share of the fabric care category decreased more than half a point. Home Care volume was in line with the prior year period as a mid-single digit decline in developed regions driven by the negative impact of price increases, offset initiative activity and distribution expansion in developing regions. Global market share of the home care category was unchanged. Batteries volume decreased low single digits due to market contraction and distribution losses in developed markets, partially offset by market growth and distribution expansion in developing regions. Global market share of the batteries category increased half a point. Pet Care volume decreased high single digits due to market contraction and customer inventory reductions. Net earnings decreased 10% to $2.3 billion as net sales growth was more than offset by a 170-basis point decrease in net earnings margin. Net earnings margin decreased due to gross margin contraction. Gross margin decreased mainly due to higher commodity costs and unfavorable product and geographic mix, partially offset by manufacturing cost savings and higher pricing. SG&A as a percentage of net sales was in line with the prior year as increased marketing spending was offset by improved overhead scale leverage from increased sales.

Baby Care and Family Care

26

Baby Care and Family Care net sales increased 5% to $4.2 billion during the third fiscal quarter on 3% volume growth. Organic sales were up 6%. Pricing added 5% to net sales growth. Mix reduced net sales by 2% due to disproportionate growth of developing markets, which have lower than segment average selling prices. Unfavorable foreign exchange decreased net sales by 1%. Volume in developing regions increased double digits, while volume in developed regions decreased low single digits. Volume in Baby Care increased low single digits as a double digit increase in developing regions behind market size growth, distribution expansion and initiative activity was partially offset by a mid-single digit decrease in developed regions due to market contraction and competitive activity. Global market share of the baby care category increased more than half a point. Volume in Family Care increased low single digits primarily due to initiative activity across developed and developing markets. In the U.S., all-outlet share of the family care category was in line with the year ago period. Net earnings increased 9% to $573 million due to sales growth and a 50-basis point increase in net earnings margin. Net earnings margin increased due to a higher gross margin and a reduction in SG&A as a percentage of net sales. The increase in gross margin was driven by the impact of higher pricing and manufacturing cost savings, partially offset by higher commodity costs and unfavorable product and geographic mix. The reduction in SG&A as a percentage of net sales was due primarily to scale benefits from increased net sales.

Baby Care and Family Care net sales increased 7% to $12.4 billion fiscal year to date on 2% volume growth. Organic sales were up 6%. Pricing added 4% to net sales growth. Favorable foreign exchange increased net sales growth by 1%. Volume grew double digits in developing regions and decreased low single digits in developed regions. Volume in Baby Care was up mid-single digits behind market size growth and distribution expansion in developing regions, partially offset by declines in North America and Western Europe from diaper market softness. Global market share of the baby care category increased about 1 point. Volume in Family Care decreased low single digits primarily due to competitive activity and the impact of a price increases in North America. In the U.S., all-outlet share of the family care category decreased slightly. Net earnings increased 6% to $1.6 billion as sales growth was partially offset by a 20-basis point reduction in net earnings margin. Net earnings margin declined mainly due to a lower gross margin, partially offset by a decrease in SG&A as a percentage of net sales. The reduction in gross margin was driven primarily by higher commodity costs, partially offset by the impact of higher pricing. SG&A as a percentage of net sales decreased due to scale leverage from increased sales.

CORPORATE

Corporate includes certain operating and non-operating activities not allocated to specific business units. These include: the incidental businesses managed at the corporate level; financing and investing activities; other general corporate items; the historical results of certain divested brands and categories; certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization; and certain significant impairment charges. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling items include income taxes (to adjust from statutory rates that are reflected in the segments to the overall Company effective tax rate), adjustments for unconsolidated entities (to eliminate net sales, cost of products sold and SG&A for entities that are consolidated in the segments but accounted for using the equity method for U.S. GAAP) and noncontrolling interest adjustments for subsidiaries where we do not have 100% ownership. Since certain unconsolidated entities and less than 100%-owned subsidiaries are managed as integral parts of the Company, they are accounted for similar to a wholly-owned subsidiary for management and segment purposes. This means our segment results recognize 100% of each income statement component through before-tax earnings in the segments, with eliminations for unconsolidated entities and noncontrolling interests in Corporate. In determining segment net earnings, we apply the statutory tax rates (with adjustments to arrive at the Company's effective tax rate in Corporate). We also eliminate the share of earnings applicable to other ownership interests.

Corporate net sales primarily reflect the adjustment to eliminate the net sales of unconsolidated entities included in business segment results. Accordingly, Corporate net sales are generally a negative balance. Negative net sales in Corporate increased by $16 million in the third fiscal quarter and decreased $25 million fiscal year to date due to adjustments required to eliminate the sales of unconsolidated entities. Net Corporate expenses increased $377 million in the third fiscal quarter primarily due to incremental after-tax restructuring costs of $346 million. Net Corporate expenses increased $1.9 billion fiscal year to date primarily due to the net after tax goodwill and intangibles impairment charges of $1.5 billion and incremental after-tax restructuring charges of $356 million. Additional discussion of the items impacting net earnings in Corporate are included in the Results of Operations section.

Productivity and Cost Savings Plan

In February 2012, the Company announced a productivity and cost savings plan to reduce costs in the areas of supply chain, research & development, marketing and overheads. The program was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes in order to fund the Company's growth strategy. The

27

Company expects to incur approximately $3.5 billion before-tax in restructuring costs over a four year period as part of this plan. The Company expects to incur more than half of the costs under this plan by the end of fiscal 2013, with the remainder incurred in fiscal years 2014 and 2015.

Restructuring accruals are classified as current liabilities. Fiscal year to date restructuring charges were $686 million, of which $285 million remains as an outstanding liability at March 31, 2012. Approximately 60% of the restructuring charges incurred during 2012 are expected to be settled with cash. Consistent with our historical policies for ongoing restructuring-type activities, the resulting charges will be funded by and included within Corporate for segment reporting.

Savings from the restructuring plan are difficult to estimate given the nature of the activities, the corollary benefits achieved, the timing of the execution and the degree of reinvestment. Overall, the plan is expected to deliver $2 billion in before-tax annual savings. The before-tax savings in the current year are not material due to the timing of the execution.

Refer to Note 9 for more details on the Restructuring program.

FINANCIAL CONDITION

Operating Activities

We generated $9.3 billion of cash from operating activities during the fiscal year to date period, a decline of $141 million versus the prior year. Operating cash flows resulted primarily from net earnings, adjusted for non-cash items (depreciation and amortization, stock based compensation, asset impairments, deferred income taxes, and gain on sale of businesses), partially offset by working capital increases. On a year-to-date basis, the net of accounts receivable, inventory, and accounts payable, accrued and other liabilities consumed $2.2 billion of cash. Accounts receivable used $347 million of cash primarily due to increased sales at the end of the period. Inventory consumed $287 million of cash, mainly to support product initiatives and to build stock to support capacity expansions and manufacturing sourcing changes. Accounts payable, accrued and other liabilities used $1.6 billion of cash, primarily related to the payment of prior-year marketing accruals and the payment of fines related to violations of the European competition laws.

Investing Activities

Cash used for investing activities was $2.3 billion fiscal year to date, a decrease of $82 million versus the prior year period. Capital expenditures consumed $2.7 billion or 4.2% of net sales, as compared to $2.1 billion in the prior year period. Cash generated from asset sales was $290 million in the current year, an increase of $201 million mainly due to proceeds from the PUR divestiture.

Financing Activities

Our financing activities consumed net cash of $5.8 billion. We used $4.0 billion for treasury stock purchases and $4.5 billion for dividends and partially funded these cash outlays through a $1.3 billion net increase in debt. Cash consumed by financing activities declined $1.4 billion versus the prior year period due to increased levels of debt, a decrease in the treasury stock purchases and proceeds from increased exercise of stock options.

As of March 31, 2012, our current liabilities exceeded current assets by $3.8 billion. We have short- and long-term debt to fund discretionary items such as acquisitions and share repurchase programs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings which have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements.

RECONCILIATION OF NON-GAAP MEASURES

Our discussion of financial results includes several measures not defined by U.S. GAAP. We believe these measures provide our investors with additional information about the underlying results and trends of the Company, as well as insight to some of the metrics used to evaluate management. When used in MD&A, we have provided the comparable GAAP measure in the discussion.

Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions,

28

divestitures and foreign exchange from year-over-year comparisons. We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis. Organic sales is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

The reconciliation of reported sales growth to organic sales for the January - March quarter:

Jan - Mar 2012	Net Sales Growth		Foreign Exchange Impact		Acquisition/ Divestiture Impact*		Organic Sales Growth
Beauty	1	%	1	%	—	%	2	%
Grooming	—	%	2	%	—	%	2	%
Health Care	2	%	1	%	(1	)%	2	%
Fabric Care and Home Care	1	%	1	%	—	%	2	%
Baby Care and Family Care	5	%	1	%	—	%	6	%
Total P&G	2	%	1	%	—	%	3	%

 * Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales.

The reconciliation of reported sales growth to organic sales for the fiscal year to date period:

Jul - Mar 2012	Net Sales Growth		Foreign Exchange Impact		Acquisition/ Divestiture Impact*		Organic Sales Growth
Beauty	4	%	(2	)%	1	%	3	%
Grooming	4	%	(2	)%	—	%	2	%
Health Care	4	%	(1	)%	(1	)%	2	%
Fabric Care and Home Care	4	%	(1	)%	—	%	3	%
Baby Care and Family Care	7	%	(1	)%	—	%	6	%
Total P&G	5	%	(1	)%	—	%	4	%

 * Acquisition/Divestiture Impacts includes rounding impacts necessary to reconcile net sales to organic sales.

Free Cash Flow: Free cash flow is defined as operating cash flow less capital spending. We view free cash flow as an important measure because it is one factor in determining the amount of cash available for dividends and discretionary investment. Free cash flow is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

Free Cash Flow Productivity: Free cash flow productivity is defined as the ratio of free cash flow to net earnings. The Company’s long-term target is to generate free cash at or above 90% of net earnings. Free cash flow productivity is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation. The reconciliation of free cash flow and free cash flow productivity is provided below (amounts in millions):

	Operating Cash Flow	Capital Spending	Free Cash  Flow	Net Earnings	Free Cash  Flow Productivity
Jul - Mar ‘12	$9,311	$(2,663)	6,648	$7,237	92%

29

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in the Company’s exposure to market risk since June 30, 2011. Additional information can be found in the section entitled Other Information, which appears on page 50, and Note 5, Risk Management Activities and Fair Value Measurements, which appears on pages 60-62 of the Annual Report to Shareholders for the fiscal year ended June 30, 2011 which can be found by reference to Exhibit 13 of the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011.

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

The Company’s Chairman of the Board, President and Chief Executive Officer, Robert A. McDonald, and the Company’s Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report. Messrs. McDonald and Moeller have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. McDonald and Moeller, to allow their timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting.

There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended March 31, 2012 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters and tax.

As previously reported, the Company has had a number of antitrust cases in Europe. The Company's policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with the relevant regulatory authorities, which the Company is doing. In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company identified violations in certain European countries and appropriate actions were taken.

As a result of certain investigations that were previously disclosed, several authorities issued separate complaints alleging that the Company, along with several other companies, engaged in violations of competition laws in the past. The Company resolved several of these matters prior to the most recent quarter.

The Company has antitrust matters at various stages of the regulatory process in Belgium, France, Germany and Greece, and other countries have issued decisions, many of which are on appeal. All of these matters involve a number of other consumer products companies and/or retail customers. Competition and antitrust violations often continue for several years and, if violations are found, can result in substantial fines. No non-monetary sanctions are being sought in these matter.

For certain of the remaining matters listed above, we have established accruals for potential fines and we do not expect any significant incremental fines or costs in excess of amounts accrued for these matters. For other remaining matters, we cannot reasonably estimate any fines to which the Company may be subject as a result of the investigations. Please refer to the Company's Risk Factors in Part II, Item 1A of this Form 10-Q for additional information.

In December 2008, the Company became aware of an investigation by Italian authorities into an environmental accident at the site of a contractor which provides services to one or more of the Company's European affiliates. The accident involved the explosion of certain pressurized cans and resulted in the death of one worker and serious injuries to another. Italian authorities have commenced a formal criminal proceeding regarding whether the Company's local affiliate and certain of its employees complied with Italian laws related to the proper classification and disposal of their products. The Company's European affiliate(s) could be levied fines in excess of $100 thousand for this accident.

Item 1A. Risk Factors.

30

We discuss our expectations regarding future performance, events and outcomes, such as our business outlook and objectives in this Form 10-Q, the Annual Report to Shareholders, other quarterly reports, press releases and other written and oral communications. All statements, except for historical and present factual information, are “forward-looking statements” and are based on financial data and business plans available only as of the time the statements are made, which may become out of date or incomplete. We assume no obligation to update any forward-looking statements as a result of new information, future events, or other factors. Forward-looking statements are inherently uncertain, and investors must recognize that events could significantly differ from our expectations.

The following discussion of “risk factors” identifies the most significant factors that may adversely affect our business, operations, financial position or future financial performance. This information should be read in conjunction with MD&A and the consolidated financial statements and related notes incorporated by reference into this report. The following discussion of risks is not all inclusive but is designed to highlight what we believe are important factors to consider when evaluating our expectations. These factors could cause our future results to differ from those in the forward-looking statements and from historical trends.

A material change in consumer demand for our products could have a significant impact on our business.

We are a consumer products company and rely on continued global demand for our brands and products. To achieve business goals, we must develop and sell products that appeal to consumers. This is dependent on a number of factors including our ability to develop effective sales, advertising and marketing programs. We expect to achieve our financial targets, in part, by shifting our portfolio towards faster growing, higher margin businesses. If demand and growth rates fall substantially below expected levels or our market share declines significantly in these businesses, our results could be negatively impacted. This could occur due to unforeseen negative economic or political events or to changes in consumer trends and habits. In addition, our continued success is dependent on leading-edge innovation, with respect to both products and operations. This means we must be able to obtain patents that lead to the development of products that appeal to our consumers across the world.

The ability to achieve our business objectives is dependent on how well we can respond to our local and global competitors.

Across all of our categories, we compete against a wide variety of global and local competitors. As a result, there are ongoing competitive product and pricing pressures in the environments in which we operate, as well as challenges in maintaining profit margins. To address these challenges, we must be able to find marketing efficiencies and successfully respond to competitive factors, including pricing, promotional incentives and trade terms, as well as technological advances and patents granted to competition.

Our businesses face cost pressures and risks inherent in global manufacturing which could affect our business results.

Our costs are subject to fluctuations, particularly due to changes in commodity prices, raw materials, labor costs, foreign exchange and interest rates. Therefore, our success is dependent, in part, on our continued ability to manage these fluctuations through pricing actions, cost savings projects (including outsourcing projects), sourcing decisions and certain hedging transactions. In addition, our financial targets assume consistent improvement in marketing and research and development efficiencies, as well as savings in manufacturing and overhead costs. In the manufacturing and general overhead areas, we need to maintain key manufacturing and supply arrangements, including any key sole supplier and sole manufacturing plant arrangements. In addition, we are subject to risks inherent in global manufacturing, such as environmental events, labor disputes, disruption in logistics, loss or impairment of key manufacturing sites, natural disasters, acts of war or terrorism and other external factors over which we have no control. While we have business continuity and contingency plans for key manufacturing sites and the supply of raw materials, significant disruption of manufacturing could interrupt product supply and, if not remedied, have an adverse impact on our business.

We face risks associated with significant international operations.

We conduct business across the globe with a significant portion of our sales outside the United States. As a result, we are subject to a number of risks, including, but not limited to, changes in exchange rates for foreign currencies, which may reduce the U.S. dollar value of revenues and earnings received and/or balances held by or invested in our foreign subsidiaries, as well as exchange controls and other limits on our ability to repatriate earnings from outside the U.S. that can increase our exposure. We have sizable businesses and maintain local currency cash balances in a number of foreign countries with exchange controls, including, but not limited to, Venezuela, China and India. Our results of operations and/or financial condition could be adversely impacted if we are unable to successfully manage these risks in an increasingly volatile environment. Further, we expect to achieve our financial targets, in part, by achieving disproportionate growth in developing regions. Growth rates in these regions may be impacted by the enactment of laws or governmental actions aimed at controlling prices. Should growth rates or our market share fall substantially below expected levels in these regions, our results could be

31

negatively impacted. In addition, economic changes, terrorist activity and political unrest may result in business interruption, inflation, deflation or decreased demand for our products. Our success will depend, in part, on our ability to manage continued global political and/or economic uncertainty, especially in our significant geographical markets, as well as any political or economic disruption due to terrorist and other hostile activities.

If the reputation of the Company or one or more of our leading brands erodes significantly, it could have a material impact on our financial results.

The Company's reputation is the foundation of our relationships with key stakeholders and other constituencies. If we are unable to effectively manage real or perceived issues, which could negatively impact sentiments toward the Company, our ability to operate freely could be impaired and our financial results could suffer. Our financial success is directly dependent on the success of our brands, particularly our billion-dollar brands. The success of these brands can suffer if our marketing plans or product initiatives do not have the desired impact on a brand's image or its ability to attract consumers, or we are unable to maintain trademark protection. Further, our results could be negatively impacted if one of our leading brands suffers a substantial impediment to its reputation due to real or perceived quality issues or the distribution and sale of counterfeit products.

Our ability to successfully adapt to ongoing organizational change could impact our business results.

We have executed a number of significant business and organizational changes including acquisitions, divestitures and workforce optimization projects to support our growth strategies. We expect these types of changes to continue for the foreseeable future. In addition, we are operating under an announced productivity and cost savings plan. Successfully managing these changes is critical to our business success. In addition, we are generally a build-from-within company, and our success is dependent on identifying, developing and retaining key employees to provide uninterrupted leadership and direction for our business. This includes developing organization capabilities in key growth markets where the depth of skilled employees is limited and competition for these resources is intense. Further, business and organizational changes may result in more reliance on third parties for various services, and that reliance may increase reputational, operational and compliance risks, including the risk of corruption. Finally, our financial targets assume a consistent level of productivity improvement and cost savings. If we are unable to deliver expected productivity improvements and cost savings, while continuing to invest in business growth, our financial results could be adversely impacted.

Our ability to successfully manage ongoing acquisition and divestiture activities could impact our business results.

As a company that manages a portfolio of consumer brands, our ongoing business model involves a certain level of acquisition and divestiture activities. We must be able to successfully manage the impacts of these activities, while at the same time delivering against base business objectives. Specifically, our financial results could be adversely impacted if: 1) we are not able to deliver the expected cost and growth synergies associated with our acquisitions, 2) changes in the cash flows or other market-based assumptions cause the value of acquired assets to fall below book value or 3) we are unable to offset the dilutive impacts from the loss of revenue streams associated with divested brands.

Our business is subject to legislation, regulation and enforcement in the U.S. and abroad.

Changes in laws, regulations and the related interpretations, as well as changes in accounting standards, taxation requirements and increased enforcement actions and penalties, may alter the environment in which we do business. Accordingly, our ability to manage regulatory, tax and legal matters (including product liability, patent, and other intellectual property matters), and to resolve pending legal matters without significant liability may materially impact our results of operations and financial position. Furthermore, the competition law and antitrust investigations described in Part II, Item 1 of this Form 10-Q, in total, may result in fines or costs in excess of the amounts accrued to date that could materially impact our results of operations and financial position. Moreover, as a U.S. based multinational company we are subject to tax regulations in the U.S. and multiple foreign jurisdictions, some of which are interdependent. For example, certain income that is earned and taxed in countries outside the U.S. is not taxed in the U.S., provided those earnings are indefinitely reinvested outside the U.S. If these or other tax regulations should change, our financial results could be impacted.

A material change in customer relationships or in customer demand for our products could have a significant impact on our business.

Our success is dependent on our ability to successfully manage relationships with our retail trade customers. This includes our ability to offer trade terms that are acceptable to our customers and are aligned with our pricing and profitability targets. Our business could suffer if we cannot reach agreement with a key customer based on our trade terms and principles. Further, retail trade consolidation could create significant cost and margin pressure and lead to more complex work across broader geographic boundaries for both us and key retailers. This can be particularly difficult when major customers are

32

addressing local trade pressures or local law and regulation changes. In addition, our business would be negatively impacted if a key customer were to significantly reduce the range or inventory level of our products.

We face risks related to changes in the global economic environment.

Our business is impacted by global economic conditions, which are increasingly volatile. If the global economy experiences significant disruptions, our business could be negatively impacted by reduced demand for our products related to a slow-down in the general economy, supplier or customer disruptions resulting from tighter credit markets, temporary interruptions in our ability to conduct day-to-day transactions through our financial intermediaries involving the payment to or collection of funds from our customers, vendors and suppliers and/or liquidity issues resulting from an inability to access credit markets to obtain cash to support operations. We could also be negatively impacted by an economic crisis in individual countries or regions, including sovereign risk related to a deterioration in the credit worthiness or a default by local governments. Such events could negatively impact our overall liquidity, as well as our ability to collect receipts due from governments, including refunds of value added taxes, and/or create significant credit risks relative to our local customers and depository institutions.

A failure of a key information technology system, process, site or service provider could have a material adverse impact on our business or reputation.

We rely extensively on information technology systems, including email and internet sites, as well as hardware, software and other applications, some of which are managed, hosted, provided or used by third-parties or their vendors, to conduct our business. The various uses of these systems and services include, but are not limited to, ordering and managing materials from suppliers, converting materials to finished products, shipping product to customers, marketing and selling products to consumers, collecting and storing customer, consumer, employee, investor and research information, processing transactions, summarizing and reporting results of operations, sharing confidential information, complying with regulatory, legal or tax requirements, providing data security, and other processes necessary to manage our business. If the systems or service providers we rely upon fail to function properly, or if we suffer a loss or disclosure of business or stakeholder information, due to any number of causes, ranging from catastrophic events to power outages to security breaches, and our business continuity plans do not effectively compensate on a timely basis, we may suffer interruptions in our ability to manage operations and reputational, competitive and/or business harm, which may adversely impact our results of operations and/or financial condition.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

ISSUER PURCHASES OF EQUITY SECURITIES

Period	Total Number of Shares Purchased (1)	Average Price Paid per Share (2)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)	Approximate Dollar Value of Shares That May Yet Be Purchased Under our Share Repurchase Program ($ in billions)
1/1/2012 - 1/31/2012	18,922,288	$66.07	18,920,128
2/1/2012 - 2/29/2012	13,411,924	$64.68	13,326,512	See Note 3
3/1/2012 - 3/1/2012	2,138,104	$64.66	2,137,967

(1) The total number of shares purchased was 34,472,316 for the quarter. This includes 87,709 shares acquired by the Company under various compensation and benefit plans. All transactions were made in the open market or pursuant to prepaid forward agreements with large financial institutions. Under these agreements, the Company prepays large financial institutions to deliver shares at future dates in exchange for a discount. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent, third party and does not repurchase stock in connection with cashless exercises.

(2) Average price paid per share is calculated on a settlement basis and excludes commission.

(3) On April 27, 2012, the Company stated that fiscal year 2011-12 share repurchases to reduce Company shares outstanding are estimated to be approximately $4 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by issuing a combination of long-term and short-term debt.

33

Item 6. Exhibits

3-1	Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-Q for the quarter ended September 30, 2011). .
3-2	Regulations (as amended by the Board of Directors effective January 16, 2012 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-Q for the quarter ended December 31, 2011.)
10-1	The Procter & Gamble 2009 Stock and Incentive Compensation Plan (incorporated by reference to Exhibit (10-3) of the Company's Form 10-Q for the quarter ended December 31, 2011) - Additional Terms and Conditions and related correspondence *
10-2	The Procter & Gamble Performance Stock Program Summary*
11	Computation of Earnings per Share.
12	Computation of Ratio of Earnings to Fixed Charges.
31.1	Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
31.2	Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
32.1	Section 1350 Certifications – Chief Executive Officer
32.2	Section 1350 Certifications – Chief Financial Officer
101.INS  (1)	XBRL Instance Document
101.SCH (1)	XBRL Taxonomy Extension Schema Document
101.CAL (1)	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF (1)	XBRL Taxonomy Definition Linkbase Document
101.LAB (1)	XBRL Taxonomy Extension Label Linkbase Document
101.PRE  (1)	XBRL Taxonomy Extension Presentation Linkbase Document

(1) XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

* Compensatory plan or arrangement

34

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

	THE PROCTER & GAMBLE COMPANY
April 27, 2012	/s/ VALARIE L. SHEPPARD
Date	(Valarie L. Sheppard)
	Senior Vice President and Comptroller

EXHIBIT INDEX

Exhibit
3-1	Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-Q for the quarter ended September 30, 2011). .
3-2	Regulations (as amended by the Board of Directors effective January 16, 2012 pursuant to authority granted by shareholders at the annual meeting on October 13, 2009). (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-Q for the quarter ended December 31, 2011.)
10-1	The Procter & Gamble 2009 Stock and Incentive Compensation Plan (incorporated by reference to Exhibit (10-3) of the Company's Form 10-Q for the quarter ended December 31, 2011) - Additional Terms and Conditions and related correspondence
10-2	The Procter & Gamble Performance Stock Program Summary
11	Computation of Earnings per Share.
12	Computation of Ratio of Earnings to Fixed Charges.
31.1	Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer
31.2	Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer
32.1	Section 1350 Certifications – Chief Executive Officer
32.2	Section 1350 Certifications – Chief Financial Officer
101.INS  (1)	XBRL Instance Document
101.SCH (1)	XBRL Taxonomy Extension Schema Document
101.CAL (1)	XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF (1)	XBRL Taxonomy Definition Linkbase Document
101.LAB (1)	XBRL Taxonomy Extension Label Linkbase Document
101.PRE  (1)	XBRL Taxonomy Extension Presentation Linkbase Document

(1) XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

EX-10.1

Exhibit (10-1)

The Procter & Gamble Stock and Incentive Compensation Plan - Additional Terms and Related Correspondence

THE PROCTER & GAMBLE COMPANY

STATEMENT OF TERMS AND CONDITIONS FOR KEY MANAGER RESTRICTED STOCK UNITS

THE PROCTER & GAMBLE 2009 STOCK AND INCENTIVE COMPENSATION PLAN

The Restricted Stock Units awarded to you as set forth in the letter you received from the Company (your “Award Letter”), and your ownership thereof, are subject to the following terms and conditions.

1.Definitions.

For purposes of this Statement of Terms and Conditions for Restricted Stock Units (“Terms and Conditions”), all capitalized terms not defined in these Terms and Conditions will have the meanings described in The Procter & Gamble 2009 Stock and Incentive Compensation Plan (the “Plan”), and the following terms will have the following meanings.

(a)“Data” has the meaning described in Section 6;

(b)“Forfeiture Date” is the date identified as such in your Award Letter;

(c)“Forfeiture Period” means the period from the Grant Date until the Forfeiture Date.

(d)“Grant Date” means the date a Restricted Stock Unit was awarded to you, as identified in your Award Letter;

(e)“Original Settlement Date” is the date identified as such in your Award Letter, as adjusted, if applicable, by Section 2;

(f)“Procter & Gamble” means the Company and/or its Subsidiaries;

(g)“Restricted Stock Unit” means an unfunded, unsecured promise by the Company, in accordance with these Terms and Conditions and the provisions of the Plan, to issue to you one share of Common Stock on the Original Settlement Date;

(h)“Separation from Service” shall have the meaning provided under Section 409A.

2.Transfer and Restrictions.

(a)Neither Restricted Stock Units nor your interest in them may be sold, exchanged, transferred, pledged, hypothecated, given or otherwise disposed of by you at any time, except by will or by the laws of descent and distribution. Any attempted transfer of a Restricted Stock Unit, whether voluntary or involuntary on your part, will result in the immediate forfeiture to the Company, and cancellation, of the Restricted Stock Unit.

(b)During the Forfeiture Period, your Restricted Stock Units will be forfeited and cancelled if you leave your employment with Procter & Gamble for any reason, except due to: (i) death; (ii) Retirement in accordance with the provisions of any appropriate Retirement plan of Procter & Gamble where you are employed through June 30^th following the Grant Date; or (iii) Special Separation where you are employed through June 30^th following the Grant Date. In the event of your death during the Forfeiture Period, your Forfeiture Date will automatically and immediately become, without any further action by you or the Company, the date of your death. In the event of your Retirement or Special Separation where you are employed through June 30^th following the Grant Date, your Forfeiture Date will automatically and immediately become, without any further action by you or the Company, the date of your Retirement or Special Separation.

(c)Upon your death, while you hold Restricted Stock Units, your Original Settlement Date will automatically and immediately become, without any further action by you or the Company, the date of your death, as applicable.

(d)Upon the occurrence of a Change in Control and in the event Article L, Paragraph 4(b) of the Plan applies, then notwithstanding anything in the Plan to the contrary (including Article L, Paragraph 4(b)(iv)), (i) the Forfeiture Date (if any) shall become the date the Change in Control occurred, (ii) if the Change in Control occurrence meets the definitional requirements of a change in control as defined under Section 409A, your Original Settlement Date will become the date the Change in Control occurred, and the award will be settled in accordance with the terms of the Plan, and (iii) if the Change in Control does not meet the Section 409A requirements, your award will be settled on the Original Settlement Date.

(e)From time to time, the Company and/or the Committee may establish procedures with which you must comply in order to accept an award of Restricted Stock Units, or to settle your Restricted Stock Units, including requiring you to do so by means of electronic signature, or charging you an administrative fee for doing so.

(f)Once your Restricted Stock Units have been settled by delivery to you of an equivalent number of shares of Common Stock, the Restricted Stock Units will have no further value, force or effect.

3.Voting and Other Shareholder Rights.

A Restricted Stock Unit is not a share of Common Stock, and thus you are not entitled to any voting, dividend or other rights as a shareholder of the Company with respect to the Restricted Stock Units you hold.

4.Suspension Periods and Termination.

The Company reserves the right from time to time to temporarily suspend your right to settle your Restricted Stock Units for shares of Common Stock where such suspension is deemed by the Company as necessary or appropriate and to the extent such action does not result in immediate taxation and penalties under Section 409A.

5. Consent

By accepting a Restricted Stock Unit, you acknowledge that: (i) the Plan is established voluntarily by The Procter & Gamble Company, is discretionary in nature, and may be amended, suspended or terminated at any time; (ii) the award of Restricted Stock Units is voluntary and occasional and does not create any contractual or other right to receive future awards of Restricted Stock Units, or benefits in lieu of Restricted Stock Units, even if Restricted Stock Units have been awarded repeatedly in the past; (iii) all decisions with respect to future Restricted Stock Unit awards, if any, will be at the sole discretion of the Company; (iv) your participation in the Plan is voluntary; (v) Restricted Stock Units are an extraordinary item and not part of normal or expected compensation or salary for any purpose, including without limitation calculating any termination, severance, resignation, redundancy, or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (vi) in the event that your employer is not the Company, the award of Restricted Stock Units will not be interpreted to form an employment relationship with the Company; and, furthermore, the award of Restricted Stock Units will not be interpreted to form an employment contract with any Procter & Gamble entity; (vii) the future value of Common Stock is unknown and cannot be predicted with certainty; and (viii) no claim or entitlement to compensation or damages arises from termination or forfeiture of Restricted Stock Units, or diminution in value of Restricted Stock Units or Common Stock received in settlement thereof, and you irrevocably release Procter & Gamble from any such claim that may arise.

6.Data Privacy.

By accepting a Restricted Stock Unit, you explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by and among, as applicable, any Procter & Gamble entity or third party for the purpose of implementing, administering and managing your

participation in the Plan. You understand that Procter & Gamble holds certain personal information about you, including without limitation your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in a Procter & Gamble entity, details of all options, Restricted Stock Units, or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of implementing, administering and managing the Plan (“Data”). You understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere, and that the recipient's country may have different data privacy laws and protections than your country. You understand that you may request a list with the names and addresses of any potential recipients of Data by contacting your local human resources representative. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data to any broker or other third party with whom you may elect to deposit any shares of Common Stock in connection with the settlement of your Restricted Stock Units. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the plan. You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents contained in this paragraph, in any case without cost, by contacting in writing your local human resources representative. You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.

7.Notices.

(a)Any notice to Procter & Gamble that is required or appropriate with respect to Restricted Stock Units held by you must be in writing and addressed to:

The Procter & Gamble Company

ATTN: Corporate Secretary's Office

P.O. Box 599

Cincinnati, OH 45201

or such other address as Procter & Gamble may from time to time provide to you in writing.

(b)Any notice to you that is required or appropriate with respect to Restricted Stock Units held or to be awarded to you will be provided to you in written or electronic form at any physical or electronic mail address for you that is on file with Procter & Gamble.

8.Successors and Assigns.

These Terms and Conditions are binding on, and inure to the benefit of, (a) the Company and its successors and assigns; and (b) you and, if applicable, the representative of your estate.

9.Governing Law.

The validity, interpretation, performance and enforcement of these Terms and Conditions, the Plan and your Restricted Stock Units will be governed by the laws of the State of Ohio, U.S.A. without giving effect to any other jurisdiction's conflicts of law principles. With respect to any dispute concerning these Terms and Conditions, the Plan and your Restricted Stock Units, you consent to the exclusive jurisdiction of the federal or state courts located in Hamilton County, Ohio, U.S.A.

10.The Plan.

All Restricted Stock Units awarded to you have been awarded under the Plan. Certain provisions of the Plan may have been repeated or emphasized in these Terms and Conditions; however, all terms of the Plan, including but

not limited to Article F, apply to you and your Restricted Stock Units whether or not they have been called out in these Terms and Conditions.

11.Effect of These Terms and Conditions.

These Terms and Conditions and the terms of the Plan, which are incorporated herein by reference, describe the contractual rights awarded to you in the form of Restricted Stock Units, and the obligations imposed on you in connection with those rights. No right exists with respect to Restricted Stock Units except as described in these Terms and Conditions and the Plan.

THE PROCTER & GAMBLE COMPANY

STATEMENT OF TERMS AND CONDITIONS FOR PERFORMANCE STOCK UNITS

THE PROCTER & GAMBLE 2009 STOCK AND INCENTIVE COMPENSATION PLAN

The Performance Stock Units awarded to you as set forth in the letter you received from the Company (your “Award Letter”), and your ownership thereof, are subject to the following terms and conditions.

1.Definitions.

For purposes of this Statement of Terms and Conditions for Performance Stock Units (“Terms and Conditions”), all capitalized terms not defined in these Terms and Conditions will have the meanings described in The Procter & Gamble 2009 Stock and Incentive Compensation Plan (the “Plan”), and the following terms will have the following meanings.

(a) “Data” has the meaning described in Section 8;

(b) “Forfeiture Date” is the date identified as such in your Award Letter;

(c) “Forfeiture Period” means the period from the Grant Date until the Forfeiture Date.

(d) “Grant Date” means the date a Performance Stock Unit was awarded to you, as identified in your Award Letter;

(e) “Maximum Units” has the meaning described in section 3 and as identified as the Maximum Number of Performance Stocks Units in your Award Letter.

(f) “Original Settlement Date” is the date identified as such in your Award Letter, as adjusted, if applicable, by Section 2;

(g) “Procter & Gamble” means the Company and/or its Subsidiaries;

(h)”Performance Period” means the period identified as such in your Award Letter.

(i) “Performance Stock Unit” means an unfunded, unsecured promise by the Company, subject to, and in accordance with these Terms and Conditions and the provisions of the Plan, to issue to you one share of Common Stock or a Restricted Stock Unit on the Original Settlement Date;

(j) “Separation from Service” shall have the meaning provided under Section 409A.

(k) “Target Units” has the meaning described in Section 3 and as identified as the Target Number of PSUs in your Award Letter.

2.Transfer and Restrictions.

(a) Neither Performance Stock Units nor your interest in them may be sold, exchanged, transferred, pledged, hypothecated, given or otherwise disposed of by you at any time, except by will or by the laws of descent and distribution. Any attempted transfer of a Performance Stock Unit, whether voluntary or involuntary on your part, will result in the immediate forfeiture to the Company, and cancellation, of the Performance Stock Unit.

(b) During the Forfeiture Period, your Performance Stock Units will be forfeited and cancelled if you leave your employment with Procter & Gamble for any reason, except due to: (i) death; (ii) Retirement in accordance with the provisions of any appropriate Retirement plan of Procter & Gamble where you are employed through June 30 of the first year of the Performance Period; or (iii) Special Separation where you are employed through June 30 of the first year of the Performance Period. In the event of your death during the Forfeiture Period, your Forfeiture Date will automatically and immediately become, without any further action by you or the Company, the date of your death. In the event of your Retirement or Special Separation where you are employed through June 30 of the first year of the Performance Period, your Forfeiture Date will automatically and immediately become, without any further action by you or the Company, the date of your Retirement or Special Separation.

(d) Upon the occurrence of a Change in Control that meets the definitional requirements of a change in control event as defined under Section 409A, then notwithstanding anything in the Plan to the contrary, if not previously cancelled, forfeited or vested, (i) the Target Units will vest, (ii) your right to any Performance Stock Units greater than the Target Units will be forfeited, and (iii) your Original Settlement Date will become the date the Change in Control occurred. Upon the occurrence of a Change in Control that does not meet the definitional requirements of a change in control event as defined under Section 409A, then notwithstanding anything in the Plan to the contrary, your award will be settled in accordance with these Terms and Conditions, without the application of Article L, Paragraph 4 of the Plan.

(e) From time to time, the Company and/or the Committee may establish procedures with which you must comply in order to accept an award of Performance Stock Units, or to settle your Performance Stock Units, including requiring you to do so by means of electronic signature, or charging you an administrative fee for doing so.

3.Performance Vesting

(a) Subject to these Terms and Conditions, your targeted number of Performance Stock Units indicated in your Award Letter (the “Target Units”) will vest depending upon performance during the Performance Period, as specified below. Your Award Letter also sets forth the maximum number of Performance Stock Units (the “Maximum Units”) that you may receive pursuant to this award. Your right to receive all, any portion of, or more than the Target Units (but in no event more than the Maximum Units) will be contingent upon the achievement of specified levels of certain performance goals measured over the Performance Period. The applicable performance goals and the payout factors for each performance goal applicable to your award for the Performance Period are set forth in your Award Letter.

(b) Within 60 days following the end of the Performance Period, the Committee will determine (i) whether and to what extent the performance goals have been satisfied for the Performance Period, (ii) the number of Performance Stock Units that shall have become vested under this award, and (iii) whether the other applicable vesting and other conditions for receipt of shares of Common Stock in respect of the Performance

Stock Units have been met. Any of your Performance Stock Units that do not vest in accordance with this Section 3(b) will be forfeited and cancelled.

4.Settlement.

(a) At any time at least six months prior to the end of the Performance Period and so long as the achievement of the applicable performance goals are not yet readily ascertainable (but in no event later than your separation from service from the Company), you and the Company may agree to postpone the date on which you are entitled to receive one share of Common Stock by issuing you one Restricted Stock Unit for each vested Performance Stock Unit on the Original Settlement Date, which Restricted Stock Unit shall be paid on such later date as may be elected by you in accordance with Section 409A.

(b) The Company will settle your vested Performance Stock Units by issuing you one share of Common Stock or one Restricted Stock Unit (RSU) for each vested Performance Stock Unit on or as soon as practicable (but in no event more than 60 days) following the Original Settlement Date.

(c) Once your Performance Stock Units have been settled by delivery to you of an equivalent number of shares of Common Stock or RSUs, the Performance Stock Units will have no further value, force or effect.

5.Voting and Other Shareholder Rights.

A Performance Stock Unit is not a share of Common Stock, and thus you are not entitled to any voting, dividend or other rights as a shareholder of the Company with respect to the Performance Stock Units you hold.

6.Suspension Periods and Termination.

The Company reserves the right from time to time to temporarily suspend your right to settle your Performance Stock Units for shares of Common Stock where such suspension is deemed by the Company as necessary or appropriate and to the extent such action does not result in immediate taxation and penalties under Section 409A.

7. Consent

By accepting a Performance Stock Unit, you acknowledge that: (i) the Plan is established voluntarily by The Procter & Gamble Company, is discretionary in nature, and may be amended, suspended or terminated at any time; (ii) the award of Performance Stock Units is voluntary and occasional and does not create any contractual or other right to receive future awards of Performance Stock Units, or benefits in lieu of Performance Stock Units, even if Performance Stock Units have been awarded repeatedly in the past; (iii) all decisions with respect to future Performance Stock Unit awards, if any, will be at the sole discretion of the Company; (iv) your participation in the Plan is voluntary; (v) Performance Stock Units are an extraordinary item and not part of normal or expected compensation or salary for any purpose, including without limitation calculating any termination, severance, resignation, redundancy, or end-of-service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (vi) in the event that your employer is not the Company, the award of Performance Stock Units will not be interpreted to form an employment relationship with the Company; and, furthermore, the award of Performance Stock Units will not be interpreted to form an employment contract with any Procter & Gamble entity; (vii) the future value of Common Stock is unknown and cannot be predicted with certainty; and (viii) no claim or entitlement to compensation or damages arises from termination or forfeiture of Performance Stock Units, or diminution in value of Performance Stock Units or Common Stock received in settlement thereof, and you irrevocably release Procter & Gamble from any such claim that may arise.

8.Data Privacy.

By accepting a Performance Stock Unit, you explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this document by and among, as applicable, any Procter & Gamble entity or third party for the purpose of implementing, administering and managing your participation in the Plan. You understand that Procter & Gamble holds certain personal information about you, including without limitation your name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in a Procter & Gamble entity, details of all options, Performance Stock Units, or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in your favor, for the purpose of implementing, administering and managing the Plan (“Data”). You understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in your country or elsewhere, and that the recipient's country may have different data privacy laws and protections than your country. You understand that you may request a list with the names and addresses of any potential recipients of Data by contacting your local human resources representative. You authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing your participation in the Plan, including any requisite transfer of such Data to any broker or other third party with whom you may elect to deposit any shares of Common Stock in connection with the settlement of your Performance Stock Units. You understand that Data will be held only as long as is necessary to implement, administer and manage your participation in the plan. You understand that you may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data, or refuse or withdraw the consents contained in this paragraph, in any case without cost, by contacting in writing your local human resources representative. You understand, however, that refusing or withdrawing your consent may affect your ability to participate in the Plan. For more information on the consequences of your refusal to consent or withdrawal of consent, you understand that you may contact your local human resources representative.

9.Notices.

(a) Any notice to Procter & Gamble that is required or appropriate with respect to Performance Stock Units held by you must be in writing and addressed to:

The Procter & Gamble Company

ATTN: Corporate Secretary's Office

P.O. Box 599

Cincinnati, OH 45201

or such other address as Procter & Gamble may from time to time provide to you in writing.

(b) Any notice to you that is required or appropriate with respect to Performance Stock Units held or to be awarded to you will be provided to you in written or electronic form at any physical or electronic mail address for you that is on file with Procter & Gamble.

10.Successors and Assigns.

These Terms and Conditions are binding on, and inure to the benefit of, (a) the Company and its successors and assigns; and (b) you and, if applicable, the representative of your estate.

11.Governing Law.

The validity, interpretation, performance and enforcement of these Terms and Conditions, the Plan and your Performance Stock Units will be governed by the laws of the State of Ohio, U.S.A. without giving effect to any other jurisdiction's conflicts of law principles. With respect to any dispute concerning these Terms and Conditions, the Plan and your Performance Stock Units, you consent to the exclusive jurisdiction of the federal or state courts located in Hamilton County, Ohio, U.S.A.

12.The Plan.

All Performance Stock Units awarded to you have been awarded under the Plan. Certain provisions of the Plan may have been repeated or emphasized in these Terms and Conditions; however, all terms of the Plan, including but not limited to Article F, apply to you and your Performance Stock Units whether or not they have been called out in these Terms and Conditions.

13.Effect of These Terms and Conditions.

These Terms and Conditions and the terms of the Plan, which are incorporated herein by reference, describe the contractual rights awarded to you in the form of Performance Stock Units, and the obligations imposed on you in connection with those rights. No right exists with respect to Performance Stock Units except as described in these Terms and Conditions and the Plan.

_____________________________________________________________________________

[GRANT_DATE][GLOBALID]

[FIRST_NAME] [MIDDLE_NAME] [LAST_NAME]

Subject: NON-STATUTORY STOCK OPTION SERIES XX-AA

In recognition of your contributions to the future success of the business, The Procter & Gamble Company (“Company”) hereby grants to you an option to purchase shares of Procter & Gamble Common Stock as follows:

Grant Value:$[DELIVERED_GRANT_VALUE]

Option Price per Share:$[STOCK_PRCE]

Number of Shares:[SHARES]

Date of Grant:[GRANT_DATE]

Expiration of Option:[EXPIRATION DATE]

Option Vest Date:100% after [vest date]

Acceptance Deadline:[ACCEPTANCE DATE]

This stock option is granted in accordance with and subject to the terms of The Procter & Gamble 2009 Stock and Incentive Compensation Plan (including any applicable sub-plan) (the “Plan”), the Regulations of the Compensation and Leadership Development Committee of the Board of Directors (“Committee”), and the Exercise Instructions in place as may be revised from time to time.

You may access, download and/or print the terms, or any portion thereof, of the Plan by activating this hyperlink: The Procter & Gamble 2009 Stock and Incentive Compensation Plan and the Regulations by activating this hyperlink: Regulations of the Committee (sub-plans included). Nonetheless, if you would prefer to receive a paper copy of The Procter & Gamble 2009 Stock and Incentive Compensation Plan and/or Regulations, please send a written request via email to Execcomp.IM@pg.com. Please understand that you will continue to receive future Plan materials and information via electronic mail even though you may have requested a paper copy.

The option is not transferable other than by will or the laws of descent and distribution and is exercisable during your life only by you. This option will become void upon any separation (including retirement) from the Company or any of its subsidiaries unless you are employed through June 30^th following the grant date. This option may also become void upon separation from the Company or any of its subsidiaries at any time after June 30^th following the grant date (see Article G,paragraph 9(a) of the Plan). For the purposes of this option, separation from the Company or any of its subsidiaries and termination of employment will be effective as of the date that you are no longer actively employed and will not be extended by any notice period required under local law.

Please note that when the issue or transfer of the Common Stock covered by this option may, in the opinion of the Company, conflict or be inconsistent with any applicable law or regulation of any governmental agency, the Company reserves the right to refuse to issue or transfer said Common Stock and that any outstanding options may be suspended or terminated and net proceeds may be recovered by the Company if you fail to comply with the terms and conditions governing this award.

This option to purchase shares of Common Stock of the Company is subject to the Employee Acknowledgement and Consent Form below and to the terms of the Plan and Regulations of the Committee, with which you acknowledge you are familiar by accepting this award, including the non-compete and non-solicitation provisions and other terms of Article F of the Plan. The option is also subject to and bound by the actions of the Compensation and Leadership Development Committee and of the Company's Board of Directors. This option grant, the Plan and Regulations of the Committee together constitute an agreement between the Company and you in accordance with the terms thereof and hereof, and no other understandings and/or agreements have been entered by you with the Company regarding this specific stock option grant. Any legal action related to this option, including Article F, may be brought in any federal or state court located in Hamilton County, Ohio, USA, and you hereby agree to accept the jurisdiction of these courts and consent to service of process from said courts solely for legal actions related to this option grant.

Under IRS standards of professional practice, certain tax advice must meet requirements as to form and substance. To assure compliance with these standards, we disclose to you that this communication is not intended or written to be used, and cannot be used, for the purpose of avoiding penalties or promoting, marketing, or recommending to another party any transaction or matter addressed herein.

THE PROCTER & GAMBLE COMPANY

Moheet Nagrath

Global Human Resources Officer

ATTACHMENTS

To Accept Your Stock Option

Read and check each of the boxes below:

o I have read, understand and agree to be bound by each of: the terms of this letter and attachments above; The Procter & Gamble 2009 Stock and Incentive Compensation Plan; Regulations of the Committee and the Employee Acknowledgement and Consent Form (below).

o I accept the stock option grant detailed above. (To accept this option, you must also check the box above.)

To Reject Your Stock Option

Read and check the box below:

o I have read and understand the terms noted above. I do not agree to be bound by these terms, and hereby reject the stock option grant detailed above.

Employee Acknowledgement and Consent Form

I understand that I am eligible to receive a grant or restricted stock units (“RSUs”) under The Procter & Gamble 2009 Stock and Incentive Compensation Plan referred to as the “Plan”.

Data Privacy

I hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this document by and among, as applicable, my employer (“Employer”) and The Procter & Gamble Company and its subsidiaries and affiliates (“P&G”) for the exclusive purpose of implementing, administering and managing my participation in the Plan.

I understand that P&G and my Employer hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in P&G, details of all grants or RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in my favor, for the purpose of implementing, administering and managing the Plan (“Data”). I understand that Data may be transferred to

any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in my country or elsewhere, and that the recipient's country may have different data privacy laws and protections than my country. I understand that I may request a list with the names and addresses of any potential recipients of the Data by contacting my local human resources representative. I authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom I may elect to deposit any shares of stock acquired upon exercise or settlement of the grant or RSUs. I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the Plan. I understand that I may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing my local human resources representative. I understand, however, that refusing or withdrawing my consent may affect my ability to participate in the Plan. For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.

Nature of Grant

By completing this form and accepting the grant or RSUs evidenced hereby, I acknowledge that: i) the Plan is established voluntarily by The Procter & Gamble Company, it is discretionary in nature and it may be amended, suspended or terminated at any time; ii) the grant or RSUs under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants or RSUs, or benefits in lieu of a grant or RSUs, even if grants or RSUs have been granted repeatedly in the past; iii) all decisions with respect to future grants or RSUs, if any, will be at the sole discretion of P&G; iv) my participation in the Plan is voluntary; v) the grant or RSUs is an extraordinary item and not part of normal or expected compensation or salary for any purposes including, but not limited to, calculating any termination, severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; vi) in the event that my employer is not P&G, the grant or RSUs will not be interpreted to form an employment relationship with P&G; and furthermore, the grant or RSUs will not be interpreted to form an employment contract with my Employer; vii) the future value of the shares purchased under the Plan is unknown and cannot be predicted with certainty, may increase or decrease in value and potentially have no value; iix) my participation in the Plan shall not create a right to further employment with my Employer and shall not interfere with the ability of my Employer to terminate my employment relationship at any time, with or without cause; ix) and no claim or entitlement to compensation or damages arises from the termination of the grant or RSUs or the diminution in value of the grant or RSUs or shares purchased and I irrevocably release P&G and my Employer from any such claim that may arise.

Responsibility for Taxes

Regardless of any action P&Gor my Employer takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), I acknowledge that the ultimate liability for all Tax-Related Items is and remains my responsibility and that P&G and/or my Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the grant or RSUs, including the issuance, vesting or exercise, settlement, the subsequent sale of shares acquired, the receipt of any dividends or the potential impact of current or future tax legislation in any jurisdiction; and (2) do not commit to structure the terms of the grant or RSUs or any aspect of the grant or RSUs to reduce or eliminate my liability for Tax-Related Items.

Prior to exercise or settlement of a grant or RSUs , I shall pay or make adequate arrangements satisfactory to P&G and/or my Employer to satisfy all withholding and payment on account obligations of P&G and/or my Employer. In this regard, I authorize P&G and/or my Employer to withhold all applicable Tax-Related Items from my wages or other cash compensation paid to me by P&G and/or my Employer or from proceeds of the sale of the shares. Alternatively, or in addition, if permissible under local law, P&G may (1) sell or arrange for the sale of shares that I acquire to meet the withholding obligation for Tax-Related Items, and/or (2) withhold in shares, provided that P&G only withholds the amount of shares necessary to satisfy the minimum withholding amount. Finally, I shall pay to P&G or my Employer any amount of Tax-Related Items that P&G or my Employer may be required to withhold as a result of my participation in the Plan or my purchase of shares that cannot be satisfied by the means previously described. P&G may refuse to honor the exercise and refuse to deliver the shares if I fail to comply with my obligations in connection with the Tax-Related Items as described in this section.

_____________________________________________________________________________

[GRANT_DATE][GLOBALID]

[FIRST_NAME] [MIDDLE_NAME] [LAST_NAME]

Subject: AWARD OF RESTRICTED STOCK UNITS SERIES XX-KM-RSU

In recognition of your contributions to the future success of the business, The Procter & Gamble Company (“Company”) hereby grants to you Restricted Stock Units (“RSUs”) as follows:

Number of Restricted Stock Units:[RSUSHARES]

Date of Grant<date>

Forfeiture Date: <forfeiture date>

Settlement Date(Shares Delivered on):<settlement date>

Acceptance Deadline: <acceptance date>

These RSUs are granted in accordance with and subject to the terms of The Procter & Gamble 2009 Stock and Incentive Compensation Plan (including any applicable sub-plan) (the “Plan”), the Regulations of the Compensation and Leadership Development Committee of the Board of Directors (“Committee”), the Settlement Instructions in place as may be revised from time to time, and the attached Statement of Terms and Conditions Form KM.

You may access, download and/or print the terms, or any portion thereof, of the Plan by activating this hyperlink: The Procter & Gamble 2009 Stock and Incentive Compensation Plan and the Regulations byactivating this hyperlink: Regulations of the Committee (sub-plans included). Nonetheless, if you would prefer to receive a paper copy of The Procter & Gamble 2009 Stock and Incentive Compensation Plan and/or Regulations, please send a written request via email to Execcomp.IM@pg.com. Please understand that you will continue to receive future Plan materials and information via electronic mail even though you may have requested a paper copy.

RSUs are not transferable other than by will or the laws of descent and distribution and are exercisable during your life only by you. RSUs will become void upon any separation (including retirement) from the Company or any of its subsidiaries unless you are employed through June 30^th following the grant date. RSUs may also become void upon separation from the Company or any of its subsidiaries at any time after June 30^th following the grant date (see Section 2(b) of Terms and Conditions Form KM). For the purposes of this RSU grant, separation from the Company or any of its subsidiaries and termination of employment will be effective as of the date that you are no longer actively employed and will not be extended by any notice period required under local law.

Please note that when the issue or transfer of the Common Stock covered by this RSU grant may, in the opinion of the Company, conflict or be inconsistent with any applicable law or regulation of any governmental agency, the Company reserves the right to refuse to issue or transfer said Common Stock and that any outstanding RSUs may be suspended or terminated and net proceeds may be recovered by the Company if you fail to comply with the terms and conditions governing this award.

RSUs granted hereunder are subject to the Employee Acknowledgement and Consent Form below, the terms of the Plan and Regulations of the Committee, and the attached statement of Terms and Conditions Form KM, with which you acknowledge you are familiar by accepting this award, including the non-compete and non-solicitation provisions and other terms of Article F of the Plan. These RSUs are also subject to and bound by the actions of the Compensation and Leadership Development Committee and of the Company's Board of Directors. This RSU grant, the Plan and Regulations of the Committee, and the attached statement of Terms and Conditions Form KM together constitute an agreement between the Company and you in accordance with the terms thereof and hereof, and no other understandings and/or agreements have been entered by you with the Company regarding these RSUs. Any legal action related to these RSUs, including the non-compete provisions, may be brought in any federal or state court located in Hamilton County, Ohio, USA, and you hereby agree to accept the jurisdiction of these courts and consent to service of process from said courts solely for legal actions related to this RSU grant.

Under IRS standards of professional practice, certain tax advice must meet requirements as to form and substance. To assure compliance with these standards, we disclose to you that this communication is not intended or written to be used, and cannot be used, for the purpose of avoiding penalties or promoting, marketing, or recommending to another party any transaction or matter addressed herein.

THE PROCTER & GAMBLE COMPANY

Moheet Nagrath

Global Human Resources Officer

ATTACHMENTS

To Accept Your Restricted Stock Unit Grant

Read and check each of the boxes below:

o I have read, understand and agree to be bound by each of: the terms of this letter and attachments above; The Procter & Gamble 2009 Stock and IncentiveCompensation Plan; Regulations of the Committee; Terms and Conditions Form KM; and the Employee Acknowledgement and Consent Form (below).

o I accept the Restricted Stock Unit grant detailed above. (To accept this grant, you must also check the box above.)

To Reject Your Restricted Stock Unit Grant

Read and check the box below:

o I have read and understand the terms noted above. I do not agree to be bound by these terms, and hereby reject the Restricted Stock Unit grant detailed above.

Employee Acknowledgement and Consent Form

I understand that I am eligible to receive a grant or restricted stock units (“RSUs”) under The Procter & Gamble 2009 Stock and Incentive Compensation Plan referred to as the “Plan”.

Data Privacy

I hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this document by and among, as applicable, my employer (“Employer”) and The Procter & Gamble Company and its subsidiaries and affiliates (“P&G”) for the exclusive purpose of implementing, administering and managing my participation in the Plan.

I understand that P&G and my Employer hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in P&G, details of all grants or RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in my favor, for the purpose of implementing, administering and managing the Plan (“Data”). I understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in my country or elsewhere, and that the recipient's country may have different data privacy laws and protections than my country. I understand that I may request a list with the names and addresses of any potential recipients of the Data by contacting my local human resources representative. I authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom I may elect to deposit any shares of stock acquired upon exercise or settlement of the grant or RSUs. I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the Plan. I understand that I may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing my local human resources representative. I understand, however, that refusing or withdrawing my consent may affect my ability to participate in the Plan. For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.

Nature of Grant

By completing this form and accepting the grant or RSUs evidenced hereby, I acknowledge that: i) the Plan is established voluntarily by The Procter & Gamble Company, it is discretionary in nature and it may be amended, suspended or terminated at any time; ii) the grant or RSUs under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants or RSUs, or benefits in lieu of a grant or RSUs, even if grants or RSUs have been granted repeatedly in the past; iii) all decisions with respect to future grants or RSUs, if any, will be at the sole discretion of P&G; iv) my participation in the Plan is voluntary; v) the grant or RSUs is an extraordinary item and not part of normal or expected compensation or salary for any purposes including, but not limited to, calculating any termination, severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; vi) in the event that my employer is not P&G, the grant or RSUs will not be interpreted to form an employment relationship with P&G; and furthermore, the grant or RSUs will not be interpreted to form an employment contract with my Employer; vii) the future value of the shares purchased

under the Plan is unknown and cannot be predicted with certainty, may increase or decrease in value and potentially have no value; iix) my participation in the Plan shall not create a right to further employment with my Employer and shall not interfere with the ability of my Employer to terminate my employment relationship at any time, with or without cause; ix) and no claim or entitlement to compensation or damages arises from the termination of the grant or RSUs or the diminution in value of the grant or RSUs or shares purchased and I irrevocably release P&G and my Employer from any such claim that may arise.

Responsibility for Taxes

Regardless of any action P&Gor my Employer takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), I acknowledge that the ultimate liability for all Tax-Related Items is and remains my responsibility and that P&G and/or my Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the grant or RSUs, including the issuance, vesting or exercise, settlement, the subsequent sale of shares acquired, the receipt of any dividends or the potential impact of current or future tax legislation in any jurisdiction; and (2) do not commit to structure the terms of the grant or RSUs or any aspect of the grant or RSUs to reduce or eliminate my liability for Tax-Related Items.

Prior to exercise or settlement of a grant or RSUs , I shall pay or make adequate arrangements satisfactory to P&G and/or my Employer to satisfy all withholding and payment on account obligations of P&G and/or my Employer. In this regard, I authorize P&G and/or my Employer to withhold all applicable Tax-Related Items from my wages or other cash compensation paid to me by P&G and/or my Employer or from proceeds of the sale of the shares. Alternatively, or in addition, if permissible under local law, P&G may (1) sell or arrange for the sale of shares that I acquire to meet the withholding obligation for Tax-Related Items, and/or (2) withhold in shares, provided that P&G only withholds the amount of shares necessary to satisfy the minimum withholding amount. Finally, I shall pay to P&G or my Employer any amount of Tax-Related Items that P&G or my Employer may be required to withhold as a result of my participation in the Plan or my purchase of shares that cannot be satisfied by the means previously described. P&G may refuse to honor the exercise and refuse to deliver the shares if I fail to comply with my obligations in connection with the Tax-Related Items as described in this section.

_____________________________________________________________________________

<GRANT_DATE>>

«FIRST_NAME» «MIDDLE_NAME» «LAST_NAME»«GLOBAL_ID»

Subject: AWARD OF PERFORMANCE STOCK UNIT SERIES XX-XX-PSP

In recognition of your contributions to the future success of the business, The Procter & Gamble Company (“Company”) hereby grants to you Performance Stock Units (“PSUs”) as follows:

Target Number of PSUs:	«PSP_TARGET_PSUs»
Maximum Number of PSUs:	«MAXIMUM_NUMBER_OF_PSUs»
Grant Date:	<date>
Forfeiture Date:	<forfeiture date>
Performance Period:	July 1, 20XX - June 30, 20XX
Original Settlement Date (Shares Delivered on):	<settlement date>
Acceptance Deadline:	<acceptance date>

These PSUs are granted in accordance with and subject to the terms of The Procter & Gamble 2009 Stock and Incentive Compensation Plan (including any applicable sub-plan) (the “Plan”), the Performance Stock Plan, the Regulations of the Compensation and Leadership Development Committee of the Board of Directors (“Committee”), the Settlement Instructions in place as may be revised from time to time, and the attached Statement of Terms and Conditions Form-PP.

PSUs are not transferable other than by will or the laws of descent and distribution. PSUs will become void upon any separation (including retirement) from the Company or any of its subsidiaries unless you are employed through June 30, 20XX. PSUs may also become void upon separation from the Company or any of its subsidiaries at any time after

June 30, 20XX (see Section 4 of Terms and Conditions Form PP). For the purposes of this PSU grant, separation from the Company or any of its subsidiaries and termination of employment will be effective as of the date that you are no longer actively employed and will not be extended by any notice period required under local law.

Your right to receive all, any portion of or more than the Target Number of PSUs (but in no event more than the Maximum Number of PSUs) is contingent upon the achievement of specified levels of certain performance goals measured over the Performance Period. The applicable performance goals and payout factors for each performance goal applicable to your award for the Performance Period are set forth in attachment A.

Please note that when the issue or transfer of the Common Stock covered by this PSU grant may, in the opinion of the Company, conflict or be inconsistent with any applicable law or regulation of any governmental agency, the Company reserves the right to refuse to issue or transfer said Common Stock and that any outstanding PSUs may be suspended or terminated and net proceeds may be recovered by the Company, if you fail to comply with the terms and conditions governing this award.

PSUs granted hereunder are subject to the Employee Acknowledgement and Consent Form enclosed, the terms of the Plan, the Performance Stock Plan, and Regulations of the Committee, and the attached statement of Terms and Conditions Form-PP, with which you acknowledge you are familiar by accepting this award, including the non-compete and non-solicitation provisions and other terms of Article F of the Plan. These PSUs are also subject to and bound by the actions of the Compensation and Leadership Development Committee and of the Company's Board of Directors. This PSU grant, the Plan, the Performance Stock Plan and Regulations of the Committee, and the attached statement of Terms and Conditions Form-PP together constitute an agreement between the Company and you in accordance with the terms thereof and hereof, and no other understandings and/or agreements have been entered by you with the Company regarding these PSUs. Any legal action related to these PSUs, including the non-compete provisions, may be brought in any federal or state court located in Hamilton County, Ohio, USA, and you hereby agree to accept the jurisdiction of these courts and consent to service of process from said courts solely for legal actions related to this PSU grant.

Under IRS standards of professional practice, certain tax advice must meet requirements as to form and substance. To assure compliance with these standards, we disclose to you that this communication is not intended or written to be used, and cannot be used, for the purpose of avoiding penalties or promoting, marketing, or recommending to another party any transaction or matter addressed herein.

THE PROCTER & GAMBLE COMPANY

Moheet Nagrath

Global Human Resources Officer

ATTACHMENTS

To Accept Your Performance Stock Units Award

Read and check each of the boxes below:

o I have read, understand and agree to be bound by each of: the terms of this letter and attachments above; The Procter & Gamble 2009 Stock and Incentive Compensation Plan; The Performance Stock Plan, Regulations of the Committee, Terms and Conditions Form PP, and the Employee Acknowledgement and Consent Form (below).

o I accept the Performance Stock Units detailed above. (To accept this option, you must also check the box above.)

To Reject Your Performance Stock Units Award

Read and check the box below:

o I have read and understand the terms noted above. I do not agree to be bound by these terms, and hereby reject the Performance Stock Units grant detailed above.

Employee Acknowledgement and Consent Form

I understand that I am eligible to receive a grant or restricted stock units (“RSUs”) under The Procter & Gamble 2009 Stock and Incentive Compensation Plan referred to as the “Plan”.

Data Privacy

I hereby explicitly and unambiguously consent to the collection, use and transfer, in electronic or other form, of my personal data as described in this document by and among, as applicable, my employer (“Employer”) and The Procter & Gamble Company and its subsidiaries and affiliates (“P&G”) for the exclusive purpose of implementing, administering and managing my participation in the Plan.

I understand that P&G and my Employer hold certain personal information about me, including, but not limited to, my name, home address and telephone number, date of birth, social insurance number or other identification number, salary, nationality, job title, any shares of stock or directorships held in P&G, details of all grants or RSUs or any other entitlement to shares of stock awarded, canceled, exercised, vested, unvested or outstanding in my favor, for the purpose of implementing, administering and managing the Plan (“Data”). I understand that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in my country or elsewhere, and that the recipient's country may have different data privacy laws and protections than my country. I understand that I may request a list with the names and addresses of any potential recipients of the Data by contacting my local human resources representative. I authorize the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom I may elect to deposit any shares of stock acquired upon exercise or settlement of the grant or RSUs. I understand that Data will be held only as long as is necessary to implement, administer and manage my participation in the Plan. I understand that I may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing my local human resources representative. I understand, however, that refusing or withdrawing my consent may affect my ability to participate in the Plan. For more information on the consequences of my refusal to consent or withdrawal of consent, I understand that I may contact my local human resources representative.

Nature of Grant

By completing this form and accepting the grant or RSUs evidenced hereby, I acknowledge that: i) the Plan is established voluntarily by The Procter & Gamble Company, it is discretionary in nature and it may be amended, suspended or terminated at any time; ii) the grant or RSUs under the Plan is voluntary and occasional and does not create any contractual or other right to receive future grants or RSUs, or benefits in lieu of a grant or RSUs, even if grants or RSUs have been granted repeatedly in the past; iii) all decisions with respect to future grants or RSUs, if any, will be at the sole discretion of P&G; iv) my participation in the Plan is voluntary; v) the grant or RSUs is an extraordinary item and not part of normal or expected compensation or salary for any purposes including, but not limited to, calculating any termination, severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; vi) in the event that my employer is not P&G, the grant or RSUs will not be interpreted to form an employment relationship with P&G; and furthermore, the grant or RSUs will not be interpreted to form an employment contract with my Employer; vii) the future value of the shares purchased under the Plan is unknown and cannot be predicted with certainty, may increase or decrease in value and potentially have no value; iix) my participation in the Plan shall not create a right to further employment with my Employer and shall not interfere with the ability of my Employer to terminate my employment relationship at any time, with or without cause; ix) and no claim or entitlement to compensation or damages arises from the termination of the grant or RSUs or the diminution in value of the grant or RSUs or shares purchased and I irrevocably release P&G and my Employer from any such claim that may arise.

Responsibility for Taxes

Regardless of any action P&Gor my Employer takes with respect to any or all income tax, social insurance, payroll tax, payment on account or other tax-related withholding (“Tax-Related Items”), I acknowledge that the ultimate liability for all Tax-Related Items is and remains my responsibility and that P&G and/or my Employer (1) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the grant or RSUs, including the issuance, vesting or exercise, settlement, the subsequent sale of shares acquired, the receipt of any dividends or the potential impact of current or future tax legislation in any jurisdiction; and (2) do not commit to structure the terms of the grant or RSUs or any aspect of the grant or RSUs to reduce or eliminate my liability for Tax-Related Items.

Prior to exercise or settlement of a grant or RSUs , I shall pay or make adequate arrangements satisfactory to P&G and/or my Employer to satisfy all withholding and payment on account obligations of P&G and/or my Employer. In this regard, I authorize P&G and/or my Employer to withhold all applicable Tax-Related Items from my wages or other cash compensation paid to me by P&G and/or my Employer or from proceeds of the sale of the shares. Alternatively, or in

addition, if permissible under local law, P&G may (1) sell or arrange for the sale of shares that I acquire to meet the withholding obligation for Tax-Related Items, and/or (2) withhold in shares, provided that P&G only withholds the amount of shares necessary to satisfy the minimum withholding amount. Finally, I shall pay to P&G or my Employer any amount of Tax-Related Items that P&G or my Employer may be required to withhold as a result of my participation in the Plan or my purchase of shares that cannot be satisfied by the means previously described. P&G may refuse to honor the exercise and refuse to deliver the shares if I fail to comply with my obligations in connection with the Tax-Related Items as described in this section.

EX-10.2

Exhibit (10-2)

The Procter & Gamble Performance Stock Program Summary

PERFORMANCE STOCK PROGRAM SUMMARY

The Performance Stock Program (“PSP”) is a part of The Procter & Gamble Company’s (the “Company”) long-term incentive compensation and is designed to provide additional focus on key Company measures for top executives with senior management responsibility for total Company results. Awards granted under the PSP (“PSP Awards”) are made pursuant to authority delegated to the Compensation & Leadership Development Committee (the “C&LD Committee”) by the Board of Directors for determining compensation for the Company’s principal officers and for making awards under the Procter & Gamble 2009 Stock and Incentive Compensation Plan (the “2009 Plan”) or any successor stock plan approved in accordance with applicable listing standards. To the extent awarded under the 2009 Plan, the PSP Awards are Performance Awards (as defined in the 2009 Plan).

I.    ELIGIBILITY

The Chairman of the Board and Chief Executive Officer and those principal officers at Band 7 or above recommended by management and approved by the C&LD Committee are eligible to participate (“Participants”).

II.    OVERVIEW

PSP rewards Participants for Company performance against certain three-year performance goals in categories established by the C&LD Committee. The C&LD Committee sets these performance goals for each three-year period that begins on July 1 and ends on June 30 three years later (“Performance Period”). In the first year of each Performance Period, the C&LD Committee grants Performance Stock Units (“PSUs”) to Participants that will vest at the end of the Performance Period based on the Company’s performance relative to the pre-established performance goals (“Initial PSU Grant”). The number of PSUs that vest at the end of the Performance Period depends on the Company’s performance against the pre-established performance goals. Vested PSUs are converted into shares of the Company’s common stock (“Common Stock”) delivered to the applicable Participant within 60 days following the end of the Performance Period, or such later date as may be elected by the Participant in accordance with Section 409A of the Internal Revenue Code (“Section 409A”).

III.    THE INITIAL PSU GRANT

The C&LD Committee has the sole discretion to establish the target award (“PSP Target”) for each Participant. The PSP Target will be a cash amount and will be the basis for the Initial PSU Grant. The C&LD Committee will make the Initial PSU Grant on the last business date in February (“Grant Date”) following the beginning of each Performance Period. The Initial PSU Grant will set forth a target and maximum number of PSUs. The Initial PSU Grant target will be determined by dividing the PSP Target by the price of the Company’s Common Stock as determined by the Regulations of the Compensation and Leadership Development Committee for the 2009 Plan, rounding to the nearest whole unit. The Initial PSU Grant maximum will be two times the Initial PSU Grant target.

IV. PERFORMANCE CATEGORIES

The PSP Award is based on the Company’s performance in each of the following categories (each a “Performance Category”):

• Organic sales growth (percentile rank in peer group)

• Before-tax operating profit growth

• Core earnings per share (EPS) growth

• Free cash flow productivity

Within the first 90 days of each Performance Period, the C&LD Committee sets three-year performance goals (“Performance Goals”) for each Performance Category for such Performance Period and establishes a sliding scale to measure the Company’s performance against each Performance Goal in each Performance Category. The C&LD Committee uses the sliding scale to establish a payout factor between 0% and 200% for each Performance Category ( a “Sales Factor”, “Profit Factor”, “EPS Factor” and “Cash Flow Factor”, collectively, “Performance Factors”).

In all cases, the C&LD Committee retains the discretion to include or exclude certain of the Performance Categories for purposes of determining the PSP Award. The C&LD Committee may reduce or eliminate any payment if it determines that such payout is inconsistent with long-term shareholders’ interests.

V.     PSU VESTING AND PAYMENT

After the Performance Period is complete, the C&LD Committee will establish the Payout Factors for each of the Performance Categories based on the Company’s results versus the pre-established Performance Goals. The number of PSUs that vest will be determined by multiplying the average of the Performance Factors by the number of PSUs in the Initial PSU Grant target, rounding up to the nearest whole number. The number of PSUs that vest may be equal to, above or below the Initial PSU Grant target depending on the Company’s performance in the Performance Categories, but in no event more than the Initial PSU Grant maximum. Vested PSUs are converted into shares of Common Stock delivered to the applicable Participant within 60 days following the end of the Performance Period, or such later date as may be elected by the Participant in accordance with Section 409A.

VI.     SEPARATION FROM THE COMPANY (Defined terms shall have the meaning designated in the 2009 Plan or related award documents)

• Retirement or Special Separation (less than age 55 and therefore not eligible for regular retirement) prior to payment:

o The Participant must be an active employee through June 30^th of the first year of the Performance Period.

o The PSP Award will vest and be paid according to the terms and conditions set forth herein.

o The Participant must comply with all terms and conditions set forth in the 2009 Plan, including those set forth in Article F.

• Death prior to payment:

o All PSP Awards will vest and be paid to the decedent’s estate according to the terms and conditions set forth herein, and shall be subject to the terms and conditions set forth in the 2009 Plan,

including those set forth in Article F.

• Voluntary resignation or termination for cause:

o If a Participant voluntarily resigns or is terminated for cause prior to the completion of the Performance Period, the PSP Award shall be void.

o If a Participant voluntarily resigns or is terminated for cause after the Performance Period is complete, but prior to payment, the PSP Award shall vest and be paid according to the terms and conditions set forth herein.

o The Participant must comply with all terms and conditions set forth in the 2009 Plan, including those set forth in Article F.

VII.    CHANGE IN CONTROL

Notwithstanding the foregoing, if there is a Change in Control that meets the requirements of a change in control event under Section 409A, all outstanding PSP Awards will vest at 100% of the Initial PSU Grant target (or 100% of the PSP Target if the Change in Control occurs prior to the Initial PSU Grant) and shall be paid in shares of Common Stock at the time of such Change in Control. If there is a Change in Control event that does not meet the requirements of a change in control event under Section 409A, all outstanding PSP Awards will be settled according to the terms and conditions set forth herein, without the application of Article L, Paragraph 4 of the Plan. “Change in Control” shall have the same meaning as defined in the 2009 Plan or any successor stock plan approved in accordance with applicable listing standards.

VIII.    GENERAL TERMS AND CONDITIONS

It shall be understood that the PSP does not give to any officer or employee any contract rights, express or implied, against any Company for any PSP Award, or for compensation in addition to the salary paid to him or her, or any right to question the action of the Board of Directors or the C&LD Committee.

Each PSP Award made to an individual at Band 7 and above is subject to the Senior Executive Recoupment Policy adopted by the C&LD Committee in December 2006.

To the extent applicable, it is intended that the PSP comply with the provisions of Section 409A. The PSP will be administered and interpreted in a manner consistent with this intent. Neither a Participant nor any of a Participant’s creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Section 409A) payable under the PSP to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A, any deferred compensation (within the meaning of Section 409A) payable to a Participant under the PSP may not be reduced by, or offset against, any amount owing by a Participant to the Company.

This program document may be amended at any time by the C&LD Committee.

EX-11

EXHIBIT 11

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

Computation of Earnings Per Share

	Three Months Ended March 31				Nine Months Ended March 31
Amounts in millions except per share amounts	2012		2011		2012		2011
BASIC NET EARNINGS PER SHARE
Net earnings from continuing operations	$	2,377	$	2,826	$	6,992	$	9,129
Preferred dividends, net of tax benefit	$	62	$	51	$	181	$	167
Net earnings from continuing operations available to common shareholders	$	2,315	$	2,775	$	6,811	$	8,962
Net earnings from discontinued operations	$	34	$	47	$	133	$	158
Net earnings available to common shareholders (1)	$	2,349	$	2,822	$	6,944	$	9,120
Basic weighted average common shares outstanding	2,745.8		2,802.2		2,752.8		2,810.5
Basic net earnings per common share - continuing operations	$	0.84	$	0.99	$	2.47	$	3.18
Basic net earnings per common share - discontinued operations	$	0.01	$	0.02	$	0.05	$	0.06
Basic net earnings per common share	$	0.85	$	1.01	$	2.52	3.24
DILUTED NET EARNINGS PER SHARE
Diluted net earnings from continuing operations	$	2,377	$	2,826	$	6,992	$	9,129
Diluted net earnings from discontinued operations	$	34	$	47	$	133	$	158
Diluted net earnings (1)	$	2,411	$	2,873	$	7,125	$	9,287
Basic weighted average common shares outstanding	2,745.8		2,802.2		2,752.8		2,810.5
Add potential effect of:
Conversion of preferred shares	123.4		127.8		124.4		129.1
Exercise of stock options and other Unvested Equity awards	68.6		69.3		67.7		69.0
Diluted weighted average common shares outstanding	2,937.8		2,999.3		2,944.9		3,008.6
Diluted net earnings per common share - continuing operations	$	0.81	$	0.94	$	2.37	$	3.04
Diluted net earnings per common share - discontinued operations	$	0.01	$	0.02	$	0.05	$	0.05
Diluted net earnings per common share	$	0.82	$	0.96	$	2.42	$	3.09

⁽¹⁾ Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble

EX-12

EXHIBIT 12

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES

COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES

	Years Ended June 30										Nine Months Ended March 31
	2011		2010		2009		2008		2007		2012		2011
EARNINGS, AS DEFINED
Earnings from operations before income taxes and after eliminating undistributed earnings of equity method investees	$	15,021	$	14,881	$	14,275	$	14,692	$	13,448	$	9,916	$	11,935
Fixed charges (excluding capitalized interest)	1,052		1,167		1,576		1,640		1,458		763		783
TOTAL EARNINGS, AS DEFINED	$	16,073	$	16,048	$	15,851	$	16,332	$	14,906	$	10,679	$	12,718
FIXED CHARGES, AS DEFINED
Interest expense (including capitalized interest)	$	888	$	1,014	$	1,431	$	1,546	$	1,374	$	643	$	661
1/3 of rental expense	170		176		177		137		124		135		126
TOTAL FIXED CHARGES, AS DEFINED	$	1,058	$	1,190	l,608		$	1,683	$	1,498	$	778	$	787
RATIO OF EARNINGS TO FIXED CHARGES	15.2x		13.5x		9.9x		9.7x		10.0x		13.7x		16.2x

EX-31.1

EXHIBIT 31.1

Rule 13a-14(a)/15d-14(a) Certifications

I, Robert A. McDonald, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ ROBERT A. MCDONALD

(Robert A. McDonald)

Chairman of the Board, President and

Chief Executive Officer

April 27, 2012

Date

EX-31.2

EXHIBIT 31.2

Rule 13a-14(a)/15d-14(a) Certifications

I, Jon R. Moeller, certify that:

(1) I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ JON R. MOELLER

(Jon R. Moeller)

Chief Financial Officer

April 27, 2012

Date

EX-32.1

EXHIBIT 32.1

Section 1350 Certifications

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ ROBERT A. MCDONALD

(Robert A. McDonald)

Chairman of the Board, President and

Chief Executive Officer

April 27, 2012

Date

A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

Section 1350 Certifications

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:

(1) The Quarterly Report on Form 10-Q of the Company for the quarterly period ended March 31, 2012 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.

/s/ JON R. MOELLER

(Jon R. Moeller)

Chief Financial Officer

April 27, 2012

Date

A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Risk Management Activities and Fair Value Measurements - Fair Value (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2012	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 1 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 2 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Fair Value, Inputs, Level 3 [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Portion at Other than Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Foreign Exchange Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Other Foreign Currency Instruments [Member] Portion at Fair Value, Fair Value Disclosure [Member]		Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Interest Rate Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Net Investment Hedging [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Jun. 30, 2011 Fair Value, Measurements, Recurring [Member] Estimate of Fair Value, Fair Value Disclosure [Member] Commodity Contract [Member] Portion at Fair Value, Fair Value Disclosure [Member]	Mar. 31, 2012 Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Real Estate Held-for-sale	$ 8
Impairment of Real Estate	220
Assets, Fair Value Disclosure [Abstract]
Investment securities				11		16																				0		0																		22		23																				33		39
Derivative assets												0	0	0	[1]	0	[1]	0	0	0	0	0	0											11	1	85	[1]	182	[1]	286	163	68	0	10	4									0	0	0	[1]	0	[1]	0	0	0	0	0	0											11	1	85	[1]	182	[1]	286	163	68	0	10	4
Total assets recorded at fair value				11	[2]	16	[2]																			460	[2]	350	[2]																	22	[2]	23	[2]																			493	[2]	389	[2]
Liabilities, Fair Value Disclosure [Abstract]
Derivative liabilities												0	0	0	[1]	0	[1]	0	0	0	0	0	0											116	119	38	[1]	43	[1]	30	0	36	138	8	1									0	0	0	[1]	0	[1]	0	0	0	0	0	0											116	119	38	[1]	43	[1]	30	0	36	138	8	1
Long-term debt instruments								22,658	[3]	22,423	[3]																			1,086	[3]	995	[3]																	0	[3]	0	[3]																			23,744	[3]	23,418	[3]
Liabilities recorded at fair value		22,658	22,423	0	[4]	0	[4]																	1,314	1,296	228	[4]	301	[4]																	0	[4]	0	[4]																	23,972	23,719	228	[4]	301	[4]
Derivative, Net Liability Position, Aggregate Fair Value																																																																																								$ 81

[1] Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.

[2] Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets.

[3] Long-term debt instruments are not recorded at fair value on a recurring basis however are measured at fair value for disclosure purposes.

[4] All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.

XML

New Accoutning Pronouncements and Policies (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Accounting Changes and Error Corrections [Abstract]
Net Income (Loss) Attributable to Noncontrolling Interest	$ 56	$ 33	$ 112	$ 101
Payments of Dividends, Noncontrolling Interest				$ 67

XML

Commitments and Contingencies (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2012
Regulatory Decision Made [Member]
Loss Contingencies [Line Items]
Reserves for potential fines for competition law violations	$ 16
Estimated Obligation [Member]
Loss Contingencies [Line Items]
Reserves for potential fines for competition law violations	$ 19

XML

Segment Information

9 Months Ended

Mar. 31, 2012

Segment Reporting [Abstract]

Segment Information

Segment Information - Effective during the quarter ended December 31, 2011, we implemented a number of changes to the organization structure of the Beauty and Grooming GBU, which resulted in changes to the components of our reportable segment structure. Female blades and razors were formerly included in the Beauty reportable segment and are now included in the Grooming reportable segment. Certain male-focused brands and businesses, such as Old Spice and Gillette personal care, moved from the Grooming reportable segment to the Beauty reportable segment. These changes have been reflected in our segment reporting for all periods presented.

In February 2012, we announced an agreement to divest the Snacks business to The Kellogg Company subject to necessary regulatory approvals. As a result of this transaction the Snacks business is reported as discontinued operations effective with the quarter ended March 31, 2012. Therefore Snacks sales and earnings are no longer included in the results of the continuing operations of the Company. The transaction is expected to close by the end of the current fiscal year. Additionally, as a result of this change, the Pet Care business is now included in the Fabric Care and Home Care segment. These changes have been reflected in our consolidated and segment reporting for all periods presented.

Following is a summary of segment results.

		Three Months Ended March 31									Nine Months Ended March 31
Amounts in millions		Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations			Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations
Beauty	2012	$	4,844		$	710		$	523		$	15,512		$	2,652		$	2,008
	2011	4,814			704			510			14,955			2,836			2,161
Grooming	2012	1,962			530			398			6,332			1,861			1,401
	2011	1,963			580			416			6,103			1,831			1,370
Health Care	2012	3,018			638			411			9,492			2,222			1,490
	2011	2,962			658			427			9,084			2,178			1,453
Fabric Care and Home Care	2012	6,595			1,161			716			20,703			3,643			2,280
	2011	6,548			1,250			789			19,951			3,906			2,533
Baby Care and Family Care	2012	4,153			903			573			12,394			2,511			1,583
	2011	3,968			832			528			11,550			2,383			1,500
Corporate	2012	(378		)	(755		)	(188		)	(965		)	(3,009		)	(1,658		)
	2011	(362		)	(417		)	189			(990		)	(1,266		)	213
Total	2012	20,194			3,187			2,433			63,468			9,880			7,104
	2011	19,893			3,607			2,859			60,653			11,868			9,230

XML

Goodwill and Other Intangible Assets - Identifiable Intangible Assets (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2012
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 35,926
Accumulated Amortization	4,497
INTANGIBLE ASSETS WITH DETERMINABLE LIVES
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	8,880
Accumulated Amortization	4,497
INTANGIBLE ASSETS WITH INDEFINITE LIVES
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 27,046

XML

Goodwill and Other Intangible Assets - Change in the Net Carrying Amount of Goodwill by Global Business Unit (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended
	Mar. 31, 2012
Goodwill [Roll Forward]
GOODWILL, beginning of period	$ 57,562
Acquisitions and divestitures	437
Goodwill, Impairment Loss	(1,330)
Goodwill, Reclassification to Held-for-sale	(95)
Translation and other	(1,741)
GOODWILL, end of period	54,833
BEAUTY
Goodwill [Roll Forward]
GOODWILL, beginning of period	18,039
Acquisitions and divestitures	(2)
Goodwill, Impairment Loss	(431)
Goodwill, Reclassification to Held-for-sale	0
Translation and other	(716)
GOODWILL, end of period	16,890
GROOMING
Goodwill [Roll Forward]
GOODWILL, beginning of period	22,650
Acquisitions and divestitures	(10)
Goodwill, Impairment Loss	(899)
Goodwill, Reclassification to Held-for-sale	0
Translation and other	(643)
GOODWILL, end of period	21,098
HEALTH CARE
Goodwill [Roll Forward]
GOODWILL, beginning of period	8,179
Acquisitions and divestitures	415
Goodwill, Impairment Loss	0
Goodwill, Reclassification to Held-for-sale	0
Translation and other	(194)
GOODWILL, end of period	8,400
FABRIC CARE AND HOME CARE
Goodwill [Roll Forward]
GOODWILL, beginning of period	6,735
Acquisitions and divestitures	34
Goodwill, Impairment Loss	0
Goodwill, Reclassification to Held-for-sale	0
Translation and other	(128)
GOODWILL, end of period	6,641
BABY CARE AND FAMILY CARE
Goodwill [Roll Forward]
GOODWILL, beginning of period	1,553
Acquisitions and divestitures	0
Goodwill, Impairment Loss	0
Goodwill, Reclassification to Held-for-sale	0
Translation and other	(58)
GOODWILL, end of period	1,495
Corporate
Goodwill [Roll Forward]
GOODWILL, beginning of period	406
Acquisitions and divestitures	0
Goodwill, Impairment Loss	0
Goodwill, Reclassification to Held-for-sale	(95)
Translation and other	(2)
GOODWILL, end of period	$ 309

XML

Goodwill and Other Intangible Assets - Additional Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011	Jun. 30, 2011
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss			$ 1,330
Amortization of intangible assets	122	128	373	399
Goodwill	54,833		54,833		57,562
Indefinite-lived Intangible Assets, Impairment Losses			246
Indefinite-lived Intangible Assets, Impairment Losses, Net of Tax			173
Koleston Perfect Trade Name [Member]
Goodwill and Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	308		308
Wella Trade Name [Member]
Goodwill and Intangible Assets [Line Items]
Indefinite-lived Intangible Assets	605		605
Appliances Reporting Units [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss			899
Goodwill	614		614
Salon Professional Reporting Unit [Member]
Goodwill and Intangible Assets [Line Items]
Goodwill, Impairment Loss			431
Goodwill	$ 422		$ 422

XML

Share-Based Compensation (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Share-Based Compensation
Allocated Share-based Compensation Expense	$ 109	$ 115	$ 277	$ 295
Stock Options [Member]
Share-Based Compensation
Allocated Share-based Compensation Expense	86	101	224	254
Other Share-based Awards [Member]
Share-Based Compensation
Allocated Share-based Compensation Expense	$ 23	$ 14	$ 53	$ 41

XML

Comprehensive Income

9 Months Ended

Mar. 31, 2012

Equity [Abstract]

Comprehensive Income

Comprehensive Income - Total comprehensive income is comprised primarily of net earnings, net currency translation gains and losses, impacts of net investment and cash flow hedges, net unrealized gains and losses on investment securities and defined benefit and other retiree benefit plan activities. Total comprehensive income for the three months ended March 31, 2012 and 2011 was $3,778 millionand $4,767 million, respectively. For the nine months ended March 31, 2012 and 2011, total comprehensive income was $4,228 millionand $13,715 million, respectively.

XML

Postretirement Benefits (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended		12 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011	Jun. 30, 2012
Pension Benefits
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Service Cost	$ 62	$ 65	$ 192	$ 191
Interest Cost	149	146	458	430
Expected Return on Plan Assets	(140)	(123)	(428)	(364)
Amortization of Deferred Amounts	6	4	17	13
Recognized Net Actuarial Loss	25	39	77	114
Gross Benefit Cost (Credit)	102	131	316	384
Dividends on ESOP Preferred Stock	0	0	0	0
Net Periodic Benefit Cost (Credit)	102	131	316	384
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected Long-term Return on Assets					7.40%
Other Retiree Benefits
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Service Cost	35	40	106	110
Interest Cost	69	72	207	203
Expected Return on Plan Assets	(109)	(108)	(325)	(323)
Amortization of Deferred Amounts	(5)	(3)	(15)	(13)
Recognized Net Actuarial Loss	25	25	74	72
Gross Benefit Cost (Credit)	15	26	47	49
Dividends on ESOP Preferred Stock	(19)	(20)	(56)	(59)
Net Periodic Benefit Cost (Credit)	$ (4)	$ 6	$ (9)	$ (10)
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected Long-term Return on Assets					9.20%

XML

CONSOLIDATED STATEMENTS OF EARNINGS (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended				9 Months Ended
	Mar. 31, 2012		Mar. 31, 2011		Mar. 31, 2012		Mar. 31, 2011
Net Sales	$ 20,194		$ 19,893		$ 63,468		$ 60,653
Cost of products sold	10,237		9,789		31,894		29,327
Selling, general and administrative expense	6,636		6,399		19,769		19,010
Goodwill and indefinite lived intangibles impairment charges	22		0		1,576		0
Operating Income	3,299		3,705		10,229		12,316
Interest expense	179		202		587		619
Other non-operating income/(expense), net	67		104		238		171
Earnings from conitnuing operations before income taxes	3,187		3,607		9,880		11,868
Income taxes	754		748		2,776		2,638
Net earnings from continuing operations	2,433		2,859		7,104		9,230
Net earnings from discontinued operations	34		47		133		158
Net Earnings	2,467		2,906		7,237		9,388
Less: Net earnings attributable to noncontrolling interests	56		33		112		101
Net Earnings Attributable to Procter & Gamble	$ 2,411		$ 2,873		$ 7,125		$ 9,287
Basic Net Earnings per Common Share
Basic net earnings per common share - earnings from continuing operations	$ 0.84	[1]	$ 0.99	[1]	$ 2.47	[1]	$ 3.18	[1]
Basic net earnings per common share - earnings from discontinued operations	$ 0.01	[1]	$ 0.02	[1]	$ 0.05	[1]	$ 0.06	[1]
Basic net earnings	$ 0.85	[1]	$ 1.01	[1]	$ 2.52	[1]	$ 3.24	[1]
Diluted Net Earnings per Common Share
Diluted net earnings per common share - earnings from conitnuing operations	$ 0.81	[1]	$ 0.94	[1]	$ 2.37	[1]	$ 3.04	[1]
Diluted net earnings per common share - earnings from discontinued operations	$ 0.01	[1]	$ 0.02	[1]	$ 0.05	[1]	$ 0.05	[1]
Diluted net earnings	$ 0.82	[1]	$ 0.96	[1]	$ 2.42	[1]	$ 3.09	[1]
Dividends	$ 0.5250		$ 0.4818		$ 1.5750		$ 1.4454
Diluted Weighted Average Common Shares Outstanding	2,937.8		2,999.3		2,944.9		3,008.6

[1] Basic net earnings per share and diluted net earnings per share are calculated on net earnings attributable to Procter & Gamble

XML

Organization, Consolidation and Presentation of Financial Statements Disclosure

9 Months Ended

Mar. 31, 2012

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure

These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated by the Company’s Form 8-K filed on February 10, 2012. The results of operations for the three-month and nine-month periods ended March 31, 2012, are not necessarily indicative of annual results

XML

Risk Management Activities and Fair Value Measurements - Gains (Losses) on Derivative Instruments (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				9 Months Ended				12 Months Ended
	Mar. 31, 2012		Mar. 31, 2011		Mar. 31, 2012		Mar. 31, 2011		Jun. 30, 2011
Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Derivatives (Effective Portion)					$ 37				$ 50
Amount of Gain (Loss) Reclassified from AOCI into Income	64	[1]	19	[1]	41	[1]	(27)	[1]
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Derivatives (Effective Portion)					12				15
Amount of Gain (Loss) Reclassified from AOCI into Income	2	[1]	1	[1]	5	[1]	5	[1]
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Derivatives (Effective Portion)					25				32
Amount of Gain (Loss) Reclassified from AOCI into Income	60	[1]	17	[1]	33	[1]	(51)	[1]
Cash Flow Hedging [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Derivatives (Effective Portion)					0				3
Amount of Gain (Loss) Reclassified from AOCI into Income	2	[1]	1	[1]	3	[1]	19	[1]
Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	(2)	[2]	2	[2]	(4)	[2]	3	[2]
Fair Value Hedging [Member] | Interest Rate Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	(19)	[2]	(90)	[2]	93	[2]	(115)	[2]
Fair Value Hedging [Member] | Debt [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	17	[2]	92	[2]	(97)	[2]	118	[2]
Net Investment Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in AOCI on Derivatives (Effective Portion)					17				(88)
Amount of Gain (Loss) Recognized in Income	9	[2]	2	[2]	1	[2]	1	[2]
Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	170	[3]	438	[3]	(822)	[3]	1,068	[3]
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	168	[3],[4]	438	[3],[4]	(823)	[3],[4]	1,064	[3],[4]
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain (Loss) Recognized in Income	$ 2	[3]	$ 0	[3]	$ 1	[3]	$ 4	[3]

[1] The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.

[2] The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.

[3] The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.

[4] The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure.

XML

Risk Management Activities and Fair Value Measurements (Tables)

9 Months Ended

Mar. 31, 2012

Risk Management Activities and Fair Value Measurements [Abstract]

Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table

The following table sets forth the Company’s financial assets and liabilities as of March 31, 2012 and June 30, 2011 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy:

	Level 1				Level 2				Level 3				Total
Amounts in millions	March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011
Assets recorded at fair value:
Investment securities	$	11	$	16	$	—	$	—	$	22	$	23	$	33	$	39
Derivatives relating to:
Foreign currency hedges	—		—		11		1		—		—		11		1
Other foreign currency instruments (1)	—		—		85		182		—		—		85		182
Interest rates	—		—		286		163		—		—		286		163
Net investment hedges	—		—		68		—		—		—		68		—
Commodities	—		—		10		4		—		—		10		4
Total assets recorded at fair value (2)	11		16		460		350		22		23		493		389
Liabilities recorded at fair value:
Derivatives relating to:
Foreign currency hedges	—		—		116		119		—		—		116		119
Other foreign currency instruments (1)	—		—		38		43		—		—		38		43
Interest rates	—		—		30		—		—		—		30		—
Net investment hedges	—		—		36		138		—		—		36		138
Commodities	—		—		8		1		—		—		8		1
Liabilities recorded at fair value (3)	—		—		228		301		—		—		228		301
Liabilities not recorded at fair value:
Long-term debt instruments (4)	22,658		22,423		1,086		995		—		—		23,744		23,418
Total liabilities recorded and not recorded at fair value	22,658		22,423		1,314		1,296		—		—		23,972		23,719

(1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.

(2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets.

(3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.

(4) Long-term debt instruments are not recorded at fair value on a recurring basis however are measured at fair value for disclosure purposes.

Schedule of Derivative Instruments

The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2012 and June 30, 2011 are as follows:

	Notional Amount				Fair Value Asset (Liability)
Amounts in Millions	March 31, 2012		June 30, 2011		March 31, 2012			June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	—	$	—	$	—		$	—
Foreign currency contracts	831		831		(105		)	(118		)
Commodity contracts	9		16		—			4
Total	840		847		(105		)	(114		)
Derivatives in Fair Value Hedging Relationships
Interest rate contracts	10,971		10,308		256			163
Derivatives in Net Investment Hedging Relationships
Net investment hedges	1,758		1,540		32			(138		)
Derivatives Not Designated as Hedging Instruments
Foreign currency contracts	11,059		14,957		47			139
Commodity contracts	157		39		2			(1		)
Total	11,216		14,996		49			138

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss)

	Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion)
Amounts in Millions	March 31, 2012		June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	12	$	15
Foreign currency contracts	25		32
Commodity contracts	—		3
Total	37		50
Derivatives in Net Investment Hedging Relationships
Net investment hedges	17		(88		)

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2012 and 2011 are as follows:

	Amount of Gain (Loss) Reclassified from Accumulated OCI into  Income (1)
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	2		$	1		$	5		$	5
Foreign currency contracts	60			17			33			(51		)
Commodity contracts	2			1			3			19
Total	64			19			41			(27		)
	Amount of Gain (Loss) Recognized in Income
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Fair Value Hedging Relationships(2)
Interest rate contracts	(19		)	(90		)	93			(115		)
Debt	17			92			(97		)	118
Total	(2		)	2			(4		)	3
Derivatives in Net Investment Hedging Relationships (2)
Net investment hedges	9			2			1			1
Derivatives Not Designated as Hedging Instruments (3)
Foreign currency contracts (4)	168			438			(823		)	1,064
Commodity contracts	2			—			1			4
Total	170			438			(822		)	1,068

(1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.

(2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.

(3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.

(4) The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure.

XML

Restructuring Program (Details) (USD $)	3 Months Ended		6 Months Ended	9 Months Ended		24 Months Ended	48 Months Ended
	Mar. 31, 2012 employees		Dec. 31, 2011	Mar. 31, 2012 employees		Jun. 30, 2013 employees	Jun. 30, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							$ 3,500,000,000
Restructuring and Related Cost, Expected Number of Positions Eliminated, Percent						10.00%
Restructuring and Related Cost, Expected Number of Positions Eliminated						5,700
Restructuring Charges	518,000,000			686,000,000
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning of period			151,000,000	151,000,000		151,000,000	151,000,000
Charges	518,000,000		168,000,000
Cash spent				239,000,000
Charges against assets				313,000,000
Restructuring accrual, end of period	285,000,000			285,000,000
Restructuring and Related Cost, Number of Positions Eliminated	1,700			2,500
BEAUTY
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	36,000,000			56,000,000
GROOMING
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	9,000,000			11,000,000
HEALTH CARE
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	11,000,000			13,000,000
FABRIC CARE AND HOME CARE
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	79,000,000			98,000,000
BABY CARE AND FAMILY CARE
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	22,000,000			38,000,000
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	361,000,000	[1]		470,000,000	[1]
Selling, General and Administrative Expense [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges				521,000,000
Employee Severance [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning of period			121,000,000	121,000,000		121,000,000	121,000,000
Charges	213,000,000		57,000,000
Cash spent				133,000,000
Charges against assets				0
Restructuring accrual, end of period	258,000,000			258,000,000
Non-manufacturing overhead personnel [Member]
Restructuring Reserve [Roll Forward]
Restructuring and Related Cost, Number of Positions Eliminated	1,200			1,600
Asset-Related Costs [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning of period			0	0		0	0
Charges	265,000,000		48,000,000
Cash spent				0
Charges against assets				313,000,000
Restructuring accrual, end of period	0			0
Other Costs [Member]
Restructuring Reserve [Roll Forward]
Restructuring accrual, beginning of period			30,000,000	30,000,000		30,000,000	30,000,000
Charges	40,000,000		63,000,000
Cash spent				106,000,000
Charges against assets				0
Restructuring accrual, end of period	$ 27,000,000			$ 27,000,000

[1] Corporate includes costs related to allocated overheads, including charges related to our MDO, GBS and Corporate Functions activities.

XML

Discontinued Operations (Tables)

9 Months Ended

Mar. 31, 2012

Discontinued Operations and Disposal Groups [Abstract]

Schedule of Discontinued Operations Disclosures

Following is selected financial information included in net earnings from discontinued operations for the snacks business:

	Three months ended September 30				Three months ended December 31				Three months ended March 31				Nine months ended March 31
Amounts in millions	2011		2010		2011		2010		2012		2011		2012		2011
Net sales	$	387	$	338	$	391	$	371	$	350	$	337	$	1,128	$	1,046
Earnings from discontinued operations before income taxes	84		77		59		73		56		67		199		217
Income tax expense	26		22		18		17		22		20		66		59
Net earnings from discontinued operations	58		55		41		56		34		47		133		158

At March 31, 2012, the major components of assets and liabilities of the snacks business held for sale were as follows:

Amounts in millions	March 31, 2012
Accounts receivable	$	119
Inventories	122
Prepaid expenses and other assets	7
Property, plant and equipment, net	354
Goodwill	95
Total assets held for sale	697
Accrued and other liabilities	55
Total liabilities held for sale	55
Assets held for sale, net	642

XML

New Accounting Pronouncements and Policies

9 Months Ended

Mar. 31, 2012

Accounting Changes and Error Corrections [Abstract]

New Accounting Pronouncements and Policies

New Accounting Pronouncements and Policies- Beginning with the quarter ended December 31, 2011, we elected to revise our Consolidated Statements of Earnings to present separately the net expense for earnings attributable to noncontrolling interests. This change was applied retrospectively. The amount reclassified to net earnings attributable to noncontrolling interests for the nine months ended March 31, 2011, totaling $101 million, had an offsetting impact on other non-operating income/(expense) within the Consolidated Statement of Earnings and on "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. In connection with this change, we also made a change to prior year Consolidated Statement of Cash Flow amounts to appropriately classify dividends paid to noncontrolling interests. Such dividends had historically been included in "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. These dividend payments ($67 million for the nine months ended March 31, 2011) were reclassified to "impact of stock options and other" within Financing Activities of the Consolidated Statement of Cash Flows.

No new accounting pronouncement issued or effective during the fiscal year had or is expected to have a material impact on the Consolidated Financial Statements.

XML

CONSOLIDATED BALANCE SHEETS (USD $) In Millions, unless otherwise specified	Mar. 31, 2012	Jun. 30, 2011
CURRENT ASSETS
Cash and cash equivalents	$ 3,991	$ 2,768
Accounts receivable	6,200	6,275
Inventories
Materials and supplies	1,866	2,153
Work in process	728	717
Finished goods	4,645	4,509
Total inventories	7,239	7,379
Deferred income taxes	1,219	1,140
Prepaid expenses and other current assets	3,817	4,408
Assets held for sale, net	642	0
TOTAL CURRENT ASSETS	23,108	21,970
PROPERTY, PLANT AND EQUIPMENT
Buildings	7,503	7,753
Machinery and equipment	32,154	32,820
Land	897	934
Total property, plant and equipment	40,554	41,507
Accumulated depreciation	(20,170)	(20,214)
NET PROPERTY, PLANT AND EQUIPMENT	20,384	21,293
GOODWILL AND OTHER INTANGIBLE ASSETS
Goodwill	54,833	57,562
Trademarks and other intangible assets, net	31,429	32,620
NET GOODWILL AND OTHER INTANGIBLE ASSETS	86,262	90,182
OTHER NON-CURRENT ASSETS	4,851	4,909
TOTAL ASSETS	134,605	138,354
CURRENT LIABILITIES
Accounts payable	6,684	8,022
Accrued and other liabilities	8,449	9,290
Debt due within one year	11,771	9,981
TOTAL CURRENT LIABILITIES	26,904	27,293
LONG-TERM DEBT	21,341	22,033
DEFERRED INCOME TAXES	11,297	11,070
OTHER NON-CURRENT LIABILITIES	9,154	9,957
TOTAL LIABILITIES	68,696	70,353
SHAREHOLDERS' EQUITY
Preferred stock	1,202	1,234
Common stock - shares issued - 31-Mar 4,008.4 30-Jun 4,007.9	4,008	4,008
Additional paid-in capital	63,068	62,405
Reserve for ESOP debt retirement	(1,356)	(1,357)
Accumulated other comprehensive income (loss)	(5,063)	(2,054)
Treasury stock	(69,918)	(67,278)
Retained earnings	73,324	70,682
Noncontrolling interest	644	361
TOTAL SHAREHOLDERS' EQUITY	65,909	68,001
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	$ 134,605	$ 138,354

XML

New Accounting Pronouncements and Policies (Policies)

9 Months Ended

Mar. 31, 2012

Accounting Changes and Error Corrections [Abstract]

Noncontrolling Interest Policy

Beginning with the quarter ended December 31, 2011, we elected to revise our Consolidated Statements of Earnings to present separately the net expense for earnings attributable to noncontrolling interests. This change was applied retrospectively. The amount reclassified to net earnings attributable to noncontrolling interests for the nine months ended March 31, 2011, totaling $101 million, had an offsetting impact on other non-operating income/(expense) within the Consolidated Statement of Earnings and on "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. In connection with this change, we also made a change to prior year Consolidated Statement of Cash Flow amounts to appropriately classify dividends paid to noncontrolling interests. Such dividends had historically been included in "changes in other operating assets and liabilities" within Operating Activities of the Consolidated Statement of Cash Flows. These dividend payments ($67 million for the nine months ended March 31, 2011) were reclassified to "impact of stock options and other" within Financing Activities of the Consolidated Statement of Cash Flows.

XML

Document and Entity Information	9 Months Ended
	Mar. 31, 2012
Document Information [Line Items]
Entity Registrant Name	PROCTER & GAMBLE CO
Entity Central Index Key	0000080424
Current Fiscal Year End Date	--06-30
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 31, 2012
Document Fiscal Year Focus	2012
Document Fiscal Period Focus	Q3
Amendment Flag	false
Trading Symbol	PG
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Common Stock, Shares Outstanding	2,740,105,964

XML

Segment Information (Tables)

9 Months Ended

Mar. 31, 2012

Segment Reporting [Abstract]

Global Segment Results

Following is a summary of segment results.

		Three Months Ended March 31									Nine Months Ended March 31
Amounts in millions		Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations			Net Sales			Earnings from Continuing Operations Before Income Taxes			Net Earnings from Continuing Operations
Beauty	2012	$	4,844		$	710		$	523		$	15,512		$	2,652		$	2,008
	2011	4,814			704			510			14,955			2,836			2,161
Grooming	2012	1,962			530			398			6,332			1,861			1,401
	2011	1,963			580			416			6,103			1,831			1,370
Health Care	2012	3,018			638			411			9,492			2,222			1,490
	2011	2,962			658			427			9,084			2,178			1,453
Fabric Care and Home Care	2012	6,595			1,161			716			20,703			3,643			2,280
	2011	6,548			1,250			789			19,951			3,906			2,533
Baby Care and Family Care	2012	4,153			903			573			12,394			2,511			1,583
	2011	3,968			832			528			11,550			2,383			1,500
Corporate	2012	(378		)	(755		)	(188		)	(965		)	(3,009		)	(1,658		)
	2011	(362		)	(417		)	189			(990		)	(1,266		)	213
Total	2012	20,194			3,187			2,433			63,468			9,880			7,104
	2011	19,893			3,607			2,859			60,653			11,868			9,230

XML

CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) In Millions, unless otherwise specified	Mar. 31, 2012	Jun. 30, 2011
SHAREHOLDERS' EQUITY
Common stock, shares issued	4,008.4	4,007.9

XML

Postretirement Benefits

9 Months Ended

Mar. 31, 2012

Compensation and Retirement Disclosure [Abstract]

Postretirement Benefits

Postretirement Benefits - The Company offers various postretirement benefits to its employees.

The components of net periodic benefit cost for defined benefit plans are as follows:

	Pension Benefits						Other Retiree Benefits
	Three Months Ended March 31						Three Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	62		$	65		$	35		$	40
Interest cost	149			146			69			72
Expected return on plan assets	(140		)	(123		)	(109		)	(108		)
Amortization of deferred amounts	6			4			(5		)	(3		)
Recognized net actuarial loss	25			39			25			25
Gross benefit cost (credit)	102			131			15			26
Dividends on ESOP preferred stock	—			—			(19		)	(20		)
Net periodic benefit cost (credit)	$	102		$	131		$	(4	)	$	6

	Pension Benefits						Other Retiree Benefits
	Nine Months Ended March 31						Nine Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	192		$	191		$	106		$	110
Interest cost	458			430			207			203
Expected return on plan assets	(428		)	(364		)	(325		)	(323		)
Amortization of deferred amounts	17			13			(15		)	(13		)
Recognized net actuarial loss	77			114			74			72
Gross benefit cost (credit)	316			384			47			49
Dividends on ESOP preferred stock	—			—			(56		)	(59		)
Net periodic benefit cost (credit)	$	316		$	384		$	(9	)	$	(10	)

For the year ending June 30, 2012, the expected return on plan assets is 7.4% and 9.2% for defined benefit and other retiree benefit plans, respectively.

XML

Share-Based Compensation

9 Months Ended

Mar. 31, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Share-Based Compensation - Pursuant to applicable accounting guidance for share-based payments, companies must recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of those awards.

Total share-based compensation for the three months and nine months ended March 31, 2012 and 2011 are summarized in the following table (amounts in millions):

	Three Months Ended March 31				Nine Months Ended March 31
	2012		2011		2012		2011
Share-Based Compensation
Stock options	$	86	$	101	$	224	$	254
Other share-based awards	23		14		53		41
Total share-based compensation	$	109	$	115	$	277	$	295

Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience.

XML

Restructuring Program (Tables)

9 Months Ended

Mar. 31, 2012

Restructuring and Related Activities [Abstract]

Schedule of Restructuring Reserve

The following table presents accrued restructuring activity for the nine months ended March 31, 2012:

							For the Nine Months Ended March 31, 2012
Amounts in millions	Accrual Balance June 30, 2011		Charges Previously Reported (Six Months ended December 31, 2011)		Charges for the Three Months ended March 31, 2012		Cash Spent		Charges Against Assets		Reserve Balance March 31, 2012
Separations	$	121	$	57	$	213	$	133	$	—	$	258
Asset-Related Costs	—		48		265		—		313		—
Other Costs	30		63		40		106		—		27
Total	151		168		518		239		313		285

Schedule of Restructuring Costs

Amounts in millions	Three Months Ended March 31, 2012		Nine Months Ended March 31, 2012
Beauty	$	36	$	56
Grooming	9		11
Health Care	11		13
Fabric & Home Care	79		98
Baby Care and Family Care	22		38
Corporate (1)	361		470
Total Company	518		686

(1) Corporate includes costs related to allocated overheads, including charges related to our MDO, GBS and Corporate Functions activities.

XML

Goodwill and Other Intangible Assets (Tables)

9 Months Ended

Mar. 31, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Change in the Net Carrying Amount of Goodwill by Global Business Unit

Goodwill and Other Intangible Assets - Goodwill as of March 31, 2012, is allocated by reportable segment as follows (amounts in millions):

	Beauty			Grooming			Health Care			Fabric Care and Home Care			Baby Care and Family Care			Corporate			Total Company
GOODWILL at June 30, 2011	$	18,039		$	22,650		$	8,179		$	6,735		$	1,553		$	406		$	57,562
Acquisitions and divestitures	(2		)	(10		)	415			34			—			—			437
Goodwill impairment charges	(431		)	(899		)	—			—			—			—			(1,330		)
Reclassification to held for sale	—			—			—			—			—			(95		)	(95		)
Translation and other	(716		)	(643		)	(194		)	(128		)	(58		)	(2		)	(1,741		)
GOODWILL at March 31, 2012	$	16,890		$	21,098		$	8,400		$	6,641		$	1,495		$	309		$	54,833

Identifiable Intangible Assets

Identifiable intangible assets as of March 31, 2012, are comprised of (amounts in millions):

	Gross Carrying Amount		Accumulated Amortization
Amortizable intangible assets with determinable lives	$	8,880	$	4,497
Intangible assets with indefinite lives	27,046		—
Total identifiable intangible assets	$	35,926	$	4,497

XML

Commitments and Contingencies

9 Months Ended

Mar. 31, 2012

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Litigation

The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark matters, advertising, contracts, environmental issues, labor and employment matters and income taxes.

As previously disclosed, the Company has had a number of antitrust matters in Europe. These matters involve a number of other consumer products companies and/or retail customers. The Company’s policy is to comply with all laws and regulations, including all antitrust and competition laws, and to cooperate with investigations by relevant regulatory authorities, which the Company is doing. Competition and antitrust law inquiries often continue for several years and, if violations are found, can result in substantial fines.

In response to the actions of the regulatory authorities, the Company launched its own internal investigations into potential violations of competition laws. The Company has identified violations in certain European countries and appropriate actions were taken.

Several regulatory authorities in Europe have issued separate decisions pursuant to their investigations alleging that the Company, along with several other companies, engaged in violations of competition laws in those countries. The Company has accrued the assessed fines for each of the decisions, of which all but $16 million has been paid as of March 31, 2012. Most of those decisions are on appeal. As a result of our initial and on-going analyses of other formal complaints, the Company has accrued liabilities for competition law violations totaling $19 million as of March 31, 2012. While the ultimate resolution of the matters for which we have accrued liabilities may result in fines or costs in excess of the amounts reserved, we do not expect any such incremental losses to materially impact our financial statements in the period in which they are accrued and paid, respectively. The remaining authorities' investigations are in various stages of the regulatory process. For these other remaining competition law matters, we cannot reasonably estimate any additional fines to which the Company may be subject as a result of the investigations. We will continue to monitor developments for all of these investigations and will record additional charges as appropriate.

With respect to other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.

We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will have a material adverse effect on our financial position, results of operations or cash flows.

Income Tax Uncertainties

The Company is present in over 150 taxable jurisdictions and, at any point in time, has 50 – 60 audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statute of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2002 and forward. We are generally not able to reliably estimate the ultimate settlement amounts or timing until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions will significantly increase or decrease within the next 12 months related to audits described above. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.

Additional information on the Commitments and Contingencies of the Company can be found in Note 10, Commitments and Contingencies, which appears in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated by the Company’s Form 8-K filed on February 10, 2012.

XML

Risk Management Activities and Fair Value Measurements

9 Months Ended

Mar. 31, 2012

Risk Management Activities and Fair Value Measurements [Abstract]

Risk Management And Fair Value Measurements

Risk Management Activities and Fair Value Measurements- As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices.

For details on the Company’s risk management activities and fair value measurement policies under the fair value hierarchy, refer to the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2011, as updated by the Company’s Form 8-K filed on February 10, 2012.

Fair Value Hierarchy

The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period.

The following table sets forth the Company’s financial assets and liabilities as of March 31, 2012 and June 30, 2011 that are measured at fair value on a recurring basis during the period, segregated by level within the fair value hierarchy:

	Level 1				Level 2				Level 3				Total
Amounts in millions	March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011		March 31, 2012		June 30, 2011
Assets recorded at fair value:
Investment securities	$	11	$	16	$	—	$	—	$	22	$	23	$	33	$	39
Derivatives relating to:
Foreign currency hedges	—		—		11		1		—		—		11		1
Other foreign currency instruments (1)	—		—		85		182		—		—		85		182
Interest rates	—		—		286		163		—		—		286		163
Net investment hedges	—		—		68		—		—		—		68		—
Commodities	—		—		10		4		—		—		10		4
Total assets recorded at fair value (2)	11		16		460		350		22		23		493		389
Liabilities recorded at fair value:
Derivatives relating to:
Foreign currency hedges	—		—		116		119		—		—		116		119
Other foreign currency instruments (1)	—		—		38		43		—		—		38		43
Interest rates	—		—		30		—		—		—		30		—
Net investment hedges	—		—		36		138		—		—		36		138
Commodities	—		—		8		1		—		—		8		1
Liabilities recorded at fair value (3)	—		—		228		301		—		—		228		301
Liabilities not recorded at fair value:
Long-term debt instruments (4)	22,658		22,423		1,086		995		—		—		23,744		23,418
Total liabilities recorded and not recorded at fair value	22,658		22,423		1,314		1,296		—		—		23,972		23,719

(1) Other foreign currency instruments are comprised of foreign currency financial instruments that do not qualify as hedges.

(2) Investment securities are presented in other noncurrent assets and all derivative assets are presented in prepaid expenses and other current assets or other noncurrent assets.

(3) All liabilities are presented in accrued and other liabilities or other noncurrent liabilities.

(4) Long-term debt instruments are not recorded at fair value on a recurring basis however are measured at fair value for disclosure purposes.

The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. In addition, there was no significant activity within the Level 3 assets and liabilities during the periods presented.

Assets and Liabilities Re-measured at Fair Value on a Non-recurring Basis

The Company re-measured operating real estate assets that qualified as held for sale during the quarter at fair value of $8 million using comparable prices for similar assets, incurring a $220 million loss. There were no additional assets or liabilities that were re-measured at fair value on a non-recurring basis during the periods presented, except for the goodwill and intangible assets discussed in Note 5.

Certain of the Company’s financial instruments used in hedging transactions are governed by industry standard netting agreements with counterparties. If the Company’s credit rating were to fall below the levels stipulated in the agreements, the counterparties could demand either collateralization or termination of the arrangement. The aggregate fair value of the instruments covered by these contractual features that are in a net liability position as of March 31, 2012 was $81 million. The Company has never been required to post any collateral as a result of these contractual features.

Fair Values of Other Financial Instruments

Other financial instruments, including cash equivalents, other investments and short-term debt, are recorded at cost, which approximates fair value.

Disclosures about Derivative Instruments

The notional amounts and fair values of qualifying and non-qualifying financial instruments used in hedging transactions as of March 31, 2012 and June 30, 2011 are as follows:

	Notional Amount				Fair Value Asset (Liability)
Amounts in Millions	March 31, 2012		June 30, 2011		March 31, 2012			June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	—	$	—	$	—		$	—
Foreign currency contracts	831		831		(105		)	(118		)
Commodity contracts	9		16		—			4
Total	840		847		(105		)	(114		)
Derivatives in Fair Value Hedging Relationships
Interest rate contracts	10,971		10,308		256			163
Derivatives in Net Investment Hedging Relationships
Net investment hedges	1,758		1,540		32			(138		)
Derivatives Not Designated as Hedging Instruments
Foreign currency contracts	11,059		14,957		47			139
Commodity contracts	157		39		2			(1		)
Total	11,216		14,996		49			138

The total notional amount of contracts outstanding at the end of the period is indicative of the level of the Company’s derivative activity during the period.

	Amount of Gain (Loss) Recognized in Accumulated OCI on Derivatives (Effective Portion)
Amounts in Millions	March 31, 2012		June 30, 2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	12	$	15
Foreign currency contracts	25		32
Commodity contracts	—		3
Total	37		50
Derivatives in Net Investment Hedging Relationships
Net investment hedges	17		(88		)

The effective portion of gains and losses on derivative instruments that was recognized in other comprehensive income (OCI) during the three and nine months ended March 31, 2012 and 2011, was not material. During the next 12 months, the amount of the March 31, 2012 accumulated OCI balance that will be reclassified to earnings is expected to be immaterial.

The amounts of gains and losses on qualifying and non-qualifying financial instruments used in hedging transactions for the three and nine months ended March 31, 2012 and 2011 are as follows:

	Amount of Gain (Loss) Reclassified from Accumulated OCI into  Income (1)
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Cash Flow Hedging Relationships
Interest rate contracts	$	2		$	1		$	5		$	5
Foreign currency contracts	60			17			33			(51		)
Commodity contracts	2			1			3			19
Total	64			19			41			(27		)
	Amount of Gain (Loss) Recognized in Income
	Three Months Ended March 31						Nine Months Ended March 31
Amounts in Millions	2012			2011			2012			2011
Derivatives in Fair Value Hedging Relationships(2)
Interest rate contracts	(19		)	(90		)	93			(115		)
Debt	17			92			(97		)	118
Total	(2		)	2			(4		)	3
Derivatives in Net Investment Hedging Relationships (2)
Net investment hedges	9			2			1			1
Derivatives Not Designated as Hedging Instruments (3)
Foreign currency contracts (4)	168			438			(823		)	1,064
Commodity contracts	2			—			1			4
Total	170			438			(822		)	1,068

(1) The gain or loss on the effective portion of cash flow hedging relationships is reclassified from accumulated OCI into net income in the same period during which the related item affects earnings. Such amounts are included in the Consolidated Statements of Earnings as follows: interest rate contracts in interest expense, foreign currency contracts in selling, general and administrative expense and interest expense and commodity contracts in cost of products sold.

(2) The gain or loss on the ineffective portion of interest rate contracts and net investment hedges, if any, is included in the Consolidated Statements of Earnings in interest expense.

(3) The gain or loss on contracts not designated as hedging instruments is included in the Consolidated Statements of Earnings as follows: foreign currency contracts in selling, general and administrative expense and commodity contracts in cost of products sold.

(4) The gain or loss on non-qualifying foreign currency contracts substantially offsets the foreign currency mark-to-market impact of the related exposure.

XML

Restructuring Program

9 Months Ended

Mar. 31, 2012

Restructuring and Related Activities [Abstract]

Restructuring Program

Restructuring Program

In February 2012, the Company announced a productivity and cost savings plan to reduce costs in the areas of supply chain, research & development, marketing and overheads. The program was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes in order to help fund the Company's growth strategy. The Company expects to incur approximately $3.5 billion in before-tax restructuring costs over a four year period as part of this plan. The Company expects to incur more than half of the costs under this plan by the end of fiscal 2013, with the remainder incurred in fiscal years 2014 and 2015.

The restructuring activities will be executed across the Company's centralized organization as well as the MDO and GBU organizations. These restructuring activities include a plan for a net reduction in non-manufacturing overhead personnel of 10%, or 5,700 separations, by the end of fiscal 2013. This will be done via the elimination of duplicate work, simplification through the use of technology, and the optimization of functional organizations, and business units. In addition, the plan includes integration of newly acquired companies, optimization of the supply chain and other manufacturing processes.

The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. These ongoing activities are included in the $3.5 billion total plan cost and in the productivity and cost savings plan information provided below. Costs incurred under the plan will consist primarily of costs to separate employees and asset-related costs to exit facilities. The Company will also incur other types of costs outlined below as a direct result of the plan. For the nine months ended March 31, 2012, the Company incurred charges of $686 million for this plan. Approximately $521 million of these charges were recorded in selling, general and administrative expense with the remainder in cost of products sold.

The following table presents accrued restructuring activity for the nine months ended March 31, 2012:

							For the Nine Months Ended March 31, 2012
Amounts in millions	Accrual Balance June 30, 2011		Charges Previously Reported (Six Months ended December 31, 2011)		Charges for the Three Months ended March 31, 2012		Cash Spent		Charges Against Assets		Reserve Balance March 31, 2012
Separations	$	121	$	57	$	213	$	133	$	—	$	258
Asset-Related Costs	—		48		265		—		313		—
Other Costs	30		63		40		106		—		27
Total	151		168		518		239		313		285

Separation Costs

Employee separation charges for the three months and nine months ended March 31, 2012 relate to severance packages for approximately 1,700 and 2,500 employees, respectively. Separations related to non-manufacturing overhead personnel were approximately 1,200 and 1,600 for the three and nine months ended March 31, 2012, respectively; these separations occurred primarily in North America and Western Europe. The packages are predominantly voluntary and the amounts are calculated based on salary levels and past service. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer.

Asset-Related Costs

Asset-related costs consist of both asset write downs and accelerated depreciation. Asset write downs relate to the establishment of a new fair value basis for assets held for sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These shortened-lived assets consist primarily of manufacturing consolidations and technology standardization. The asset-related charges will not have a significant impact on future depreciation charges. The majority of asset-related costs for the nine months ended March 31, 2012, are related to the decision to relocate operations from the Company's offices in Kobe, Japan.

Other Costs

Other restructuring-type charges are incurred as a direct result of the productivity and cost savings plan. Such charges primarily include employee relocation related to separations and office consolidations, termination of contracts related to supply chain redesign, and the cost to change internal systems and processes to support the underlying organizational changes.

Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges will be funded by and included within Corporate for segment reporting. Accordingly, 100% of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments.

Amounts in millions	Three Months Ended March 31, 2012		Nine Months Ended March 31, 2012
Beauty	$	36	$	56
Grooming	9		11
Health Care	11		13
Fabric & Home Care	79		98
Baby Care and Family Care	22		38
Corporate (1)	361		470
Total Company	518		686

(1) Corporate includes costs related to allocated overheads, including charges related to our MDO, GBS and Corporate Functions activities.

XML

Discontinued Operations

9 Months Ended

Mar. 31, 2012

Discontinued Operations and Disposal Groups [Abstract]

Discontinued Operations

Discontinued Operations

In February 2012, the Company announced an agreement to sell its global snacks business to The Kellogg Company for $2.7 billion in an all-cash transaction. The Company expects to complete the transaction by the end of the current fiscal year with final timing pending the receipt of necessary regulatory approvals.

The snacks business had historically been part of the Company’s Snacks & Pet Care reportable segment. In accordance with the applicable accounting guidance for the disposal of long-lived assets, the results of the snacks business are presented as discontinued operations and, as such, have been excluded from both continuing operations and segment results for all periods presented. Additionally, the balance sheet positions as of March 31, 2012, that are anticipated to transition to The Kellogg Company are presented as held for sale in the Consolidated Balance Sheet.

Following is selected financial information included in net earnings from discontinued operations for the snacks business:

	Three months ended September 30				Three months ended December 31				Three months ended March 31				Nine months ended March 31
Amounts in millions	2011		2010		2011		2010		2012		2011		2012		2011
Net sales	$	387	$	338	$	391	$	371	$	350	$	337	$	1,128	$	1,046
Earnings from discontinued operations before income taxes	84		77		59		73		56		67		199		217
Income tax expense	26		22		18		17		22		20		66		59
Net earnings from discontinued operations	58		55		41		56		34		47		133		158

At March 31, 2012, the major components of assets and liabilities of the snacks business held for sale were as follows:

Amounts in millions	March 31, 2012
Accounts receivable	$	119
Inventories	122
Prepaid expenses and other assets	7
Property, plant and equipment, net	354
Goodwill	95
Total assets held for sale	697
Accrued and other liabilities	55
Total liabilities held for sale	55
Assets held for sale, net	642

XML

Risk Management Activities and Fair Value Measurements - Derivative Notional Amounts and Fair Value (Details) (USD $) In Millions, unless otherwise specified	Mar. 31, 2012	Jun. 30, 2011
Cash Flow Hedging [Member]
Derivative [Line Items]
Notional amount	$ 840	$ 847
Fair Value Asset (Liability)	(105)	(114)
Cash Flow Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Notional amount	0	0
Fair Value Asset (Liability)	0	0
Cash Flow Hedging [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Notional amount	831	831
Fair Value Asset (Liability)	(105)	(118)
Cash Flow Hedging [Member] | Commodity Contract [Member]
Derivative [Line Items]
Notional amount	9	16
Fair Value Asset (Liability)	0	4
Fair Value Hedging [Member] | Interest Rate Contract [Member]
Derivative [Line Items]
Notional amount	10,971	10,308
Fair Value Asset (Liability)	256	163
Net Investment Hedging [Member]
Derivative [Line Items]
Notional amount	1,758	1,540
Fair Value Asset (Liability)	32	(138)
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Notional amount	11,216	14,996
Fair Value Asset (Liability)	49	138
Not Designated as Hedging Instrument [Member] | Foreign Exchange Contract [Member]
Derivative [Line Items]
Notional amount	11,059	14,957
Fair Value Asset (Liability)	47	139
Not Designated as Hedging Instrument [Member] | Commodity Contract [Member]
Derivative [Line Items]
Notional amount	157	39
Fair Value Asset (Liability)	$ 2	$ (1)

XML

Postretirement Benefits (Tables)

9 Months Ended

Mar. 31, 2012

Compensation and Retirement Disclosure [Abstract]

Components of the Net Periodic Benefit Cost

The components of net periodic benefit cost for defined benefit plans are as follows:

	Pension Benefits						Other Retiree Benefits
	Three Months Ended March 31						Three Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	62		$	65		$	35		$	40
Interest cost	149			146			69			72
Expected return on plan assets	(140		)	(123		)	(109		)	(108		)
Amortization of deferred amounts	6			4			(5		)	(3		)
Recognized net actuarial loss	25			39			25			25
Gross benefit cost (credit)	102			131			15			26
Dividends on ESOP preferred stock	—			—			(19		)	(20		)
Net periodic benefit cost (credit)	$	102		$	131		$	(4	)	$	6

	Pension Benefits						Other Retiree Benefits
	Nine Months Ended March 31						Nine Months Ended March 31
Amounts in millions	2012			2011			2012			2011
Service cost	$	192		$	191		$	106		$	110
Interest cost	458			430			207			203
Expected return on plan assets	(428		)	(364		)	(325		)	(323		)
Amortization of deferred amounts	17			13			(15		)	(13		)
Recognized net actuarial loss	77			114			74			72
Gross benefit cost (credit)	316			384			47			49
Dividends on ESOP preferred stock	—			—			(56		)	(59		)
Net periodic benefit cost (credit)	$	316		$	384		$	(9	)	$	(10	)

XML

Comprehensive Income (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]
Comprehensive Income, Net of Tax, Including Portion Attributable to Noncontrolling Interest	$ 3,778	$ 4,767	$ 4,228	$ 13,715

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	$ 2,768	$ 2,879
OPERATING ACTIVITIES
Net earnings	7,237	9,388
Depreciation and amortization	2,427	2,103
Share-based compensation expense	277	295
Deferred income taxes	(5)	186
(Gain)/loss on sale of businesses	(201)	(70)
Goodwill and indefinite lived intangibles impairment charges	1,576	0
Changes in:
Accounts receivable	(347)	(495)
Inventories	(287)	(817)
Accounts payable, accrued and other liabilities	(1,558)	(223)
Other operating assets and liabilities	131	(831)
Other	61	(84)
TOTAL OPERATING ACTIVITIES	9,311	9,452
INVESTING ACTIVITIES
Capital expenditures	(2,663)	(2,066)
Proceeds from asset sales	290	89
Acquisitions, net of cash acquired	(4)	(489)
Change in investments	90	97
TOTAL INVESTING ACTIVITIES	(2,287)	(2,369)
FINANCING ACTIVITIES
Dividends to shareholders	(4,521)	(4,237)
Change in short-term debt	(122)	(420)
Additions to long-term debt	3,985	1,536
Reductions of long-term debt	(2,514)	(188)
Treasury stock purchases	(4,023)	(4,536)
Impact of stock options and other	1,439	691
TOTAL FINANCING ACTIVITIES	(5,756)	(7,154)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(45)	138
CHANGE IN CASH AND CASH EQUIVALENTS	1,223	67
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 3,991	$ 2,946

XML

Goodwill and Other Intangible Assets

9 Months Ended

Mar. 31, 2012

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Other Intangible Assets

Goodwill and Other Intangible Assets - Goodwill as of March 31, 2012, is allocated by reportable segment as follows (amounts in millions):

	Beauty			Grooming			Health Care			Fabric Care and Home Care			Baby Care and Family Care			Corporate			Total Company
GOODWILL at June 30, 2011	$	18,039		$	22,650		$	8,179		$	6,735		$	1,553		$	406		$	57,562
Acquisitions and divestitures	(2		)	(10		)	415			34			—			—			437
Goodwill impairment charges	(431		)	(899		)	—			—			—			—			(1,330		)
Reclassification to held for sale	—			—			—			—			—			(95		)	(95		)
Translation and other	(716		)	(643		)	(194		)	(128		)	(58		)	(2		)	(1,741		)
GOODWILL at March 31, 2012	$	16,890		$	21,098		$	8,400		$	6,641		$	1,495		$	309		$	54,833

On February 15, 2012, the Company announced an agreement for the sale of the global Snacks business, with an expected closing by the end of the current fiscal year subject to necessary regulatory approvals. As a result, the Snacks goodwill was moved to the Corporate Segment and is included in assets held for sale, net, in accordance with the required held for sale treatment. The Pet Care goodwill was moved to the Fabric Care and Home Care segment for all periods presented.

During the second quarter of fiscal 2012, we changed our annual goodwill impairment testing date from July 1 to October 1 of each year. This change was made to better align the timing of our annual impairment testing with the timing of the Company's annual strategic planning process. We believe this change is preferable because it allows us to more efficiently utilize the reporting units' long-term financial projections, which are generated from the annual strategic planning process, as the basis for performing our annual impairment testing. This change did not result in any delay, acceleration or avoidance of impairment, nor did this change result in adjustments to previously issued financial statements. This change was applied prospectively beginning on October 1, 2011; retrospective application to prior periods was impracticable as the Company was unable to objectively determine, without the use of hindsight, the assumptions that would have been used in those earlier periods. We also test our indefinite lived intangibles for impairment during the second fiscal quarter of each year, and accordingly performed this testing during the quarter ended December 31, 2011.

We tested goodwill for impairment as of July 1, 2011 (the testing date under our previous policy) and no impairments were indicated. Our goodwill impairment testing as of October 1, 2011 (the testing date under our new policy) determined that certain goodwill amounts were impaired. Specifically, the results of our impairment testing during the quarter ended December 31, 2011, indicated that the estimated fair values of our Appliances and Salon Professional reporting units were less than their respective carrying amounts. The test to evaluate goodwill for impairment is a two step process. In the first step, we compare the fair value of each reporting unit to its carrying value. If the fair value of any reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment. The second step of the goodwill impairment evaluations were finalized during the quarter ended March 31, 2012 resulting in no material adjustments to the impairments recorded in the prior quarter. As a result of our impairment testing, we recorded an estimated non cash before and after tax impairment charge of $1,330 million to reduce the carrying amount of goodwill for these units to an estimated fair value of $899 million related to Appliances and $431 million related to Salon Professional. Following the impairment charges, the carrying values of the Appliances and Salon Professional goodwill were $614 million and $422 million, respectively.

Our impairment testing for indefinite lived intangible assets during the quarter ended December 31, 2011, also indicated a decline in the fair value of our Koleston Perfect and Wella trade name intangible assets below their respective carrying values. This resulted in a non cash before tax impairment charge of $246 million ($173 million after tax) to reduce the carrying amounts of these assets to their respective fair values. Following the impairment charges, the carrying values of the Koleston Perfect and Wella trade names were $308 million and $605 million, respectively. All of the impairment charges are included in Corporate for segment reporting.

To determine the fair value of our reporting units and indefinite lived intangibles, we use a discounted cash flow (DCF) approach, which we believe is the most reliable indicator of fair value of the business, and is most consistent with the approach a market-place participant would use. Under this approach, we estimate the future cash flows of the respective reporting units and indefinite lived intangible assets and discount those cash flows at a rate of return that reflects the relative risk of each business.

The declines in the fair value of the Appliances and Salon Professional reporting units and the underlying Koleston Perfect and Wella trade name intangibles were driven by a combination of similar competitive and economic factors, which are resulting in a reduction in the forecasted growth rates and cash flows used to estimate fair value. These factors include: (1) a more prolonged and deeper deterioration of the macroeconomic environment than was previously expected which, due to the more discretionary nature of the Appliances and Salon Professional businesses, is leading to a reduction in the overall market size in the short term and a more significant and prolonged reduction in the expected underlying market growth rates and resulting sales levels in the longer term. This is particularly evident in Europe, which is where we have historically generated a majority of the Appliances and Salon Professional sales; (2) increasing competitive levels of innovation in Salon Professional negatively impacting our current and nearer-term projected market share progress; and (3) an increasing level of competitive pricing activities negatively impacting pricing levels and lowering overall category profitability. As a result of these factors, we have recently reduced our current and longer-term sales and earnings forecasts for these businesses.

The goodwill and intangible asset valuations are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment and margin expansion, and Company business plans. We believe these estimates and assumptions are reasonable. However, actual events and results could differ substantially from those used in our valuation. To the extent such factors result in a failure to achieve the level of projected cash flows used in our valuations, we may need to record additional non cash impairment charges in the future.

Goodwill also decreased from June 30, 2011, due to currency translation across reportable segments and the divestiture of PUR, the water filtration brand, in our Health Care reportable segment. These decreases were partially offset by the establishment of goodwill related to the business combinations with Teva Pharmaceuticals Industries in our Health Care reportable segment and Powermat Ltd. in our Fabric Care and Home Care segment.

Identifiable intangible assets as of March 31, 2012, are comprised of (amounts in millions):

	Gross Carrying Amount		Accumulated Amortization
Amortizable intangible assets with determinable lives	$	8,880	$	4,497
Intangible assets with indefinite lives	27,046		—
Total identifiable intangible assets	$	35,926	$	4,497

Amortizable intangible assets consist principally of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist primarily of brands.

The amortization of intangible assets for the three months ended March 31, 2012 and 2011 was $122 million and $128 million, respectively. For the nine months ended March 31, 2012 and 2011, the amortization of intangible assets was $373 million and $399 million, respectively.

XML

Segment Information (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		9 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011
Segment Reporting Information [Line Items]
Net Sales	$ 20,194	$ 19,893	$ 63,468	$ 60,653
Earnings from conitnuing operations before income taxes	3,187	3,607	9,880	11,868
Net earnings from continuing operations	2,433	2,859	7,104	9,230
BEAUTY
Segment Reporting Information [Line Items]
Net Sales	4,844	4,814	15,512	14,955
Earnings from conitnuing operations before income taxes	710	704	2,652	2,836
Net earnings from continuing operations	523	510	2,008	2,161
GROOMING
Segment Reporting Information [Line Items]
Net Sales	1,962	1,963	6,332	6,103
Earnings from conitnuing operations before income taxes	530	580	1,861	1,831
Net earnings from continuing operations	398	416	1,401	1,370
HEALTH CARE
Segment Reporting Information [Line Items]
Net Sales	3,018	2,962	9,492	9,084
Earnings from conitnuing operations before income taxes	638	658	2,222	2,178
Net earnings from continuing operations	411	427	1,490	1,453
FABRIC CARE AND HOME CARE
Segment Reporting Information [Line Items]
Net Sales	6,595	6,548	20,703	19,951
Earnings from conitnuing operations before income taxes	1,161	1,250	3,643	3,906
Net earnings from continuing operations	716	789	2,280	2,533
BABY CARE AND FAMILY CARE
Segment Reporting Information [Line Items]
Net Sales	4,153	3,968	12,394	11,550
Earnings from conitnuing operations before income taxes	903	832	2,511	2,383
Net earnings from continuing operations	573	528	1,583	1,500
Corporate
Segment Reporting Information [Line Items]
Net Sales	(378)	(362)	(965)	(990)
Earnings from conitnuing operations before income taxes	(755)	(417)	(3,009)	(1,266)
Net earnings from continuing operations	$ (188)	$ 189	$ (1,658)	$ 213

XML

Discontinued Operations (Details) (USD $)	3 Months Ended		9 Months Ended			3 Months Ended						9 Months Ended		1 Months Ended
	Mar. 31, 2012	Mar. 31, 2011	Mar. 31, 2012	Mar. 31, 2011	Jun. 30, 2011	Mar. 31, 2012 Snacks Business Segment [Member]	Dec. 31, 2011 Snacks Business Segment [Member]	Sep. 30, 2011 Snacks Business Segment [Member]	Mar. 31, 2011 Snacks Business Segment [Member]	Dec. 31, 2010 Snacks Business Segment [Member]	Sep. 30, 2010 Snacks Business Segment [Member]	Mar. 31, 2012 Snacks Business Segment [Member]	Mar. 31, 2011 Snacks Business Segment [Member]	Feb. 29, 2012 The Kellogg Company [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Disontinued Operations, Agreed Upon Sale Price														$ 2,700,000,000
Disposal Group, Not Discontinued Operation, Income Statement Disclosures [Abstract]
Net sales						350,000,000	391,000,000	387,000,000	337,000,000	371,000,000	338,000,000	1,128,000,000	1,046,000,000
Earnings from discontinued operations before income taxes						56,000,000	59,000,000	84,000,000	67,000,000	73,000,000	77,000,000	199,000,000	217,000,000
Income tax expense						22,000,000	18,000,000	26,000,000	20,000,000	17,000,000	22,000,000	66,000,000	59,000,000
Net earnings from discontinued operations	34,000,000	47,000,000	133,000,000	158,000,000		34,000,000	41,000,000	58,000,000	47,000,000	56,000,000	55,000,000	133,000,000	158,000,000
Disposal Group, Including Discontinued Operation, Balance Sheet Disclosures [Abstract]
Accounts receivable						119,000,000						119,000,000
Inventories						122,000,000						122,000,000
Prepaid expenses and other assets						7,000,000						7,000,000
Property, plant and equipment, net						354,000,000						354,000,000
Goodwill						95,000,000						95,000,000
Total assets held for sale						697,000,000						697,000,000
Accrued and other liabilities						55,000,000						55,000,000
Total liabilities held for sale						55,000,000						55,000,000
Assets held for sale, net	$ 642,000,000		$ 642,000,000		$ 0	$ 642,000,000						$ 642,000,000

XML

Share-Based Compensation (Tables)

9 Months Ended

Mar. 31, 2012

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Share-Based Compensation

Total share-based compensation for the three months and nine months ended March 31, 2012 and 2011 are summarized in the following table (amounts in millions):

	Three Months Ended March 31				Nine Months Ended March 31
	2012		2011		2012		2011
Share-Based Compensation
Stock options	$	86	$	101	$	224	$	254
Other share-based awards	23		14		53		41
Total share-based compensation	$	109	$	115	$	277	$	295

Assumptions utilized in the model are evaluated and revised, as necessary, to reflect market conditions and experience.